Master author index to volumes 458–482 (2003)

European Journal of Pharmacology www.elsevier.com/locate/ejphar

Master author index to volumes 458–482 (2003) Abdelrahman, A.M. and Pang, C.C.Y. Regional haemodynamic effects of urocortin in the anaesthetized rat (466) 317 Abe, K., Taguchi, K., Kato, M., Utsunomiya, I., Chikuma, T., Hojyo, H. and Miyatake, T. Characterization of muscarinic receptor subtypes in the rostral ventrolateral medulla and effects on morphine-induced antinociception in rats (465) 237 Abe, S., see Yasuda, N. (459) 159 Abe, Y., see Fujii, T. (481) 241 ´ braha´m, C., see Benko A }, I. (477) 179 Abraham, P., see Byrnes-Blake, K.A. (461) 119 Accomazzo, M.R., see Capra, V. (474) 149 Aceto, M.D., see Breivogel, C.S. (459) 139 Adachi, K., Hasegawa, M., Ikeda, H., Sato, M., Koshikawa, N. and Cools, A.R. The superior colliculus contains a discrete region involved in the control of jaw movements: role of GABAA receptors (464) 147 Adachi, K., Hasegawa, M., Fujita, S., Lee, J., Cools, A.R., Waddington, J.L. and Koshikawa, N. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors (473) 47 Adachi, N., see Mitsuyo, T. (465) 267 Adachi-Akahane, S., see Hagiwara, M. (466) 63 Adachi-Akahane, S., see Kobayashi, H. (470) 9 Adan, R.A.H., see Ter Laak, M.P. (462) 179 Adan, R.A.H., see Kas, M.J.H. (480) 13 Adeagbo, A.S.O., Patel, D., Iddrissu, A., Walker, J., Thirumalai, S., Joshua, I.G., Schuschke, D. and Wang, Y. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptormediated contractions of rat aorta: role of endothelium (458) 145 Adeagbo, A.S.O., Joshua, I.G., Falkner, C. and Matheson, P.J. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension (481) 91 Adegunloye, B.J., Su, X., Camper, E.V. and Moreland, R.S. Sensitivity of rabbit aorta and mesenteric artery to norepinephrine: role of tyrosine kinases (476) 201 Adinolfi, B., see Nieri, P. (459) 75 Adkins, E.M., see Rasmussen, S.G.F. (479) 13 Afify, E.A., see El-Mas, M.M. (468) 217 Agil, A., see Horvath, G. (458) 291 Ago, Y., see Sakaue, M. (458) 141 Agrawal, S.M., see McCullumsmith, R.E. (477) 101 Aguiar, M.I.S., see Zapata-Sudo, G. (470) 79 Aiden McCormick, P., see Vandeputte, C. (466) 129 Akaike, A., see Takahata, K. (458) 81 Akaike, A., see Osakada, F. (465) 15 Akaike, A., see Taguchi, R. (477) 195 Akaike, A., see Shimazu, S. (482) 9 Akaishi, E., see Kubohara, Y. (460) 93 Akasofu, S., Kosasa, T., Kimura, M. and Kubota, A. Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen – glucose deprivation (472) 57 Alarco´n de la Lastra, C., see Villegas, I. (460) 209 Alarco´n de la Lastra, C., see Martı´n, A.R. (481) 281 doi:10.1016/S0014-2999(04)00400-5

Albarello, L., see Giaroni, C. (476) 63 Albertini, M., Clement, M.G. and Hussain, S.N.A. Role of endothelin ETA receptors in sepsis-induced mortality, vascular leakage, and tissue injury in rats (474) 129 Albillos, A., see Arroyo, G. (475) 11 Albino de Almeida, A.B., Melo, P.S., Hiruma-Lima, C.A., Gracioso, J.S., Carli, L., Nunes, D.S., Haun, M. and Souza Brito, A.R.M. Antiulcerogenic effect and cytotoxic activity of semi-synthetic crotonin obtained from Croton cajucara Benth. (472) 205 Alborch, E., see Torregrosa, G. (482) 227 Albrecht, J., see Hilgier, W. (468) 21 Aldea, M., see Arroyo, G. (475) 11 Alejandra Hossen, M., see Sugimoto, Y. (470) 113 Alessandro, M., see Serio, R. (460) 183 Alexander, B., see Yang, W. (461) 41 Alexander, S., see Dickenson, J.M. (474) 43 Alexandrenne, C., see Wijkhuisen, A. (468) 175 Alexoff, D., see Gerasimov, M.R. (477) 45 Alguacil, L.F., see Herrado´n, G. (465) 251 Alkana, R.L., see Davies, D.L. (469) 37 Al-Khrasani, M., see Borvendeg, S.J. (474) 71 Allan, A.M., see Carta, M. (459) 167 Allen, P., see Braam, B. (464) 87 Allgaier, C., see Borvendeg, S.J. (474) 71 Alloatti, G., see Bedendi, I. (476) 87 Alloui, A., Begon, S., Chassaing, C., Eschalier, A., Gueux, E., Rayssiguier, Y. and Dubray, C. Does Mg2+ deficiency induce a long-term sensitization of the central nociceptive pathways? (469) 65 Alloui, A., see Ardid, D. (473) 27 Almeida, M.C., Pela´, I.R. and Branco, L.G.S. Fever induced by platelet-derived growth factor, in contrast to fever induced by lipopolysaccharide, depends only on nitric oxide, but not on carbon monoxide pathway (467) 133 Alsasua, A., see Pascual, D. (462) 99 Altar, C.A., see Nakai, S. (472) 89 Altura, B.M., see Su, J. (482) 61 Altura, B.T., see Su, J. (482) 61 Alvarez-Guerra, M., Hannaert, P., Hider, H., Chiavaroli, C. and Garay, R.P. Vascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: antagonism by antioxidants (466) 199 Alvarez-Guerra, M., see Hannaert, P. (466) 207 Alvinerie, M., see Roulet, A. (460) 85 Amano, Y., Nishimoto, T., Tozawa, R.-i., Ishikawa, E., Imura, Y. and Sugiyama, Y. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia (466) 155 Amano, Y., see Nakajima, M. (459) 113 Amara, S.G., see Mortensen, O.V. (479) 159 Ammar, A., see So¨dersten, P. (480) 67 Amobi, N., Guillebaud, J., Kaisary, A., Lloyd-Davies, R.W., Turner, E. and Smith, I.C.H. Contractile actions of imidazoline a-adrenoceptor agonists and effects of noncompetitive a1-adrenoceptor antagonists in human vas deferens (462) 169

2

Master author index to volumes 458 – 482 (2003)

Amobi, N., Guillebaud, J., Kaisary, A., Lloyd-Davies, R.W., Turner, E. and Smith, I.C.H. Corrigendum to ‘‘Contractile actions of imidazoline a-adrenoceptor agonists and effects of noncompetitive a1-adrenoceptor antagonists in human vas deferens’’ [Eur. J. Pharmacol. 462 (2003) 169 – 177] (464) 241 Anai, M., see Fukushima, Y. (468) 47 Anavi-Goffer, S. and Coutts, A.A. Cellular distribution of vanilloid VR1 receptor immunoreactivity in the guinea-pig myenteric plexus (458) 61 Andersen, H.S., see Høy, M. (466) 213 Anderson, J.J., Bradbury, M.J., Giracello, D.R., Chapman, D.F., Holtz, G., Roppe, J., King, C., Cosford, N.D.P. and Varney, M.A. In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine) (473) 35 Andersson, K.-E., see Johansson, R. (476) 221 Anderzhanova, E., see Hilgier, W. (468) 21 Andreadou, I., see Poussios, D. (465) 275 Andre´n, P.E., see Klintenberg, R. (459) 231 Anic, T., see Bedekovic, V. (477) 73 Anning, P.B., see Price, S. (472) 111 Antkiewicz-Michaluk, L., Karolewicz, B., Roman´ska, I., Michaluk, J., Bojarski, A.J. and Vetulani, J. 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain (466) 263 Anto, R.J., see Srinivas, G. (473) 117 Antohe, F., see Manduteanu, I. (477) 269 Antonicelli, F., see Gimonet, D. (482) 25 Antunes, E., see Baracat, J.S. (477) 163 Anzai, N., see Khamdang, S. (465) 1 Aoki, K., Watanabe, K., Sato, M., Ikekita, M., Hakamatsuka, T. and Oikawa, T. Effects of rhizoxin, a microbial angiogenesis inhibitor, on angiogenic endothelial cell functions (459) 131 Aoki, M., see Yatsu, T. (461) 191 Aoki, M., see Itoh, F. (477) 9 Aoun, P., Watson, D.G. and Simpkins, J.W. Neuroprotective effects of PPARg agonists against oxidative insults in HT-22 cells (472) 65 Aoyagi, S., see Itoh, F. (477) 9 Appell, M., see Chen, N. (478) 89 Arago´n, C. and Lo´pez-Corcuera, B. Structure, function and regulation of glycine neurotransporters (479) 249 Arai, I., see Takano, N. (471) 223 Arai, T., see Mitsuyo, T. (465) 267 Araki, H., see Kitamura, Y. (481) 75 Ardid, D., Lamberty, Y., Alloui, A., Coudore-Civiale, M.A., Klitgaard, H. and Eschalier, A. Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats (473) 27 Ardizzoni, A., see de Cupis, A. (473) 83 Arıkan, O., see Bu¨yu¨kafsßar, K. (459) 263 Arita, H., see Tomita, Y. (472) 147 Ark, M., see Bu¨yu¨kafsßar, K. (459) 263 Armijo, J.A., see Cuadrado, A. (465) 43 Armstead, W.M. PTK, ERK and p38 MAPK contribute to impaired NMDA-induced vasodilation after brain injury (474) 249 Aroni, K., see Poussios, D. (465) 275 Arroyo, G., Aldea, M., Fuentealba, J., Albillos, A. and Garcı´a, A.G. SNX482 selectively blocks P/Q Ca2+ channels and delays the inactivation of Na+ channels of chromaffin cells (475) 11 Arsenyan, P., Shestakova, I., Rubina, K., Domracheva, I., Nesterova, A., Vosele, K., Pudova, O. and Lukevics, E. Organoammonium hydroselenites: antitumor action through radical balance regulation (465) 229

Arts, J., see Klintenberg, R. (459) 231 Arulmani, U., see Kapoor, K. (475) 69 Arvidsson, S., see Johansen, J.E. (480) 171 Arvidsson, U., see Salmi, P. (458) 101 Asano, O., see Yasuda, N. (459) 159 Asano, T., see Fukushima, Y. (468) 47 Ashida, Y., see Fukuda, S. (476) 239 Assadi, E., see Zarrindast, M.-R. (471) 105 Astier, B., Lamba´s Sen˜as, L., Soulie`re, F., Schmitt, P., Urbain, N., Rentero, N., Bert, L., Denoroy, L., Renaud, B., Lesourd, M., Mun˜oz, C. and Chouvet, G. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity (459) 17 Atar, D., see Malinin, A.I. (462) 139 Au, A., Louch, W.E., Ferrier, G.R. and Howlett, S.E. L-Arginine ameliorates effects of ischemia and reperfusion in isolated cardiac myocytes (476) 45 Au, A.L.S., Kwan, Y.W., Kwok, C.C., Zhang, R.-Z. and He, G.-W. Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery (468) 199 Au, A.L.S., see Chau, W.H. (464) 177 Au, A.L.S., see Lau, W.H. (470) 45 Awabdy, D., Bryan-Lluka, L.J. and Wanstall, J.C. 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats (459) 1 Axelsson, L.-G., Wallin, B., Gillberg, P.-G., Sjo¨berg, B., So¨derberg, C. and Hellstro¨m, P.M. Regulatory role of 5-HT and muscarinic receptor antagonists on the migrating myoelectric complex in rats (467) 211 Ayada, K., Oguri, S., Yamaguchi, K., Kumagai, K. and Endo, Y. Elevation of histidine decarboxylase activity in the stomach of mice by ulcerogenic drugs (460) 63 Ayalasomayajula, S.P. and Kompella, U.B. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model (458) 283 Azevedo, V., see Carvalho, V.F. (472) 221

Baba, A., see Sakaue, M. (458) 141 Baba, A., see Takahashi, K. (458) 155 Babu, E., see Khamdang, S. (465) 1 Bachrach, U., see Han, B. (474) 15 Backer, M.M., see Weizman, T. (478) 155 Backx, P.H., see Jiang, J. (481) 133 Bacskay, I., see Vecsernyes, M. (470) 177 Badagnani, I., see Mangravite, L.M. (479) 269 Baeyens, J.M., see Horvath, G. (458) 291 Baeyens, J.M., see Moncada, A. (465) 53 Bagcivan, I., see Kilicarslan, H. (462) 155 Bai, C.-X., Sunami, A., Namiki, T., Sawanobori, T. and Furukawa, T. Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes (476) 35 Bai, J.-P., Shi, Y.-L., Fang, X. and Shi, Q.-X. Effects of demethylzeylasteral and celastrol on spermatogenic cell Ca2+ channels and progesterone-induced sperm acrosome reaction (464) 9 Balasubramaniam, A., see Parker, S.L. (474) 31 Baldani-Guerra, B., see Carbonnelle, E. (471) 85 Baldessarini, R.J., see Neumeyer, J.L. (474) 137 Balfago´n, G., see Ferrer, M. (466) 289 Balster, R.L., see Gerasimov, M.R. (477) 45 Balt, J.C., see Nap, A. (469) 117 Banai, Y., see Khare, S. (465) 23 Bandoh, T., see Hayashi, M. (462) 61 Banerjee, B., see Masood, A. (458) 135

Master author index to volumes 458 – 482 (2003) Bani, D., see Vannacci, A. (465) 289 Baracat, J.S., Teixeira, C.E., Okuyama, C.E., Priviero, F.B.M., Faro, R., Antunes, E. and De Nucci, G. Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum (477) 163 Barbe, F., Gautier, E., Bidouard, J.-P., Grosset, A., O’Connor, S.E. and Janiak, P. SL65.0472 blocks 5-hydroxytryptamine-induced vasoconstriction in a dog hindlimb ischemia model (474) 117 Barda, L., see Fride, E. (461) 27 Barenghi, L., see Bradamante, S. (465) 115 Bargas, J., see Barral, J. (462) 91 Barker, E.L., see Roman, D.L. (479) 53 Baronti, R., see Vannacci, A. (465) 289 Barral, J., Mendoza, E., Galarraga, E. and Bargas, J. The presynaptic modulation of corticostriatal afferents by A-opioids is mediated by K+ conductances (462) 91 Barreiro, E.J., see Zapata-Sudo, G. (470) 79 Barrera, D., see Pedraza-Chaverrı´, J. (473) 71 Barreto, E.O., see Carvalho, V.F. (472) 221 Barros, M., Mello Jr., E.L., Maior, R.S., Mu¨ller, C.P., de Souza Silva, M.A., Carey, R.J., Huston, J.P. and Tomaz, C. Anxiolytic-like effects of the selective 5-HT1A receptor antagonist WAY 100635 in non-human primates (482) 197 Bartfai, T., see Wu, W.-P. (482) 133 Bartho´, L., see Benko´, R. (478) 73 Bartoszyk, G.D., van Amsterdam, C., Bo¨ttcher, H. and Seyfried, C.A. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist (473) 229 Basavarajappa, B.S., Saito, M., Cooper, T.B. and Hungund, B.L. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons (466) 73 Batelja, L., see Bedekovic, V. (477) 73 Battastini, A.M.O., see da Silva Torres, I.L. (481) 197 Baumann, M.H., see Rothman, R.B. (479) 23 Ba¨umer, W., Tschernig, T., Su¨lzle, B., Seegers, U., Lu¨hrmann, A. and Kietzmann, M. Effects of cilomilast on dendritic cell function in contact sensitivity and dendritic cell migration through skin (481) 271 Baur, F., see Fozard, J.R. (475) 79 Bauzo, R.M., see Holder, J.R. (462) 41 Baydas, G., Nedzvetskii, V.S., Tuzcu, M., Yasar, A. and Kirichenko, S.V. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E (462) 67 Bazela, K., see Harsch, I.A. (481) 249 Bazzani, C., see Mioni, C. (477) 227 Beak, S.-M., see Soo Lee, Y. (476) 173 Beckmann, N., see Tigani, B. (482) 319 Bedekovic, V., Mise, S., Anic, T., Staresinic, M., Gjurasin, M., Kopljar, M., Kalogjera, L., Drvis, P., Boban Blagaic, A., Batelja, L., Seiwerth, S. and Sikiric, P. Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy (477) 73 Bedendi, I., Alloatti, G., Marcantoni, A., Malan, D., Catapano, F., Ghe´, C., Deghenghi, R., Ghigo, E. and Muccioli, G. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin (476) 87 Bednarek, M.A., see Shearman, L.P. (475) 37 Beemster, P., see Bradamante, S. (465) 115 Beer, B., see Skolnick, P. (461) 99 Beeri, R., see Han, B. (474) 15 Begon, S., see Alloui, A. (469) 65 Beletskaya, I.O., see Breivogel, C.S. (459) 139 Bellasio, S., Nicolussi, E., Bertorelli, R. and Reggiani, A. Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test (482) 127

3

Bellintani, M.C., see Soares, M.B.P. (459) 107 Belogi, L., see Tubaro, E. (467) 173 Belsey, M.J., Culliford, S.J., Morley, R.M., Witchel, H.J. and Kozlowski, R.Z. Newly identified structurally disparate modulators of osmosensitive taurine efflux inhibit cell cycle progression (474) 185 Belzung, C., see Prut, L. (463) 3 Benedek, G., see Horvath, G. (458) 291 Benedetti, G., see Evans, N.M. (466) 31 Benedi, J., see Molina-Jimenez, M.F. (472) 81 Benes, E., see Braam, B. (464) 87 Benhamu´, B., see Pascual, D. (462) 99 Benjamin, I.S., see Yang, W. (461) 41 Benko´, R., La´za´r, Z., Po´rsza´sz, R., Somogyi, G.T., Bartho´, L. Effect of experimental diabetes on cholinergic, purinergic and peptidergic motor responses of the isolated rat bladder to electrical field stimulation or capsaicin (478) 73 ´ braha´m, C., Zsuga, J. and Szilva´ssy, Z. Benko }, I., A Rosiglitazone-induced protection against myelotoxicity produced by 5fluorouracil (477) 179 Benthem, L., see van Dijk, G. (480) 31 Bentley, M.T., see Webster, J.M. (474) 1 Benton, J.P., see Evans, N.M. (466) 31 Benvenuti, F., see Harrison, S. (475) 107 Berendsen, H.H.G. and Kloosterboer, H.J. Oestradiol and mirtazapine restore the disturbed tail-temperature of oestrogen-deficient rats (482) 329 Berens, K., see Onai, Y. (481) 217 Bere˛sewicz, A., see Ma˛czewski, M. (461) 139 Berfield, J.L., see Chen, N. (478) 89 Berg, T. The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats (466) 301 Berger, J.P., see Bruemmer, D. (466) 225 Berger Bu¨ter, K., see Simmen, U. (458) 251 Bergh, C., see So¨dersten, P. (480) 67 Bergman, J., see Yasar, S. (465) 257 Bergman, J., see Neumeyer, J.L. (474) 137 Bermejo, J., see Rivero, A. (482) 77 Berrino, L., see De Novellis, V. (462) 73 Bert, L., see Astier, B. (459) 17 Bertelli, A.A.E., see Bradamante, S. (465) 115 Berti, F., see Rossoni, G. (477) 59 Bertolini, A., see Mioni, C. (477) 227 Bertorelli, R., see Bellasio, S. (482) 127 Bespalov, A., see Sevostianova, N. (462) 109 Bespalov, A., see Semenova, S. (472) 99 Bettelli, E., see Tubaro, E. (467) 173 Beuming, T., see Goldberg, N.R. (479) 3 Bezard, E., see Guillin, O. (480) 89 Bhattacharjee, S., see Qiu, Y. (472) 73 Biala, G., see Kotlinska, J. (474) 233 Bianchi, R., see De Novellis, V. (462) 73 Bidouard, J.-P., Duval, N., Kapui, Z., Herbert, J.-M., O’Connor, S.E. and Janiak, P. SSR69071, an elastase inhibitor, reduces myocardial infarct size following ischemia – reperfusion injury (461) 49 Bidouard, J.-P., see Barbe, F. (474) 117 Bifulco, M., see Harrison, S. (475) 107 Biggio, G., see Dazzi, L. (476) 55 Bilak, M.M., see Thomas, A.G. (471) 177 Bilszta, J.L., see Ritchie, R.H. (461) 171 Birnir, B., see Eghbali, M. (468) 75 Birnir, B., see Smith, M. (478) 21 Bkaily, G., see Eric, J. (475) 129 Bkaily Jr., G.B., see Eric, J. (475) 129

4

Master author index to volumes 458 – 482 (2003)

Black, S.C., see Hildebrandt, A.L. (462) 125 Blackburn-Munro, G. and Jensen, B.S. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain (460) 109 Blackburn-Munro, G., see Erichsen, H.K. (458) 275 Blalock, J.E., see Ten Broeke, R. (476) 151 Blanchard, D.C., Griebel, G. and Blanchard, R.J. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic (463) 97 Blanchard, R.J., see Blanchard, D.C. (463) 97 Blau, H., see Fride, E. (461) 27 Bleau, A.-M., Maurel, P., Pichette, V., Leblond, F. and du Souich, P. Interleukin-1h, interleukin-6, tumour necrosis factor-a and interferon-g released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes (473) 197 Bloch, M., see Weizman, T. (478) 155 Blume, A., see Sandmann, S. (458) 3 Boban Blagaic, A., see Bedekovic, V. (477) 73 Bobirnac, I., see Simmen, U. (458) 251 Bocci, G., Danesi, R., Del Tacca, M. and Kerbel, R.S. Selective anti-endothelial effects of protracted low-dose BAL-9504, a novel geranylgeranyl-transferase inhibitor (477) 17 Bofilis, E., see Sbarouni, E. (467) 163 Bo¨hm, M., see Cremers, B. (467) 169 Bojarski, A.J., see Antkiewicz-Michaluk, L. (466) 263 Bøkenes, J., see Qvigstad, E. (481) 83 Bokvist, K., see Høy, M. (466) 213 Boland, A., Ge´rardy, J., Mossay, D. and Seutin, V. Pre- and post-treatment with pirlindole and dehydropirlindole protects cultured brain cells against nitric oxide-induced death (466) 21 Bo¨lck, B., see Bundkirchen, A. (460) 19 Bo¨lck, B., see Bundkirchen, A. (476) 97 Bollaert, P.-E., see Mansart, A. (475) 61 Bonab, A.A., see Madras, B.K. (479) 41 Bonan, C.D., see da Silva Torres, I.L. (481) 197 Bondarev, M.L., Bondareva, T.S., Young, R. and Glennon, R.A. Behavioral and biochemical investigations of bupropion metabolites (474) 85 Bondareva, T.S., see Bondarev, M.L. (474) 85 Bonifa´cio, M.J., Vieira-Coelho, M.A. and Soares-da-Silva, P. Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor (460) 163 Bonnet, J.-J. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter (479) 199 Boquet, D., see Wijkhuisen, A. (468) 175 Bordet, R., see Six, I. (458) 327 Boros, I., see Rakonczay Jr., Z. (464) 217 Borsodi, A., see Oakley, S.M. (466) 91 Borvendeg, S.J., Al-Khrasani, M., Rubini, P., Fischer, W., Allgaier, C., Wirkner, K., Himmel, H.M., Gillen, C. and Illes, P. Subsensitivity of P2X but not vanilloid 1 receptors in dorsal root ganglia of rats caused by cyclophosphamide cystitis (474) 71 Bose, S., see Evans, N.M. (466) 31 Bo¨ttcher, H., see Bartoszyk, G.D. (473) 229 Boules, M., see Fredrickson, P. (458) 111 Bourin, M. and Hascoe¨t, M. The mouse light/dark box test (463) 55 Bouwknecht, A., see Olivier, B. (463) 117 Bova, S., Cavalli, M., Cima, L., Luciani, S., Saponara, S., Sgaragli, G., Cargnelli, G. and Fusi, F. Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles (470) 185

Braam, B., Allen, P., Benes, E., Koomans, H.A., Navar, L.G. and Hammond, T. Human proximal tubular cell responses to angiotensin II analyzed using DNA microarray (464) 87 Brackett, D.J., see Matsumoto, R.R. (469) 1 Bradaı¨a, A., see Seddik, R. (471) 165 Bradamante, S., Barenghi, L., Piccinini, F., Bertelli, A.A.E., De Jonge, R., Beemster, P. and De Jong, J.W. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism (465) 115 Bradbury, M.J., see Anderson, J.J. (473) 35 Brakkee, J.H., see Ter Laak, M.P. (462) 179 Branco, L.G.S., see Almeida, M.C. (467) 133 Branda˜o, M.L., Troncoso, A.C., De Souza Silva, M.A. and Huston, J.P. The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations (463) 225 Brandhorst, M.C., see Ten Broeke, R. (476) 151 Bratt, A.M., see Kelley, S.P. (461) 19 Bravo, J., see Cuadrado, A. (465) 43 Breivogel, C.S., Scates, S.M., Beletskaya, I.O., Lowery, O.B., Aceto, M.D. and Martin, B.R. The effects of D9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors (459) 139 Breivogel, C.S., see Darmani, N.A. (459) 83 Breschi, M.C., see Nieri, P. (459) 75 Breschi, M.C., see Nieri, P. (475) 115 Bressan, E., see Gavioli, E.C. (471) 21 Bril, A., see Maddock, H.L. (477) 235 Brioni, J.D., see Hsieh, G.C. (458) 183 Bristow, L.J., see Guscott, M.R. (476) 193 Brixius, K., see Bundkirchen, A. (460) 19 Brixius, K., see Bundkirchen, A. (476) 97 Broad, L.M., see Evans, N.M. (466) 31 Broadley, K.J., see Maddock, H.L. (477) 235 Brocco, M., see Millan, M.J. (463) 67 Brodde, O.-E., see Wangemann, T. (458) 163 Brown, D.R., see Townsend IV, D. (482) 111 Brown, J., see Kurokawa, M. (474) 283 Bruemmer, D., Yin, F., Liu, J., Kiyono, T., Fleck, E., Van Herle, A., Graf, K. and Law, R.E. Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells (462) 15 Bruemmer, D., Berger, J.P., Liu, J., Kintscher, U., Wakino, S., Fleck, E., Moller, D.E. and Law, R.E. A non-thiazolidinedione partial peroxisome proliferator-activated receptor g ligand inhibits vascular smooth muscle cell growth (466) 225 Bruins Slot, L.A., Koek, W., Tarayre, J.-P. and Colpaert, F.C. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640 (466) 271 Brunette, E., see Tauskela, J.S. (464) 17 Brussaard, A.B., see Mansvelder, H.D. (480) 117 Bryan-Lluka, L.J., see Awabdy, D. (459) 1 Brzozowski, T., see Konturek, P.C. (472) 213 Brzozowski, T., see Harsch, I.A. (481) 249 Buck, J., see Neudeck, B.L. (467) 81 Bueters, T.J.H., van Duivenvoorde, L.M., Danhof, M., IJzerman, A.P. and van Helden, H.P.M. Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degree (481) 141 Bueters, T.J.H., see Harrison, P.K. (471) 97 Buijs, R.M., see Kreier, F. (480) 51

Master author index to volumes 458 – 482 (2003) Bundkirchen, A., Brixius, K., Bo¨lck, B., Nguyen, Q. and Schwinger, R.H.G. h1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies (460) 19 Bundkirchen, A., Nguyen, Q., Brixius, K., Bo¨lck, B., Mehlhorn, U. and Schwinger, R.H.G. Lack of inverse agonistic activity of nebivolol, its D- and L-enantiomers and of in vivo metabolized nebivolol in human myocardium (476) 97 Burbach, J.P.H., see Smidt, M.P. (480) 75 Burbach, J.P.H., see Vogelaar, C.F. (480) 233 Burcher, E., see Mansfield, K.J. (482) 101 Bu¨rger, E., see Touret, N. (459) 151 Burgermeister, E., Endl, J. and Scheuer, W.V. Activation of cytosolic phospholipase A2 in human T-lymphocytes involves inhibitor-nB and mitogen-activated protein kinases (466) 169 Burguete, M.C., see Torregrosa, G. (482) 227 Burns, D.M., see Kawase, T. (470) 125 Burris, K.D., see Nakai, S. (472) 89 Buschard, K., see Høy, M. (466) 213 Buschauer, A., see Parker, S.L. (474) 31 Butler, R., see Symonds, E. (470) 95 Buwalda, B., see van Dijk, G. (480) 31 ¨ zveren, E. ¨ n, I˙., Ark, M., Arikan, O. and O Bu¨yu¨kafsßar, K., Levent, A., U Mediation of nitric oxide from photosensitive stores in the photorelaxation of the rabbit corpus cavernosum (459) 263 ¨ n, ˙I. Bu¨yu¨kafsßar, K. and U Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice (472) 235 Byrnes-Blake, K.A., Laurenzana, E.M., Carroll, F.I., Abraham, P., Gentry, W.B., Landes, R.D. and Owens, S.M. Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats (461) 119

Caballero-George, C., Vanderheyden, P.M.L., Solis, P.N., Gupta, M.P., Pieters, L., Vauquelin, G. and Vlietinck, A. In vitro effect of sanguinarine alkaloid on binding of [3H]candesartan to the human angiotensin AT1 receptor (458) 257 Cainazzo, M.M., see Mioni, C. (477) 227 Calderone, V., see Nieri, P. (459) 75 Calienni, M., see Spampinato, S. (469) 89 Calixto, J.B., see El Sayah, M. (458) 175 Calixto, J.B., see Lavich, T.R. (462) 185 Calixto, J.B., see Kassuya, C.A.L. (478) 145 Callahan, K.P., see Malinin, A.I. (462) 139 Calvo, D.J., see Goutman, J.D. (461) 79 Camacho, R.E., see Shearman, L.P. (475) 37 Cameron, N.E., see Nangle, M.R. (475) 99 Campana, G., see Loizzo, A. (458) 201 Campbell-Meiklejohn, D., see Gorzalka, B. (471) 129 Camper, E.V., see Adegunloye, B.J. (476) 201 Campiani, G., see Mennini, T. (479) 291 Campos, M., de Lucena Morais, P. and Pupo, A.S. Effects of castration and of testosterone replacement on a1-adrenoceptor subtypes in the rat vas deferens (471) 149 Cannon, K.E., Nalwalk, J.W., Stadel, R., Ge, P., Lawson, D., Silos-Santiago, I. and Hough, L.B. Activation of spinal histamine H3 receptors inhibits mechanical nociception (470) 139 Cansev, M., see Savci, V. (468) 129 Canu-Boido, C., see Carbonnelle, E. (471) 85 Cao, E.-H., see Zhang, Y. (474) 141 Cao, J., see Inoue, M. (461) 207

5

Cao, J., see Kitazawa, T. (469) 135 Cao, J.B., see Li, Y.F. (469) 81 Capasso, A., see Loizzo, A. (458) 201 Capella, C., see Giaroni, C. (476) 63 Capra, V., Habib, A., Accomazzo, M.R., Ravasi, S., Citro, S., Levy-Toledano, S., Nicosia, S. and Rovati, G.E. Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation (474) 149 Capraru, M., see Manduteanu, I. (477) 269 Carageorgiou, H., see Pantos, C. (460) 155 Carageorgiou, H., see Pantos, C. (478) 53 Carai, M.A.M., see Casu, M.A. (459) 97 Caramona, M., see Castel-Branco, M. (482) 163 Carbonnelle, E., Sparatore, F., Canu-Boido, C., Salvagno, C., Baldani-Guerra, B., Terstappen, G., Zwart, R., Vijverberg, H., Clementi, F. and Gotti, C. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes (471) 85 Carcillo, J.A., see Thomas, N.J. (465) 133 Cardillo, G., see Spampinato, S. (469) 89 Carey, R.J., see Barros, M. (482) 197 Cargnelli, G., see Bova, S. (470) 185 Carli, L., see Albino de Almeida, A.B. (472) 205 Carlier, B., see Christophe, B. (470) 87 Caronti, B., see Granata, F. (482) 17 Carpe´ne´, C., see Visentin, V. (466) 235 Carr, M.J., see Stebbins, K.J. (471) 205 Carrasco, G.A. and Van de Kar, L.D. Neuroendocrine pharmacology of stress (463) 235 Carroll, F.I., see Byrnes-Blake, K.A. (461) 119 Carroll, F.I., see Rasmussen, S.G.F. (479) 13 Carta, M., Allan, A.M., Partridge, L.D. and Valenzuela, C.F. Cocaine inhibits 5-HT3 receptor function in neurons from transgenic mice overexpressing the receptor (459) 167 Carter, R.B., see Kaminski, R.M. (474) 217 Carvalho, V.F., Barreto, E.O., Diaz, B.L., Serra, M.F., Azevedo, V., Cordeiro, R.S.B., Martins, M.A. and e Silva, P.M.R. Systemic anaphylaxis is prevented in alloxan-diabetic rats by a mechanism dependent on glucocorticoids (472) 221 Cassar, S., see Yao, B.B. (482) 49 Cassola, A.C., see Picolo, G. (469) 57 Castan˜e´, A., see Ce´le´rier, E. (465) 69 Castel-Branco, M., Lebre, V., Falca˜o, A., Figueiredo, I. and Caramona, M. Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats (482) 163 Castorina, M., Marino, R., Grassi, M. and Drago, F. Very low doses of ethanol induce behavioral changes involving dopamine D2 receptors (477) 129 Casu, M.A., Porcella, A., Ruiu, S., Saba, P., Marchese, G., Carai, M.A.M., Reali, R., Gessa, G.L. and Pani, L. Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract (459) 97 Catalanotti, B., see Mennini, T. (479) 291 Catapano, F., see Bedendi, I. (476) 87 Cavalli, M., see Bova, S. (470) 185 Cavet, M.E., see Lowes, S. (458) 49 Cavicchioni, G., see Spisani, S. (469) 13 Cavun, S., see Savci, V. (468) 129 Ce´le´rier, E., Yazdi, M., Casn˜e´, A., Ghozland, S., Nyberg, F. and Maldonado, R. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice (465) 69 Cenda´n, C.M., see Moncada, A. (465) 53 Ceranowicz, P., see Dembin´ski, A. (473) 207

6

Master author index to volumes 458 – 482 (2003)

Cerda´-Nicola´s, M., see Sala, A. (461) 53 Cerda´-Nicola´s, M., see Njamen, D. (468) 67 Chabot, J.-G., see Juaneda, C. (474) 165 Chaki, S., Kawashima, N., Suzuki, Y., Shimazaki, T. and Okuyama, S. Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents (464) 49 Chaki, S., Ogawa, S.-i., Toda, Y., Funakoshi, T. and Okuyama, S. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents (474) 95 Chan, H.-C., Kuo, S.-C., Huang, L.-J., Liu, C.-H. and Hsu, S.-L. A phenylacetate derivative, SCK6, inhibits cell proliferation via G1 cell cycle arrest and apoptosis (467) 31 Chandrasekhar, B., see Oriowo, M.A. (482) 255 Chang, A.H., see King, M.A. (459) 203 Chang, J., see Levandoski, M.M. (471) 9 Chang, L., Zhao, J., Yang, J., Zhang, Z., Du, J. and Tang, C. Therapeutic effects of ghrelin on endotoxic shock in rats (473) 171 Chapman, A.G., see Moldrich, R.X. (476) 3 Chapman, D.F., see Anderson, J.J. (473) 35 Chapman, V., see Kelly, S. (474) 209 Chassaing, C., see Alloui, A. (469) 65 Chatelain, P., see Christophe, B. (470) 87 Chatelain, P., see Gillard, M. (478) 1 Chatelain, P., see Fuks, B. (478) 11 Chatterjee, P.K., di Villa Bianca, R.D., Sivarajah, A., McDonald, M.C., Cuzzocrea, S. and Thiemermann, C. Pyrrolidine dithiocarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney (482) 271 Chatterjee, P.K., see McDonald, M.C. (466) 181 Chau, W.H., Lee, W.H., Lau, W.H., Kwan, Y.W., Au, A.L.S. and Raymond, K. Role of Na+/H+ exchanger in acetylcholine-mediated pulmonary artery contraction of Spontaneously hypertensive rats (464) 177 Chaudhuri, T., see Maity, S. (470) 103 Che, Y., Rand, M.J. and Li, C.G. Inhibition by ebselen on nitric oxide mediated relaxations in the rat anococcygeus muscle (462) 161 Chebib, M., see Huang, S.H. (464) 1 Chee, K.-M., see Choi, E.J. (482) 281 Chen, A., see Tsao, C.-M. (477) 183 Chen, B.-Y., see Zhang, L.-R. (462) 9 Chen, C.-F., see Chiou, W.-F. (458) 217 Chen, C.-F., see Liao, J.-F. (464) 141 Chen, C.-F., see Shen, Y.-C. (465) 171 Chen, C.-F., see Liou, K.-T. (475) 19 Chen, H.-z., see Qiu, Y. (468) 1 Chen, J., Liu, C. and Lovenberg, T.W. Molecular and pharmacological characterization of the mouse histamine H3 receptor (467) 57 Chen, J., see Zhang, L. (482) 169 Chen, L.-M., see Chen, X.-C. (473) 1 Chen, N., Appell, M., Berfield, J.L. and Reith, M.E.A. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter (478) 89 Chen, N. and Reith, M.E.A. Na+ and the substrate permeation pathway in dopamine transporters (479) 213 Chen, T.-F., see Hsiao, G. (465) 281 Chen, X.-C., Zhu, Y.-G., Zhu, L.-A., Huang, C., Chen, Y., Chen, L.-M., Fang, F., Zhou, Y.-C. and Zhao, C.-H. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress (473) 1 Chen, X.-L., see Kang, J. (458) 25 Chen, Y., see Chen, X.-C. (473) 1 Chen, Y., see Zhang, Y.-H. (481) 301

Chen, Y.-Z., see Lai, Z.-F. (482) 1 Chen, Z., see Zhang, L. (482) 169 Cheng, J.T.Y., see Sam, T.S.W. (472) 135 Cheng, N.-N., see Zhang, L.-R. (462) 9 Cheng, X., Leung, S.W.S., Lim, S.L. and Pang, C.C.Y. Attenuated arterial and venous constriction in conscious rats with streptozotocin-induced diabetes (458) 299 Cheng, X., Cheng, X.S. and Pang, C.C.Y. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats (470) 171 Cheng, X.S., see Cheng, X. (470) 171 Cheng, Y.W., see Hu, C.M. (468) 37 Cheng, Z.J., Finckenberg, P., Louhelainen, M., Merasto, S., Tikkanen, I., Vapaatalo, H. and Mervaala, E.M.A. Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27) (461) 159 Cherchi, G., see Dazzi, L. (476) 55 Chessa, M.L., see Peana, A.T. (460) 37 Chetty, C.S., see Rajgopal, Y. (470) 117 Cheung, D.W. Modulation of spontaneous transient Ca2+-activated K+ channel currents by cADP-ribose in vascular smooth muscle cells (458) 57 Cheung, H.-Y., see Wu, J.-C. (473) 9 Cheung, W.H., see Lau, W.H. (470) 45 Cheung, Y.-F., see Xiao, G.-S. (473) 97 Chiaravalli, A.M., see Giaroni, C. (476) 63 Chiavaroli, C., see Alvarez-Guerra, M. (466) 199 Chiavaroli, C., see Hannaert, P. (466) 207 Chiba, K., see Koriyama, Y. (458) 235 Chiba, S., see Yang, X.-P. (466) 311 Chida, Y., see Hirayama, K. (481) 59 Chikuma, T., see Abe, K. (465) 237 Chiou, W.-F., Yau-Chik Shum, A., Peng, C.-H., Chen, C.-F. and Chou, C.-J. Piperlactam S suppresses macrophage migration by impeding F-actin polymerization and filopodia extension (458) 217 Chiou, W.-F., see Shen, Y.-C. (465) 171 Cho, C.H., Wu, K.K., Wu, S., Wong, T.M., So, W.H.L., Liu, E.S.L., Chu, K.M., Shin, V.Y., Ye, Y.N. and Wong, B.C.Y. Morphine as a drug for stress ulcer prevention and healing in the stomach (460) 177 Choi, E.J., Chee, K.-M. and Lee, B.H. Anti- and prooxidant effects of chronic quercetin administration in rats (482) 281 Choi, H.S., see Lee, Y.S. (465) 191 Choi, S., Lee, J.-H., Kim, Y.I., Kang, M.-J., Rhim, H., Lee, S.-M. and Nah, S.-Y. Effects of ginsenoside on G protein-coupled inwardly rectifying K+ channel activity expressed in Xenopus oocytes (468) 83 Chojnacka-Wo´jcik, E., see WesoJowska, A. (471) 27 Chou, C.-J., see Chiou, W.-F. (458) 217 Chou, C.-Y., see Hsiao, G. (465) 281 Chou, D.-S., see Hsiao, G. (465) 281 Chou, Y.-C., see Shen, Y.-C. (465) 171 Chouvet, G., see Astier, B. (459) 17 Chow, K.B.S., Jones, R.L. and Wise, H. Protein kinase A-dependent coupling of mouse prostacyclin receptors to Gi is cell-type dependent (474) 7 Chow, S.S.M., see Lau, A.H.Y. (464) 229 Christensen, J.K., see Dupuis, D.S. (465) 201 Christophe, B., Carlier, B., Gillard, M., Chatelain, P., Peck, M. and Massingham, R. Histamine H1 receptor antagonism by cetirizine in isolated guinea pig tissues: influence of receptor reserve and dissociation kinetics (470) 87 Christophersen, P., see Dupuis, D.S. (465) 201

Master author index to volumes 458 – 482 (2003) Chu, K.M., see Cho, C.H. (460) 177 Chu, Y., see Stirone, C. (478) 35 Cima, L., see Bova, S. (470) 185 Ciottoli, G.B., see Lacroix, P. (477) 69 Citro, G., see Granata, F. (482) 17 Citro, S., see Capra, V. (474) 149 Civelli, O., see Reinscheid, R.K. (478) 27 Clancy, J., see Qiu, Y. (472) 73 Clark, M.A., see Hurst, R.S. (482) 31 Clarke, H.F., see Guscott, M.R. (476) 193 Cleary, L. and Docherty, J.R. Actions of amphetamine derivatives and cathinone at the noradrenaline transporter (476) 31 Clement, M.G., see Albertini, M. (474) 129 Clementi, F., see Carbonnelle, E. (471) 85 Clifford, J.J., see Wong, J.Y.F. (472) 39 Climent, B., see Garcı´a-Villalo´n, A.L. (459) 247 Climent, B., see Sanz, E. (471) 35 Climent, B., see Martı´nez, M.A. (473) 55 Climent, B., see Ferna´ndez, N. (481) 109 Coccia, C.F., see Thomas, A.G. (471) 177 Coddou, C., Morales, B. and Huidobro-Toro, J.P. Neuromodulator role of zinc and copper during prolonged ATP applications to P2X4 purinoceptors (472) 49 Coghlan, M.J., see Parihar, A.S. (471) 157 Cohen, V., see Fride, E. (461) 27 Coker, S.J., see Farkas, A. (472) 189 Cokkinos, A.D., see Pantos, C. (478) 53 Cokkinos, D., see Pantos, C. (460) 155 Cokkinos, D.D., see Pantos, C. (460) 155 Cokkinos, D.V., see Pantos, C. (478) 53 Collier, D.A. and Li, T. The genetics of schizophrenia: glutamate not dopamine? (480) 177 Collier, L., see Gerasimov, M.R. (477) 45 Collin, M. and Thiemermann, C. The PPAR-g ligand 15-deoxyD12,14 prostaglandin J2 reduces the liver injury in endotoxic shock (476) 257 Colonna, G., see Di Micco, B. (460) 59 Colpaert, F.C., see Bruins Slot, L.A. (466) 271 Colpaert, F.C., see Wu, W.-P. (478) 131 Colvin, R.A., Fontaine, C.P., Laskowski, M. and Thomas, D. Zn2+ transporters and Zn2+ homeostasis in neurons (479) 171 Comas, T., see Tauskela, J.S. (464) 17 Coninx, P., see Gimonet, D. (482) 25 Conrath, M., see Wijkhuisen, A. (468) 175 Cools, A.R., see Adachi, K. (464) 147 Cools, A.R., see Adachi, K. (473) 47 Coop, A., see McMahon, L.R. (466) 113 Coop, A., see Lamb, R.J. (470) 157 Cooper, E.J., Hudson, A.L., Parker, C.A. and Morgan, N.G. Effects of the h-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans (482) 189 Cooper, T.B., see Basavarajappa, B.S. (466) 73 Cordeiro, R.S.B., see Lavich, T.R. (462) 185 Cordeiro, R.S.B., see Carvalho, V.F. (472) 221 Cornish, J.L., see Norwood, C.S. (465) 105 Cornish, J.L., Shahnawaz, Z., Thompson, M.R., Wong, S., Morley, K.C., Hunt, G.E. and McGregor, I.S. Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats (482) 339 Correa, S.A.A., see Francßa, L.P. (476) 25 Correia-de-Sa´, P., see Timo´teo, M.A. (464) 115 Corse, A.M., see Thomas, A.G. (471) 177 Corsi, C., Pinna, A., Gianfriddo, M., Melani, A., Morelli, M. and Pedata, F. Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats (464) 33 Cosford, N.D.P., see Anderson, J.J. (473) 35

7

Cossu, M., see D’Aquila, P.S. (458) 129 Cossu, M., see D’Aquila, P.S. (460) 71 Cotter, M.A., see Nangle, M.R. (475) 99 Coudore-Civiale, M.A., see Ardid, D. (473) 27 Counillon, L., see Touret, N. (459) 151 Couraud, J.-Y., see Wijkhuisen, A. (468) 175 Coutts, A.A., see Anavi-Goffer, S. (458) 61 Covington III, H.E. and Miczek, K.A. Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress (467) 1 Cowell, S.M., see Okura, T. (459) 9 Cowley, M.A. Hypothalamic melanocortin neurons integrate signals of energy state (480) 3 Craig, E., see Qiu, Y. (472) 73 Craig, P.J., see Evans, N.M. (466) 31 Creaven, B., see Finn, G. (481) 159 Creed, K.E., see Yunoki, T. (482) 287 Crema, L., see da Silva Torres, I.L. (481) 197 Cremers, B., Schmidt, K.I., Maack, C., Scha¨fers, H.-J. and Bo¨hm, M. Catecholamine release in human heart by bupropion (467) 169 Cre´minon, C., see Wijkhuisen, A. (468) 175 Crenesse, D., Laurens, M., Heurteaux, C., Cursio, R., Saint-Paul, M.C., Schmid-Alliana, A. and Gugenheim, J. Rat liver ischemia – reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment (473) 177 Crim, J.L., see Darmani, N.A. (459) 83 Crumb, W.J., see Lacroix, P. (477) 69 Cruz, J.W.M.C., see Zanardo, R.C.O. (478) 211 Cruz, S.L., see Herna´ndez-Delgadillo, G.P. (469) 71 Csonka, C., see Csont, T. (476) 107 Csont, T., Csonka, C., Kova´cs, P., Jancso´, G. and Ferdinandy, P. Capsaicin-sensitive sensory neurons regulate myocardial nitric oxide and cGMP signaling (476) 107 Cuadrado, A., Bravo, J. and Armijo, J.A. Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice (465) 43 Cui, P., see Kitamura, H. (465) 31 Culliford, S.J., see Belsey, M.J. (474) 185 Cursio, R., see Crenesse, D. (473) 177 Cury, Y., see Zanchet, E.M. (467) 111 Cury, Y., see Picolo, G. (469) 57 Cuzzocrea, S., see McDonald, M.C. (466) 181 Cuzzocrea, S., see Chatterjee, P.K. (482) 271 Czarnecki, J., see Konturek, S.J. (481) 1 Czepiel, K., see Filip, M. (459) 239 Da Silva, F.R., Lazzarini, R., de Sa´-Rocha, L.C., Morgulis, M.S.F.A., de Oliveira Massoco, C. and Palermo-Neto, J. Effects of acute and long-term diazepam administrations on neutrophil activity: a flow cytometric study (478) 97 Da Silva Torres, I.L., Bonan, C.D., Crema, L., De Leon Nunes, M., Battastini, A.M.O., Sarkis, J.J.F., Dalmaz, C. and Ferreira, M.B.C. Effect of drugs active at adenosine receptors upon chronic stressinduced hyperalgesia in rats (481) 197 Dahchour, A. and De Witte, P. Excitatory and inhibitory amino acid changes during repeated episodes of ethanol withdrawal: an in vivo microdialysis study (459) 171 Dalby, N.O. Inhibition of g-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures (479) 127 Dalmaz, C., see da Silva Torres, I.L. (481) 197 Da¨mmgen, J., see Touret, N. (459) 151 Danesi, R., see Bocci, G. (477) 17 Danhof, M., see Bueters, T.J.H. (481) 141

8

Master author index to volumes 458 – 482 (2003)

Daniels, S., see Hadipour-Jahromy, M. (477) 81 Danysz, W., see Sevostianova, N. (462) 109 Danysz, W., see Lo¨scher, W. (466) 99 D’Aquila, P.S., Peana, A.T., Panin, F., Grixoni, C., Cossu, M. and Serra, G. Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal (458) 129 D’Aquila, P.S., Panin, F., Cossu, M., Peana, A.T. and Serra, G. Dopamine D1 receptor agonists induce penile erections in rats (460) 71 D’Aquila, P.S., see Peana, A.T. (460) 37 Darmani, N.A., Sim-Selley, L.J., Martin, B.R., Janoyan, J.J., Crim, J.L., Parekh, B. and Breivogel, C.S. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation (459) 83 Darpolar, M., see Wu, H.-e. (473) 143 Darvesh, A.S. and Gudelsky, G.A. Activation of 5-HT2 receptors induces glycogenolysis in the rat brain (464) 135 Das, P.K., see Maity, S. (470) 103 DaSilva, J.N., see Schwartz, R.A. (459) 195 Datta, N., see Maity, S. (470) 103 Davies, D.L. and Alkana, R.L. Benzodiazepine agonist and inverse agonist coupling in GABAA receptors antagonized by increased atmospheric pressure (469) 37 Davis, M., see Walker, D.L. (463) 199 Dazzi, L., Seu, E., Cherchi, G. and Biggio, G. Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine (476) 55 De Backer, W.A., see van Overveld, F.J. (477) 261 De Blasi, A., see Granata, F. (482) 17 De Boer, S.F. and Koolhaas, J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology (463) 145 De Boer, S.F., see Mechiel Korte, S. (463) 163 De Clerck, F., see Ten Broeke, R. (476) 151 De Cupis, A., Semino, C., Pirani, P., Loprevite, M., Ardizzoni, A. and Favoni, R.E. Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines (473) 83 De Groote, L., Olivier, B. and Westenberg, H.G.M. Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice (476) 71 De Jong, J.W., see Bradamante, S. (465) 115 De Jonge, R., see Bradamante, S. (465) 115 De Jongh, R., see Groenink, L. (463) 185 De La Garza, R., see Madras, B.K. (479) 41 De Leon Nunes, M., see da Silva Torres, I.L. (481) 197 De Lima, T.C.M., see Gavioli, E.C. (471) 21 De Lucca, F.L., see Watanabe, M.A.E. (465) 205 De Lucena Morais, P., see Campos, M. (471) 149 De Novellis, V., Marabese, I., Palazzo, E., Rossi, F., Berrino, L., Rodella, L., Bianchi, R., Rossi, F. and Maione, S. Group I metabotropic glutamate receptors modulate glutamate and gaminobutyric acid release in the periaqueductal grey of rats (462) 73 De Nucci, G., see Baracat, J.S. (477) 163 De Oliveira, M.Ap., see Zanardo, R.C.O. (478) 211 De Oliveira Massoco, C., see da Silva, F.R. (478) 97 De Petrocellis, L., see Harrison, S. (475) 107 De Rover, M., see Mansvelder, H.D. (480) 117 De Sa´-Rocha, L.C., see da Silva, F.R. (478) 97 De Sarro, G., see Moldrich, R.X. (476) 3 De Souza Silva, M.A., see Branda˜o, M.L. (463) 225 De Souza Silva, M.A., see Barros, M. (482) 197 De Vries, K., see van Dijk, G. (480) 31 De Vry, J., see Hofmann, H.A. (470) 17 De Witte, P., see Dahchour, A. (459) 171

Debey, S., Kirchrath, L., Schro¨r, K. and Meyer-Kirchrath, J. Iloprost down-regulates the expression of the growth regulatory gene Cyr61 in human vascular smooth muscle cells (474) 161 De´ciga-Campos, M., Lo´pez, U.G., Reval, Ma.I.D. and Lo´pez-Mun˜oz, F.J. Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats (460) 99 Deepa, P.R. and Varalakshmi, P. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity (478) 199 Deghenghi, R., see Bedendi, I. (476) 87 Dehghani, M., see Sadeghipour, H. (460) 201 Dehpour, A.R., see Sadeghipour, H. (460) 201 Dehpour, A.R., see Mehr, S.E. (467) 205 Del Pozo, E., see Moncada, A. (465) 53 Del Soldato, P., see Rossoni, G. (477) 59 Del Soldato, P., see Gaita´n, G. (481) 181 Del Tacca, M., see Bocci, G. (477) 17 Dembin´ski, A., Dembin´ski, M., Pabian´czyk, M., Stachura, J. and Konturek, S.J. Ischemic preconditioning reduces the severity of ischemia/reperfusioninduced pancreatitis (473) 207 Dembin´ski, M., see Dembin´ski, A. (473) 207 ¨ . (458) 171 Demiryu¨rek, A.T., see Uzun, O Demiryu¨rek, A.T., see So¨ylemez, S. (464) 163 Demkow, U.A., see van Overveld, F.J. (477) 261 D’Emmanuele di Villa Bianca, R., see McDonald, M.C. (466) 181 Denoroy, L., see Astier, B. (459) 17 Denzer, D., see Hofmann, H.A. (470) 17 Der, P., see Vecsernyes, M. (470) 177 Deshpande, S.B., see Jha, A. (481) 189 Dhawan, B.N., see Kumar, R. (462) 133 Di Leo, F., see Nicosia, A. (469) 103 Di Marzo, V., see Harrison, S. (475) 107 Di Marzo, V., see van der Stelt, M. (480) 133 Di Micco, B., Colonna, G., Di Micco, P., Di Micco, G., Russo, B.M., Macalello, M.A. and Ragone, R. Anti-thrombin action of low-dose acetylsalicylic acid (460) 59 Di Micco, G., see Di Micco, B. (460) 59 Di Micco, P., see Di Micco, B. (460) 59 Di Padova, F., see Tigani, B. (482) 319 Di Villa Bianca, R.D., see Chatterjee, P.K. (482) 271 Diaz, B.L., see Carvalho, V.F. (472) 221 Diaz, J., see Guillin, O. (480) 89 Dickenson, J.M., Reeder, S., Rees, B., Alexander, S. and Kendall, D. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106 (474) 43 Die´guez, G., see Garı´a-Villalo´n, A.L. (459) 247 Die´guez, G., see Sanz, E. (471) 35 Die´guez, G., see Marı´nez, M.A. (473) 55 Die´guez, G., see Ferna´ndez, N. (481) 109 Dieterich, M., see Rothermund, L. (468) 209 Dimitrijevic, N., see Satta, R. (473) 149 Ding, J., see Tan, W.-f. (459) 255 Diniz, C., Leal, S. and Goncßalves, J. Regional differences in the adenosine A2 receptor-mediated modulation of contractions in rat vas deferens (460) 191 Dinn, A.E., see Lenkowski, P.W. (467) 23 Dirks, A., see Groenink, L. (463) 185 Dixon, R., see Onai, Y. (481) 217 Djazayeri, K., see Benko }, I. (477) 179 Dobos, I., see Horvath, G. (458) 291 Dobrev, D. and Ravens, U. Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum (461) 105 Docherty, J.R., see Vandeputte, C. (466) 129 Docherty, J.R., see Cleary, L. (476) 31

Master author index to volumes 458 – 482 (2003) Dohi, T., see Kitayama, S. (479) 65 Doi, Y., see Kitaichi, K. (464) 39 Domı´nguez, J.N., see Rojas, J. (465) 183 Dominioni, L., see Giaroni, C. (476) 63 Domracheva, I., see Arsenyan, P. (465) 229 Don˜ate-Oliver, F., see Goutman, J.D. (461) 79 Donsante, S., see Granata, F. (482) 17 Doods, H., see Kapoor, K. (475) 69 Doroshenko, N. and Doroshenko, P. Ion dependence of cytotoxicity of carmustine against PC12 cells (476) 185 Doroshenko, P., see Doroshenko, N. (476) 185 Drag, M., see Roulet, A. (460) 85 Drago, F., see Nicosia, A. (469) 103 Drago, F., see Castorina, M. (477) 129 Drago, F., see Mazzola, C. (477) 219 Drago, J., see Wong, J.Y.F. (472) 39 Dragomir, E., see Manduteanu, I. (477) 269 Drvis, P., see Bedekovic, V. (477) 73 Du, J., see Chang, L. (473) 171 Du Souich, P., see Bleau, A.-M. (473) 197 Duarte, A.I., see Monteiro, P. (482) 245 Duarte, F.S., see Gavioli, E.C. (471) 21 Dubray, C., see Alloui, A. (469) 65 Duckles, S.P., see Stirone, C. (478) 35 Duda, E., see Rakonczay Jr., Z. (464) 217 Dugina, T.N., Kiseleva, E.V., Glusa, E. and Strukova, S.M. Activation of mast cells induced by agonists of proteinase-activated receptors under normal conditions and during acute inflammation in rats (471) 141 Duiker, N.J., see Lamb, R.J. (470) 157 Duke, R.K., see Huang, S.H. (464) 1 Dumont, Y., see Juaneda, C. (474) 165 Dunlop, J., see Zhang, J.Y. (472) 33 Dunn, B., see Nakai, S. (472) 89 Dunn III, W., see Wu, H.-e. (473) 143 Dupuis, D.S., Schrøder, R.L., Jespersen, T., Christensen, J.K., Christophersen, P., Jensen, B.S. and Olesen, S.P. Corrigendum to ‘‘Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352’’ [Eur. J. Pharmacol. 437 (2002) 129 – 137] (465) 201 Durando, L., see Lacroix, P. (477) 69 Dusting, G.J., see Ritchie, R.H. (461) 171 Dutta, A.K., Zhang, S., Kolhatkar, R. and Reith, M.E.A. Dopamine transporter as target for drug development of cocaine dependence medications (479) 93 Duval, N., see Bidouard, J.-P. (461) 49 Dylag, T., see Kotlinska, J. (474) 233

E Silva, P.M.R., see Lavich, T.R. (462) 185 E Silva, P.M.R., see Carvalho, V.F. (472) 221 Easton, A., see Mong, J. (480) 229 Ebenezer, I.S. The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis (461) 113 ´. (467) 49 Ebert, B., see Sto´rustovu, S.ı. Ebert, B., see Mortensen, M. (476) 17 Ebert, B., see Voss, J. (482) 215 Ecarnot-Laubriet, A., see Oudot, A. (462) 145 Edvinsson, L., see Malmsjo¨, M. (458) 305 Edvinsson, L., see Jansen-Olesen, I. (481) 207 Edvinsson, L., see Uddman, E. (482) 39 Edwards, S.R. and Mather, L.E. Alfentanil potentiates anaesthetic and electroencephalographic responses to ketamine in the rat (460) 27

9

Egan, D., see Finn, G. (481) 159 Eghbali, M., Gage, P.W. and Birnir, B. Effects of propofol on GABAA channel conductance in rat-cultured hippocampal neurons (468) 75 Egi, Y., see Nakajima, M. (459) 113 Egido, E.M., see Silvestre, R.A. (469) 195 Eidi, A., see Eidi, M. (465) 91 Eidi, A., see Oryan, S. (477) 123 Eidi, A., see Eidi, M. (478) 105 Eidi, M., Zarrindast, M.-R., Eidi, A., Oryan, S. and Parivar, K. Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats (465) 91 Eidi, M., Oryan, S., Eidi, A. and Sepehrara, L. Effect of morphine, naloxone and histamine system on water intake in adult male rats (478) 105 Eidi, M., see Oryan, S. (477) 123 Eiroa, J.L., see Rivero, A. (482) 77 El Sayah, M. and Calixto, J.B. Study of the mechanisms involved in the bradykinin-induced contraction of the pig iris sphincter muscle in vitro (458) 175 Elimadi, A., Jullien, V., Tillement, J.-P. and Morin, D. S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties (468) 93 Ellis, J.L., see Stebbins, K.J. (471) 205 El-Mahmoudy, A., see Thapaliya, S. (461) 129 El-Mas, M.M., Afify, E.A., Omar, A.G., Mohy El-Din, M.M. and Sharabi, F.M. Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations (468) 217 Emmerson, P.J., see Statnick, M.A. (482) 139 Emri, Z., see Nyitrai, G. (478) 111 Endl, J., see Burgermeister, E. (466) 169 Endo, Y., see Ayada, K. (460) 63 Endou, H., see Khamdang, S. (465) 1 Endou, H., see Enomoto, A. (466) 13 Engel, J.A., see Ericson, M. (467) 85 Engel, U., see Jansen-Olesen, I. (481) 207 Enomoto, A., Takeda, M., Taki, K., Takayama, F., Noshiro, R., Niwa, T. and Endou, H. Interactions of human organic anion as well as cation transporters with indoxyl sulfate (466) 13 Enomoto, A., see Khamdang, S. (465) 1 Enzan, H., see Okatani, Y. (465) 163 Enzan, H., see Okatani, Y. (469) 145 Eric, J., Bkaily, G., Bkaily Jr., G.B., Volkov, L., Gabra, B.H. and Sirois, P. Des-Arg9-bradykinin increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized and -challenged mice (475) 129 Erichsen, H.K., Hao, J.-X., Xu, X.-J. and Blackburn-Munro, G. A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain (458) 275 Ericson, M., Molander, A., Lo¨f, E., Engel, J.A. and So¨derpalm, B. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors (467) 85 Erlinge, D., see Malmsjo¨, M. (458) 305 Esbenshade, T.A., see Yao, B.B. (482) 49 Eschalier, A., see Alloui, A. (469) 65 Eschalier, A., see Ardid, D. (473) 27 Eskesen, K., see Uddman, E. (482) 39 Este´vez, F., see Rivero, A. (482) 77 Evans, N.M., Bose, S., Benedetti, G., Zwart, R., Pearson, K.H., McPhie, G.I., Craig, P.J., Benton, J.P., Volsen, S.G., Sher, E. and Broad, L.M. Expression and functional characterisation of a human chimeric nicotinic receptor with a6h4 properties (466) 31

10

Master author index to volumes 458 – 482 (2003)

Evans, S.M. and Whittle, B.J.R. Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat (461) 63 Evans, T.W., see Price, S. (472) 111 Evans, T.W., see Stanford, S.J. (473) 135

Facer, P., see Hagner, S. (481) 147 Fahey, M.A., see Madras, B.K. (479) 41 Faigenboim, M., see Fride, E. (461) 27 Falca˜o, A., see Castel-Branco, M. (482) 163 Falkner, C., see Adeagbo, A.S.O. (481) 91 Falter, U., see Lamberty, Y. (469) 97 Falter, U., see Gower, A.J. (481) 67 Falzarano, S., see Spisani, S. (469) 13 Fan, Y., Wu, D.-Z., Gong, Y.-Q., Zhou, J.-Y. and Hu, Z.-B. Effects of calycosin on the impairment of barrier function induced by hypoxia in human umbilical vein endothelial cells (481) 33 Fang, F., see Chen, X.-C. (473) 1 Fang, X., see Bai, J.-P. (464) 9 Fanselow, M.S., see Sanders, M.J. (463) 217 Farges, R.C., see Gavioli, E.C. (471) 21 Faria, M., see Timo´teo, M.A. (464) 115 Farkas, A. and Coker, S.J. Prevention of clofilium-induced torsade de pointes by prostaglandin E2 does not involve ATP-dependent K+ channels (472) 189 Farmer, M.R., see Ralevic, V. (460) 145 Faro, R., see Baracat, J.S. (477) 163 Fattorusso, C., see Mennini, T. (479) 291 Favoni, R.E., see de Cupis, A. (473) 83 Feher, P., see Vecsernyes, M. (470) 177 Fehlmann, D., see Nunn, C. (465) 211 Feighner, S.D., see Shearman, L.P. (475) 37 Felix, S.B., see Staudt, Y. (466) 1 Feng, X., see Min, J.-Y. (471) 41 Feng, Y., Fratkin, J.D. and LeBlanc, M.H. Inhibiting caspase-8 after injury reduces hypoxic – ischemic brain injury in the newborn rat (481) 169 Feniuk, W., see Jenkins, D.W. (469) 29 Ferdinandy, P., see Csont, T. (476) 107 Ferna´ndez, N., Martı´nez, M.A., Climent, B., Garcı´a-Villalo´n, A.L., Monge, L., Sanz, E. and Die´guez, G. In vivo coronary effects of endothelin-1 after ischemia – reperfusion. Role of nitric oxide and prostanoids (481) 109 Ferna´ndez, N., see Garcı´a-Villalo´n, A.L. (459) 247 Ferna´ndez, N., see Sanz, E. (471) 35 Ferna´ndez, N., see Martı´nez, M.A. (473) 55 Ferna´ndez-Pe´rez, S., see Pache, D.M. (477) 205 Ferra´ndiz, Ma.L., see Rojas, J. (465) 183 Ferrara, P., see Gavioli, E.C. (471) 21 Ferreira, M.B.C., see da Silva Torres, I.L. (481) 197 Ferrer, M., Salaices, M., Sa´nchez, M. and Balfago´n, G. Different effects of acute clenbuterol on vasomotor response in mesenteric arteries from young and old spontaneously hypertensive rats (466) 289 Ferrier, G.R., see Au, A. (476) 45 Ferrieri, A., see Gerasimov, M.R. (477) 45 Fetissov, S., see Johansen, J.E. (480) 171 Feuerstein, G., see Vonhof, S. (473) 127 Figueiredo, I., see Castel-Branco, M. (482) 163 File, S.E. and Seth, P. A review of 25 years of the social interaction test (463) 35 Filip, M., Papla, I., Nowak, E., Czepiel, K. and Przegalin´ski, E. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on cocaine discrimination in rats (459) 239

Finberg, J.P.M., see Glezer, S. (472) 173 Finckenberg, P., see Cheng, Z.J. (461) 159 Finkelstein, D.I., see Wong, J.Y.F. (472) 39 Finn, G., Creaven, B. and Egan, D. Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells (481) 159 Fiori, A., see Granata, F. (482) 17 Fischer, H., see Johansen, J.E. (480) 171 Fischer, J., see Wijkhuisen, A. (468) 175 Fischer, W., see Borvendeg, S.J. (474) 71 Fischman, A.J., see Madras, B.K. (479) 41 Fixler, R., see Han, B. (474) 15 Fleck, E., see Bruemmer, D. (462) 15 Fleck, E., see Bruemmer, D. (466) 225 Fleckenstein, A.E. and Hanson, G.R. Impact of psychostimulants on vesicular monoamine transporter function (479) 283 Fleckenstein, A.E., see Riddle, E.L. (458) 31 Fleckenstein, A.E., see Ugarte, Y.V. (472) 165 Fleckenstein, A.E., see Truong, J.G. (474) 223 Fleckenstein, A.E., see Johnson-Davis, K.L. (482) 151 Fletcher, P.J., see Schwartz, R.A. (459) 195 Fletcher, P.J., see Higgins, G.A. (480) 151 Fliers, E., see Kreier, F. (480) 51 Foley, M., see Salomone, S. (469) 125 Folkerts, G., see Smit, J.J. (470) 193 Folkerts, G., see Ten Broeke, R. (476) 151 Fomum, Z.T., see Njamen, D. (468) 67 Fong, W.-F., see Wu, J.-C. (473) 9 Fontaine, C.P., see Colvin, R.A. (479) 171 Foox, A., see Fride, E. (461) 27 Forrest, A., see Talubmook, C. (469) 153 Fortes, Z.B., see Zanardo, R.C.O. (478) 211 Foster, A.C., see Mackay, K.B. (469) 111 Fotiadis, C., see Poussios, D. (465) 275 Foulon, C., see Gorwood, P. (480) 163 Fournier, A., see Juaneda, C. (474) 165 Fozard, J.R., Baur, F. and Wolber, C. Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog (475) 79 Fozard, J.R., see Tigani, B. (482) 319 Francßa, L.P., Pacheco, N.A.S., Correa, S.A.A., Han, S.W., Nakaie, C.R., Paiva, A.C.M. and Shimuta, S.I. Angiotensin II-mediated cellular responses: a role for the 3Vuntranslated region of the angiotensin AT1 receptor (476) 25 France, C.P., see McMahon, L.R. (466) 113 France, C.P., see Lamb, R.J. (470) 157 Franklin, A. and Stella, N. Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors (474) 195 Fratkin, J.D., see Feng, Y. (481) 169 Fredrickson, P., Boules, M., Yerbury, S. and Richelson, E. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats (458) 111 Freissmuth, M., see Sitte, H.H. (479) 229 Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., Blau, H. and Mechoulam, R. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a ‘‘CB3’’ receptor (461) 27 Frigo, G., see Giaroni, C. (476) 63 Frobert, Y., see Wijkhuisen, A. (468) 175 Fu, M., see Staudt, Y. (466) 1 Fu, M.L.X., see Matsui, S. (469) 165 Fuentealba, J., see Arroyo, G. (475) 11 Fuhrmann, M., see Koschorreck, S. (471) 229

Master author index to volumes 458 – 482 (2003) Fujii, T., Takaoka, M., Muraoka, T., Kurata, H., Tsuruoka, N., Ono, H., Kiso, Y., Tanaka, T. and Matsumura, Y. Preventive effect of L-carnosine on ischemia/reperfusion-induced acute renal failure in rats (474) 261 Fujii, T., Kurata, H., Takaoka, M., Muraoka, T., Fujisawa, Y., Shokoji, T., Nishiyama, A., Abe, Y. and Matsumura, Y. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure (481) 241 Fujimori, A., see Yuyama, H. (478) 61 Fujimoto, M., see Itagaki, S. (475) 85 Fujimoto, S., Mori, M. and Tsushima, H. Mechanisms underlying the hydrogen peroxide-induced, endotheliumindependent relaxation of the norepinephrine-contraction in guinea-pig aorta (459) 65 Fujimura, A., see Nishiki, K. (460) 171 Fujino, H. and Regan, J.W. Prostaglandin F2a stimulation of cyclooxygenase-2 promoter activity by the FPB prostanoid receptor (465) 39 Fujisawa, Y., see Fujii, T. (481) 241 Fujishiro, M., see Fukushima, Y. (468) 47 Fujita, S., see Adachi, K. (473) 47 Fujiwara, M., see Yamagishi, K. (462) 53 Fujiwara, Y., see Ogawa, N. (474) 273 Fukami, H., see Tomimori, Y. (478) 179 Fuks, B., Gillard, M., Michel, P., Lynch, B., Vertongen, P., Leprince, P., Klitgaard, H. and Chatelain, P. Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines (478) 11 Fuks, B., see Gillard, M. (478) 1 Fukuda, S., Midoro, K., Gyoten, M., Kawano, Y., Ashida, Y., Nabe, T., Kohno, S. and Nagaya, H. Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis (476) 239 Fukuda, Y., see Tomimori, Y. (478) 179 Fukushima, H., see Fukushima, Y. (468) 47 Fukushima, Y., Shindo, T., Anai, M., Saitoh, T., Wang, Y., Fujishiro, M., Ohashi, Y., Ogihara, T., Inukai, K., Ono, H., Sakoda, H., Kurihara, Y., Honda, M., Shojima, N., Fukushima, H., Haraikawa-Onishi, Y., Katagiri, H., Shimizu, Y., Ichinose, M., Ishikawa, T., Omata, M., Nagai, R., Kurihara, H. and Asano, T. Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice (468) 47 Fukuyama, Y., see Zhai, H. (474) 199 Fumagalli, E., see Mennini, T. (479) 291 Funahashi, M., see Kohjitani, A. (465) 145 Funakoshi, T., see Chaki, S. (474) 95 Furihata-Komatsu, H., see Itoh, F. (477) 9 Furue, S., see Tomita, Y. (472) 147 Furuhama, K., see Tsuchiya, Y. (475) 119 Furukawa, N., see Ohta, T. (476) 159 Furukawa, T., see Bai, C.-X. (476) 35 Fusi, F., see Bova, S. (470) 185 Gabra, B.H. and Sirois, P. Erratum to ‘‘Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice’’ [Eur. J. Pharmacol. 457 (2002) 115 – 124] (458) 329 Gabra, B.H., see Eric, J. (475) 129 Gackenheimer, S.L., see Statnick, M.A. (482) 139 Gage, P.W., see Eghbali, M. (468) 75 Gaita´n, G., Del Soldato, P. and Herrero, J.F. Low doses of nitroparacetamol or dexketoprofen trometamol enhance fentanyl antinociceptive activity (481) 181 Galarraga, E., see Barral, J. (462) 91 Galietta, G., see Loizzo, A. (458) 201 Galli, A., see Kahlig, K.M. (479) 153

11

Galli, C., see Rise´, P. (467) 73 Gama Landgraf, R., Sirois, P. and Jancar, S. Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists (460) 75 Gan, L., Zhang, S.-H., Liu, Q. and Xu, H.-B. A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells (471) 217 Gan, Q., see Williams, J.B. (464) 189 Gandı´a, L., see Ruiz-Nun˜o, A. (481) 41 Gando, S., see Zhang, X.-H. (476) 131 Ganguly, D.K., see Maity, S. (470) 103 Gao, C., see Liu, S. (459) 27 Gao, C., see Liu, S. (471) 49 Gao, N., see Liu, S. (459) 27 Gao, N., see Liu, S. (471) 49 Gao, X., see Liu, S. (459) 27 Garay, R.P., see Alvarez-Guerra, M. (466) 199 Garay, R.P., see Hannaert, P. (466) 207 Garcez do Carmo, L., see Ribeiro, R.d.A. (470) 37 Garcı´a, A.G., see Arroyo, G. (475) 11 Garcı´a, A.G., see Ruiz-Nun˜o, A. (481) 41 Garcı´a, G.A., see Perusguı´a, M. (475) 161 Garcia-Marin, L., see Moody, T.W. (474) 21 Garcı´a-Villalo´n, A.L., Sanz, E., Monge, L., Ferna´ndez, N., Martı´nez, M.A., Climent, B. and Die´guez, G. Vascular reactivity to vasopressin during diabetes: gender and regional differences (459) 247 ´ .L., see Sanz, E. (471) 35 Garcı´a-Villalo´n, A Garcı´a-Villalo´n, A.-L., see Martı´nez, M.A. (473) 55 Garcı´a-Villalo´n, A.L., see Ferna´ndez, N. (481) 109 Gardiner, S.M., see Ralevic, V. (460) 145 Gardner, N.M., see Maddock, H.L. (477) 235 Garnier, M., see Misiano, P. (468) 159 Garris, P.A., see Greco, P.G. (479) 117 Gasan, G., see Six, I. (458) 327 Gasior, M., see Kaminski, R.M. (474) 217 Gaskari, S.A., see Mehr, S.E. (467) 205 Gautier, E., see Barbe, F. (474) 117 Gavalakis, N., see Poussios, D. (465) 275 Gavioli, E.C., Duarte, F.S., Bressan, E., Ferrara, P., Farges, R.C. and De Lima, T.C.M. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test (471) 21 Ge, P., see Cannon, K.E. (470) 139 Gehlert, D.R., see Statnick, M.A. (482) 139 Geiger, J.D., see Shepel, P.N. (467) 67 Geldenhuys, W.J., Terre’Blanche, G., Van der Schyf, C.J. and Malan, S.F. Screening of novel pentacyclo-undecylamines for neuroprotective activity (458) 73 Genazzani, A.A., see Nicosia, A. (469) 103 Gentilucci, L., see Spampinato, S. (469) 89 Gentry, W.B., see Byrnes-Blake, K.A. (461) 119 George, S.E., see Schenk, J.O. (479) 223 George, S.R., see Madras, B.K. (479) 41 Geppetti, P., see Harrison, S. (475) 107 Gerard, N.P., see van der Kleij, H.P.M. (476) 249 Ge´rardy, J., see Boland, A. (466) 21 Gerasimov, M.R., Collier, L., Ferrieri, A., Alexoff, D., Lee, D., Gifford, A.N. and Balster, R.L. Toluene inhalation produces a conditioned place preference in rats (477) 45 Gessa, G.L., see Casu, M.A. (459) 97 Gesta, S., see Roulet, A. (460) 85 Gether, U., see Rasmussen, S.G.F. (479) 13 Gether, U., see Loland, C.J. (479) 187

12

Master author index to volumes 458 – 482 (2003)

Ghe´, C., see Bedendi, I. (476) 87 Ghezzi, S., see Rise´, P. (467) 73 Ghigo, E., see Bedendi, I. (476) 87 Gholami, A., Zarrindast, M.-R., Sahraei, H. and Haerri-Rohani, A. Nitric oxide within the ventral tegmental area is involved in mediating morphine reward (458) 119 Gholami, A., see Zarrindast, M.-R. (482) 205 Ghozland, S., see Ce´le´rier, E. (465) 69 Giacomini, K.M., see Mangravite, L.M. (479) 269 Gianfriddo, M., see Corsi, C. (464) 33 Giannoulaki, V., Papathanassiou, M., Sitaras, N.M. and Tiligada, E. Nadroparine inhibits the hypersensitivity response in the conjunctiva (481) 119 Giardina, L., see Nicosia, A. (469) 103 Giaroni, C., Zanetti, E., Chiaravalli, A.M., Albarello, L., Dominioni, L., Capella, C., Lecchini, S. and Frigo, G. Evidence for a glutamatergic modulation of the cholinergic function in the human enteric nervous system via NMDA receptors (476) 63 Gibson, A., Wallace, P. and McFadzean, I. Calyculin-A inhibits nitrergic relaxations of the mouse anococcygeus (471) 213 Giessler, C., see Wangemann, T. (458) 163 Gifford, A.N., see Gerasimov, M.R. (477) 45 Gil, J.V., see Torregrosa, G. (482) 227 Gillard, M., Fuks, B., Michel, P., Vertongen, P., Massingham, R. and Chatelain, P. Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain (478) 1 Gillard, M., see Christophe, B. (470) 87 Gillard, M., see Fuks, B. (478) 11 Gillberg, P.-G., see Axelsson, L.-G. (467) 211 Gillen, C., see Borvendeg, S.J. (474) 71 Gimonet, D., Grailhe, R., Coninx, P., Antonicelli, F., Haye, B. and Liautaud-Roger, F. Functional role of nicotinic acetylcholine receptors in apoptosis in HL-60 cell line (482) 25 Giner, R.M., see Sala, A. (460) 219 Giner, R.M., see Sala, A. (461) 53 Giner, R.M., see Njamen, D. (468) 67 Giracello, D.R., see Anderson, J.J. (473) 35 Giro´n, R., see Pascual, D. (462) 99 Gispen, W.H., see Ter Laak, M.P. (462) 179 Gispen, W.H., see Vogelaar, C.F. (480) 233 Giuliani, D., see Mioni, C. (477) 227 Gjurasin, M., see Bedekovic, V. (477) 73 Glennon, R.A., see Bondarev, M.L. (474) 85 Glennon, R.A., see Peddi, S. (482) 335 Glezer, S. and Finberg, J.P.M. Pharmacological comparison between the actions of methamphetamine and 1-aminoindan stereoisomers on sympathetic nervous function in rat vas deferens (472) 173 Glusa, E., see Dugina, T.N. (471) 141 Gnegy, M.E. The effect of phosphorylation on amphetamine-mediated outward transport (479) 83 Gobbi, M., see Mennini, T. (479) 291 Godart, H., see Touret, N. (459) 151 Gokce, G., see Kilicarslan, H. (462) 155 Goktalay, G., see Savci, V. (468) 129 Gokulan, K., see Khare, S. (465) 23 Goldberg, N.R., Beuming, T., Soyer, O.S., Goldstein, R.A., Weinstein, H. and Javitch, J.A. Probing conformational changes in neurotransmitter transporters: a structural context (479) 3 Goldstein, R.A., see Goldberg, N.R. (479) 3 Gomita, Y., see Kitamura, Y. (481) 75 Goncßalves, J., see Diniz, C. (460) 191

Goncßalves, L.M., see Monteiro, P. (482) 245 Gong, Y.-Q., see Fan, Y. (481) 33 Gong, Z.H., see Li, Y.F. (469) 81 Gonza´lez-Maeso, J., Wise, A., Green, A. and Koenig, J.A. Agonist-induced desensitization and endocytosis of heterodimeric GABAB receptors in CHO-K1 cells (481) 15 Gonza´lez-Orozco, A.E., see Pedraza-Chaverrı´, J. (473) 71 Goodhead, L.H., see Moss, S. (460) 117 Gopalakrishnan, M., see Parihar, A.S. (471) 157 Go´recka, D., see van Overveld, F.J. (477) 261 Gorwood, P., Kipman, A. and Foulon, C. The human genetics of anorexia nervosa (480) 163 Gorzalka, B., Hanson, L., Harrington, J., Killam, S. and CampbellMeiklejohn, D. Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone (471) 129 Gosens, R., Nelemans, S.A., Hiemstra, M., Grootte Bromhaar, M.M., Meurs, H. and Zaagsma, J. Insulin induces a hypercontractile airway smooth muscle phenotype (481) 125 Goto, N., see Nakajima, M. (459) 113 Gotoh, R., see Onai, Y. (481) 217 Gotti, C., see Carbonnelle, E. (471) 85 Goulet, M., see Madras, B.K. (479) 41 Goutman, J.D., Waxemberg, M.D., Don˜ate-Oliver, F., Pomata, P.E. and Calvo, D.J. Flavonoid modulation of ionic currents mediated by GABAA and GABAC receptors (461) 79 Gower, A.J., see Lamberty, Y. (469) 97 Gower, A.J., Falter, U. and Lamberty, Y. Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat (481) 67 Gracioso, J.S., see Albino de Almeida, A.B. (472) 205 Graf, K., see Bruemmer, D. (462) 15 Grailhe, R., see Gimonet, D. (482) 25 Granado, M., see Iba´n˜ez de Ca´ceres, I. (481) 293 Granata, F., Potenza, R.L., Fiori, A., Strom, R., Caronti, B., Molinari, P., Donsante, S., Citro, G., Iacovelli, L., De Blasi, A., Ngomba, R.T., Palladini, G. and Passarelli, F. Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium (482) 17 Grassi, J., see Wijkhuisen, A. (468) 175 Grassi, M., see Castorina, M. (477) 129 Greco, P.G. and Garris, P.A. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry (479) 117 Greco, R., see Tassorelli, C. (464) 159 Green, A., see Gonza´lez-Maeso, J. (481) 15 Greenwald, E.R., see Schwartz, R.A. (459) 195 Grider, J.S., Ott, C.E. and Jackson, B.A. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action (473) 185 Griebel, G., see Blanchard, D.C. (463) 97 Grieco, P., see Mioni, C. (477) 227 Griffon, N., see Guillin, O. (480) 89 Grimwood, S., see Guscott, M.R. (476) 193 Grixoni, C., see D’Aquila, P.S. (458) 129 Groenink, L., see Olivier, B. (463) 117 Groenink, L., Pattij, T., De Jongh, R., Van der Gugten, J., Oosting, R.S., Dirks, A. and Olivier, B. 5-HT1A receptor knockout mice and mice overexpressing corticotropinreleasing hormone in models of anxiety (463) 185 Gromada, J., see Høy, M. (466) 213 Grootte Bromhaar, M.M., see Gosens, R. (481) 125 Gross, C., see Guillin, O. (480) 89 Grosset, A., see Barbe, F. (474) 117

Master author index to volumes 458 – 482 (2003) Guan, J., see Qiu, Y. (472) 73 Guaraldo, A.M.A., see Valadares, M.C. (473) 191 Guarini, S., see Mioni, C. (477) 227 Gudelsky, G.A., see Darvesh, A.S. (464) 135 Gudka, B.D., see Vonhof, S. (459) 41 Gueux, E., see Alloui, A. (469) 65 Gugenheim, J., see Crenesse, D. (473) 177 Guillebaud, J., see Amobi, N. (462) 169 Guillebaud, J., see Amobi, N. (464) 241 Guillin, O., Griffon, N., Bezard, E., Leriche, L., Diaz, J., Gross, C. and Sokoloff, P. Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson’s disease (480) 89 Gulley, J.M. and Zahniser, N.R. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands (479) 139 Gulluyan, L.M., see Ritchie, R.H. (461) 171 Gunne, L., see Klintenberg, R. (459) 231 Guo, J. and Schofield, G.G. Activation of muscarinic m5 receptors inhibits recombinant KCNQ2/ KCNQ3 K+ channels expressed in HEK293T cells (462) 25 Gupta, M.P., see Caballero-George, C. (458) 257 Guscott, M.R., Clarke, H.F., Murray, F., Grimwood, S., Bristow, L.J. and Hutson, P.H. The effect of (F)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze (476) 193 Gutknecht, L., see Lesch, K.P. (480) 185 Gyermek, L., see Nishiyama, T. (470) 27 Gyoten, M., see Fukuda, S. (476) 239

Haapalinna, A., see Yavich, L. (462) 83 Haas, J.V., see Hurst, R.S. (482) 31 Haberberger, R., see Hagner, S. (481) 147 Habib, A., see Capra, V. (474) 149 Hada, J., Kaku, T., Jiang, M.H., Morimoto, K. and Hayashi, Y. Inhibition of high K+-evoked g-aminobutyric acid release by sodium nitroprusside in rat hippocampus (467) 119 Hadipour-Jahromy, M. and Daniels, S. Binary combinations of propofol and barbiturates on human a1 glycine receptors expressed in Xenopus oocytes (477) 81 Haeri-Rohani, A., see Zarrindast, M.-R. (482) 205 Haerri-Rohani, A., see Gholami, A. (458) 119 Hagiwara, M., Adachi-Akahane, S. and Nagao, T. High-affinity binding of [3H]DTZ323 to the diltiazem-binding site of Ltype Ca2+ channels (466) 63 Hagner, S., Haberberger, R., Hay, D.L., Facer, P., Reiners, K., Voigt, K. and McGregor, G.P. Immunohistochemical detection of the calcitonin receptor-like receptor protein in the microvasculature of rat endothelium (481) 147 Hahn, E.G., see Konturek, P.C. (472) 213 Hahn, E.G., see Harsch, I.A. (481) 249 Hainsworth, A.H., McNaughton, N.C.L., Pereverzev, A., Schneider, T. and Randall, A.D. Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents (467) 77 Haixue, W., see Xiaochao, M. (461) 89 Hakamatsuka, T., see Aoki, K. (459) 131 Hake, P.W., see Zingarelli, B. (469) 183 Hallbo¨o¨k, F., see Lindqvist, N. (482) 85 Haloui, M., Meilhac, O., Jandrot-Perrus, M. and Michel, J.-B. Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin (474) 175 Hama, A., Woon Lee, J. and Sagen, J. Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats (459) 49

13

Hamada, K., see Hosogai, N. (477) 171 Hamada, K., see Yamamoto, T. (477) 253 Hamann, M., see Richter, A. (478) 47 Hamano-Takahashi, A., see Takahashi, K. (458) 155 Hamers, F.P.T., see Ter Laak, M.P. (462) 179 Hammond, T., see Braam, B. (464) 87 Han, B., Fixler, R., Beeri, R., Wang, Y., Bachrach, U. and Hasin, Y. The opposing effects of endothelin-1 and C-type natriuretic peptide on apoptosis of neonatal rat cardiac myocytes (474) 15 Han, J.-F., see Matsui, S. (469) 165 Han, S.W., see Francßa, L.P. (476) 25 Hanaoka, K., see Kadowaki, M. (458) 197 Hanaoka, K., see Nishiyama, T. (470) 27 Hanaoka, Y., see Kubohara, Y. (460) 93 Hancock, A.A., see Yao, B.B. (482) 49 Hanioka, N., see Yamamoto, T. (477) 253 Hannaert, P., Alvarez-Guerra, M., Hider, H., Chiavaroli, C. and Garay, R.P. Vascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: antagonism by ethamsylate (466) 207 Hannaert, P., see Alvarez-Guerra, M. (466) 199 Hansen, J., see Høy, M. (466) 213 Hanson, G.R., see Riddle, E.L. (458) 31 Hanson, G.R., see Ugarte, Y.V. (472) 165 Hanson, G.R., see Truong, J.G. (474) 223 Hanson, G.R., see Fleckenstein, A.E. (479) 283 Hanson, L., see Gorzalka, B. (471) 129 Hao, J.-X., see Erichsen, H.K. (458) 275 Hao, J.-X., see Wu, W.-P. (478) 131 Hao, J.-X., see Wu, W.-P. (482) 133 Hara, A., see Niwa, M. (466) 245 Harada, H., see Yasuda, N. (459) 159 Harada, H., see Yuyama, H. (478) 61 Haraikawa-Onishi, Y., see Fukushima, Y. (468) 47 Harrington, J., see Gorzalka, B. (471) 129 Harrison, P.K., Bueters, T.J.H., Ijzerman, A.P., van Helden, H.P.M. and Tattersall, J.E.H. Partial adenosine A1 receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice (471) 97 Harrison, S., De Petrocellis, L., Trevisani, M., Benvenuti, F., Bifulco, M., Geppetti, P. and Di Marzo, V. Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder (475) 107 Harsch, I.A., Brzozowski, T., Bazela, K., Konturek, S.J., Kukharsky, V., Pawlik, T., Pawlowski, E., Hahn, E.G. and Konturek, P.C. Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines (481) 249 Hascoe¨t, M., see Bourin, M. (463) 55 Hasegawa, H., see Isomae, K. (465) 97 Hasegawa, M., see Adachi, K. (464) 147 Hasegawa, M., see Adachi, K. (473) 47 Hasegawa, T., see Kitaichi, K. (464) 39 Hasegawa, T., see Matsushima, M. (464) 111 Hashimoto, K., see Zhu, B.-M. (460) 43 Hashimoto, K., see Takahara, A. (460) 51 Hashimoto, K., see Okamura, N. (461) 93 Hashimoto, K., see Sugiyama, A. (466) 137 Hashimoto, K., see Takahara, A. (476) 115 Hashino, A., see Osakada, F. (465) 15 Hasin, Y., see Han, B. (474) 15 Haskell-Luevano, C., see Holder, J.R. (462) 41 Hasko´, G., see Mabley, J. (466) 323 Hatakeyama, D., see Niwa, M. (466) 245 Hatakeyama, H., see Kitazawa, T. (469) 135 Hattori, S., see Hattori, Y. (481) 153

14

Master author index to volumes 458 – 482 (2003)

Hattori, T., Kajikuri, J., Katsuya, H. and Itoh, T. Effects of H2O2 on membrane potential of smooth muscle cells in rabbit mesenteric resistance artery (464) 101 Hattori, Y., see Zhang, X.-H. (476) 131 Hattori, Y., Hattori, S. and Kasai, K. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation (481) 153 Hatziapostolou, M., Katsoris, P. and Papadimitriou, E. Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis (460) 1 Haun, M., see Albino de Almeida, A.B. (472) 205 Hausmann, C., see Heiser, P. (476) 167 Haworth, S.G., see Stanford, S.J. (473) 135 Hay, D.L., see Hagner, S. (481) 147 Hayashi, H., see Sone, M. (482) 313 Hayashi, K., see Nakajima, M. (459) 113 Hayashi, K.-i., Ishikawa, T., Yamashita, T., Tajima, T. and Nakayama, K. Biphasic response of cutaneous blood flow induced by passive cutaneous anaphylaxis in rats (482) 305 Hayashi, M., see Yatsu, T. (458) 191 Hayashi, M., Nakai, T., Bandoh, T. and Hoshi, K. Acute effect of simultaneous administration of tryptophan and ethanol on serotonin metabolites in the locus coeruleus in rats (462) 61 Hayashi, T. and Su, T.-P. Chronic [D-Ala2, D-Leu5]enkephalin treatment increases the nerve growth factor in adult mouse brain (464) 237 Hayashi, Y., see Hada, J. (467) 119 Hayashida, Y., see Miyamoto, O. (459) 179 Haye, B., see Gimonet, D. (482) 25 Haynes-Johnson, D., see Qiu, Y. (472) 73 He, G.-W., see Shan Au, A.L. (468) 199 Heber, D., see Roloff, T. (478) 81 Hediger, M.A., see Kanai, Y. (479) 237 Hefco, A., see Hefco, V. (474) 227 Hefco, A., see Hefco, V. (475) 55 Hefco, V., Yamada, K., Hefco, A., Hritcu, L., Tiron, A., Olariu, A. and Nabeshima, T. Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats (474) 227 Hefco, V., Yamada, K., Hefco, A., Hritcu, L., Tiron, A. and Nabeshima, T. Role of the mesotelencephalic dopamine system in learning and memory processes in the rat (475) 55 Heidbreder, C.A., see Shilliam, C.S. (477) 113 Heiligers, J.P.C., see Kapoor, K. (475) 69 Heiser, P., Schu¨ler-Springorum, M., Schulte, E., Hausmann, C., Remschmidt, H., Krieg, J.-C. and Vedder, H. Pharmacokinetics of clozapine and its metabolites in hippocampal HT22 cells (476) 167 Hellstro¨m, P.M., see Axelsson, L.-G. (467) 211 Helyes, Z., see Ne´meth, J. (458) 313 Henniger, M.S.H., Wotjak, C.T. and Ho¨lter, S.M. Long-term voluntary ethanol drinking increases expression of NMDA receptor 2B subunits in rat frontal cortex (470) 33 Henniger, M.S.H., Wotjak, C.T. and Ho¨lter, S.M. Erratum to ‘‘Long-term voluntary ethanol drinking increases expression of NMDA receptor 2B subunits in rat frontal cortex’’ [Eur. J. Pharmacol. 470 (2003) 33 – 36] (473) 231 Henriksson, M., see Uddman, E. (482) 39 Herbert, J.-M., see Bidouard, J.-P. (461) 49 Herna´ndez, A., see Pelissier, T. (477) 23 Herna´ndez-Delgadillo, G.P., Lo´pez-Mun˜oz, F.J., Salazar, L.A. and Cruz, S.L. Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception (469) 71 Herna´ndez-Guijo, J.M., see Ruiz-Nun˜o, A. (481) 41 Herna´ndez-Pando, R., see Pedraza-Chaverrı´, J. (473) 71

Herrado´n, G., Morales, L., Pe´rez-Garcı´a, C. and Alguacil, L.F. The contribution of a2-adrenoceptor and opioid receptor mechanisms to antinociception differs in Lewis and Fischer 344 rats (465) 251 Herrero, J.F., see Gaita´n, G. (481) 181 Herzer, W.A., see Thomas, N.J. (465) 133 Herzog, H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models (480) 21 Heurteaux, C., see Crenesse, D. (473) 177 Hickey, G.J., see Shearman, L.P. (475) 37 Hider, H., see Alvarez-Guerra, M. (466) 199 Hider, H., see Hannaert, P. (466) 207 Hiemstra, M., see Gosens, R. (481) 125 Higdon, N.R., see Hurst, R.S. (482) 31 Higgins, G.A. and Fletcher, P.J. Serotonin and drug reward: focus on 5-HT2C receptors (480) 151 Higuchi, S., see Sonoki, K. (475) 139 Hildebrandt, A.L., Kelly-Sullivan, D.M. and Black, S.C. Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice (462) 125 Hilgier, W., Anderzhanova, E., Oja, S.S., Saransaari, P. and Albrecht, J. Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum (468) 21 Himmel, H.M., see Borvendeg, S.J. (474) 71 Hirade, K., see Niwa, M. (466) 245 Hirakawa, H., see Miyamoto, O. (459) 179 Hirasawa, S., see Yamamoto, T. (481) 175 Hirasawa-Taniyama, Y., see Kato, Y. (473) 163 Hirata, R., Nabe, T. and Kohno, S. Augmentation of spontaneous cough by enalapril through up-regulation of bradykinin B1 receptors in guinea pigs (474) 255 Hirayama, K., Sudo, N., Sueyasu, M., Sonoda, J., Chida, Y., Oishi, R. and Kubo, C. Endogenous glucocorticoids inhibit scratching behavior induced by the administration of compound 48/80 in mice (481) 59 Hirayama, Y., Miyayasu, K., Yamagami, K., Imai, T., Ohkubo, Y. and Mutoh, S. Effect of FK3657, a non-peptide bradykinin B2 receptor antagonist, on allergic airway disease models (467) 197 Hirose, K., see Ma, J. (464) 79 Hirose, T., see Nakai, S. (472) 89 Hirosumi, J., see Hosogai, N. (477) 171 Hiruma-Lima, C.A., see Albino de Almeida, A.B. (472) 205 Hislop, A.A., see Stanford, S.J. (473) 135 Ho, M.K.C., see Wong, C.S.S. (473) 105 Ho, S.-T., see Tsao, C.-M. (477) 183 Hodge, C.W., see Kelley, S.P. (461) 19 Hoekman, M.F.M., see Vogelaar, C.F. (480) 233 Hoekstra, M.O., see Smit, J.J. (470) 193 Ho¨fler, S., see Mu¨hl, H. (482) 325 Hofmann, H.A., De Vry, J., Siegling, A., Spreyer, P. and Denzer, D. Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain (470) 17 Hojyo, H., see Abe, K. (465) 237 Ho¨kfelt, T., see Johansen, J.E. (480) 171 Holden, C.P., see Shepel, P.N. (467) 67 Holder, J.R., Marques, F.F., Xiang, Z., Bauzo, R.M. and Haskell-Luevano, C. Characterization of aliphatic, cyclic, and aromatic N-terminally ‘‘capped’’ His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors (462) 41 Holmes, A. and Rodgers, R.J. Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine (459) 221 Ho¨lter, S.M., see Henniger, M.S.H. (470) 33 Ho¨lter, S.M., see Henniger, M.S.H. (473) 231

Master author index to volumes 458 – 482 (2003) Holtman Jr., J.R., Sloan, J.W., Jing, X. and Wala, E.P. Modification of morphine analgesia and tolerance by flumazenil in male and female rats (470) 149 Holtz, G., see Anderson, J.J. (473) 35 Holy´, A., see Zı´dek, Z. (475) 149 Homayoun, H., see Mehr, S.E. (467) 205 Homer, K.L. and Wanstall, J.C. Platelet inhibitory effects of the nitric oxide donor drug MAHMA NONOate in vivo in rats (482) 265 Honda, H., see Unemoto, T. (472) 119 Honda, M., Nishida, T. and Ono, H. Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT2 receptors (458) 91 Honda, M., see Fukushima, Y. (468) 47 Honda, M., Tanabe, M. and Ono, H. Serotonergic depression of spinal monosynaptic transmission is mediated by 5-HT1B receptors (482) 155 Honda, T., see Umeuchi, H. (477) 29 Honda, Y., see Takahata, K. (458) 81 Hong, K.W., see Kim, K.Y. (465) 219 Honkanen, A., see Ingman, K. (468) 121 Hori, M., see Nagasaka, T. (472) 197 Hori, Y., see Tomita, Y. (472) 147 Horie, S., see Nemoto, T. (458) 17 Horiike, O., Shimogori, H., Ikeda, T. and Yamashita, H. Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig (464) 75 Horinouchi, T., Tanaka, Y. and Koike, K. Function of h1-adrenoceptors and mRNA expression of h1- and h2adrenoceptors in guinea-pig esophagus (473) 79 Horinouchi, T., see Matsushita, M. (482) 235 Horizoe, T., see Yasuda, N. (459) 159 Horne, M.K., see Wong, J.Y.F. (472) 39 Horvath, G., Agil, A., Joo, G., Dobos, I., Benedek, G. and Baeyens, J.M. Evaluation of endomorphin-1 on the activity of Na+,K+-ATPase using in vitro and in vivo studies (458) 291 Hosaka, K., see Kubohara, Y. (460) 93 Hoshi, K., see Hayashi, M. (462) 61 Hoshiko, S., see Tabata, Y. (461) 73 Hoshiko, S., see Tabata, Y. (465) 299 Hoshino, Y., see Yasuda, N. (459) 159 Hosogai, N., Takakura, S., Manda, T. and Mutoh, S. Enzyme activities of the nitric oxide – cGMP pathway in corpus cavernosum isolated from middle-aged rats (473) 65 Hosogai, N., Tomita, M., Hamada, K., Ogawa, T., Hirosumi, J., Manda, T. and Mutoh, S. Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats (477) 171 Hosohata, Y., see Okura, T. (459) 9 Hotta, K., see Niwa, M. (466) 245 Hou, J., see Zhang, Z. (467) 41 Hou, M., see Malmsjo¨, M. (458) 305 Hough, L.B., see Cannon, K.E. (470) 139 Houle, S., see Schwartz, R.A. (459) 195 Houlihan, W.J. and Kelly, L. Assessment of mazindane, a pro-drug form of mazindol, in assays used to define cocaine treatment agents (458) 263 Howard, A.D., see Shearman, L.P. (475) 37 Howard, E.W., see Matsumoto, R.R. (469) 1 Howlett, S.E., see Au, A. (476) 45 Høy, M., Olsen, H.L., Andersen, H.S., Bokvist, K., Buschard, K., Hansen, J., Jacobsen, P., Petersen, J.S., Rorsman, P. and Gromada, J. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca2+-dependent exocytosis in pancreatic a- and h-cells (466) 213 Hoyer, D., see Nunn, C. (465) 211 Hreniuk, D.L., see Shearman, L.P. (475) 37

15

Hritcu, L., see Hefco, V. (474) 227 Hritcu, L., see Hefco, V. (475) 55 Hruby, V.J., see Okura, T. (459) 9 Hsiao, G., Shen, M.-Y., Lin, K.-H., Chou, C.-Y., Tzu, N.-H., Lin, C.-H., Chou, D.-S., Chen, T.-F. and Sheu, J.-R. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo (465) 281 Hsieh, G.C., O’Neill, A.B., Moreland, R.B., Sullivan, J.P. and Brioni, J.D. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats (458) 183 Hsu, S.-L., see Chan, H.-C. (467) 31 Hu, C.M., Kang, J.J., Lee, C.C., Li, C.H., Liao, J.W. and Cheng, Y.W. Induction of vasorelaxation through activation of nitric oxide synthase in endothelial cells by brazilin (468) 37 Hu, H.-Z., see Liu, S. (459) 27 Hu, H.-Z., see Liu, S. (471) 49 Hu, Z.-B., see Fan, Y. (481) 33 Huang, C., see Chen, X.-C. (473) 1 Huang, L.-J., see Chan, H.-C. (467) 31 Huang, S.H., Duke, R.K., Chebib, M., Sasaki, K., Wada, K. and Johnston, G.A.R. Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant a1h2g2L GABAA receptors (464) 1 Huang, X.-L., see Khamdang, S. (465) 1 Hudson, A.L., see Cooper, E.J. (482) 189 Hughes, A.D., see Pickkers, P. (466) 281 Huidobro-Toro, J.P., see Coddou, C. (472) 49 Hu¨lsmann, M., Nickel, P., Kassack, M., Schmalzing, G., Lambrecht, G. and Markwardt, F. NF449, a novel picomolar potency antagonist at human P2X1 receptors (470) 1 Humphrey, P.P.A., see Jenkins, D.W. (469) 29 Hung, K.-c., see Mizoguchi, H. (461) 35 Hung, W.-Y., see Liao, J.-F. (464) 141 Hungund, B.L., see Basavarajappa, B.S. (466) 73 Hunt, G.E., see Cornish, J.L. (482) 339 Hurst, R.S., Higdon, N.R., Lawson, J.A., Clark, M.A., Rutherford-Root, K.L., McDonald, W.G., Haas, J.V., McGrath, J.P. and Meglasson, M.D. Dopamine receptor agonists differ in their actions on cardiac ion channels (482) 31 Hurth, K., see Nunn, C. (465) 211 Husbands, S.M., see Katz, J.L. (468) 109 Hussain, S.N.A., see Albertini, M. (474) 129 Huston, J.P., see Branda˜o, M.L. (463) 225 Huston, J.P., see Barros, M. (482) 197 Hutson, P.H., see Guscott, M.R. (476) 193 Huttunen, M.O., see Ingman, K. (468) 121 Hyytia¨, P., see Ingman, K. (468) 121

Iacovelli, L., see Granata, F. (482) 17 Iannone, C., see Mioni, C. (477) 227 Iba´n˜ez de Ca´ceres, I., Priego, T., Martı´n, A.I., Granado, M., Lo´pez-Caldero´n, A. and Villanu´a, M.A. Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats (481) 293 Ichikawa, K., see Sonoki, K. (475) 139 Ichiki, H., see Kamei, J. (469) 159 Ichinose, M., see Fukushima, Y. (468) 47 Ichinose, T., see Inoue, K.-i. (481) 261 Iddrissu, A., see Adeagbo, A.S.O. (458) 145 Igarashi, Y., see Yamagishi, K. (462) 53 Igbo, I., see Sofola, O. (474) 241 Ihenetu, K., Molleman, A., Parsons, M.E. and Whelan, C.J. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids (458) 207

16

Master author index to volumes 458 – 482 (2003)

Ihenetu, K., Molleman, A., Parsons, M. and Whelan, C. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells (464) 207 Iida, H., see Ma, J. (464) 79 Iida, H., see Yuan, Z. (464) 197 Iida, M., see Sonoki, K. (475) 139 Iijima, H., see Matsumoto, K. (473) 41 Iino, K., see Sonoki, K. (475) 139 Iizuka, Y., see Tabata, Y. (461) 73 Iizuka, Y., see Tabata, Y. (465) 299 IJzerman, A.P., see Bueters, T.J.H. (481) 141 Ijzerman, A.P., see Harrison, P.K. (471) 97 Ikeda, H., see Adachi, K. (464) 147 Ikeda, T., see Horiike, O. (464) 75 Ikekita, M., see Aoki, K. (459) 131 Iliodromitis, E.K., see Sbarouni, E. (467) 163 Illes, P., see Borvendeg, S.J. (474) 71 Illes, P., see Kru¨gel, U. (482) 185 Imai, T., see Hirayama, Y. (467) 197 Imaoka, T., see Nakai, S. (472) 89 Imazumi, K., see Yamamoto, T. (477) 253 Imura, Y., see Amano, Y. (466) 155 Imuta, H., see Ma, J. (464) 79 Inagaki, O., see Yatsu, T. (461) 191 Ingman, K., Honkanen, A., Hyytia¨, P., Huttunen, M.O. and Korpi, E.R. Risperidone reduces limited access alcohol drinking in alcoholpreferring rats (468) 121 Inokuchi, J.-i., see Yamagishi, K. (462) 53 Inoue, K.-i., Takano, H., Yanagisawa, R., Morita, M., Ichinose, T., Sadakane, K., Yoshino, S., Yamaki, K., Kumagai, Y., Uchiyama, K. and Yoshikawa, T. Effect of 15-deoxy-D12,14-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice (481) 261 Inoue, M., Kitazawa, T., Cao, J. and Taneike, T. 5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs (461) 207 Inoue, N., see Yuan, Z. (464) 197 Inoue, T., see Yasuda, N. (459) 159 Inukai, K., see Fukushima, Y. (468) 47 Iost, N., see Taka´cs, J. (470) 163 Iseki, K., see Itagaki, S. (475) 85 Ishibashi, T., see Yoshida, J. (472) 23 Ishida, H., see Yuan, Z. (464) 197 Ishii, H., see Muto, Y. (461) 181 Ishii, K., see Mitani, A. (466) 223 Ishii, K., see Kubota, Y. (467) 191 Ishii, K., see Moriuchi, H. (470) 57 Ishii, K., see Yunoki, M. (470) 65 Ishii, T., see Satoh, E. (465) 9 Ishii-Nozawa, R., see Nakazawa, K. (474) 205 Ishikawa, E., see Amano, Y. (466) 155 Ishikawa, T., see Fukushima, Y. (468) 47 Ishikawa, T., see Hayashi, K.-i. (482) 305 Ishikawa, Y., see Yuan, Z. (464) 197 Ishizuka, T., Matsui, T. and Kurita, A. Ramatroban, a TP receptor antagonist, improves vascular responses to acetylcholine in hypercholesterolemic rabbits in vivo (468) 27 Isobe, M., see Onai, Y. (481) 217 Isomae, K., Morimoto, S., Hasegawa, H., Morita, K. and Kamei, J. Effects of T-82, a novel acetylcholinesterase inhibitor, on impaired learning and memory in passive avoidance task in rats (465) 97 Itagaki, S., Sugawara, M., Kobayashi, M., Nishimura, S., Fujimoto, M., Miyazaki, K. and Iseki, K. Major role of organic anion transporters in the uptake of phenolsulfonphthalein in the kidney (475) 85

Itano, T., see Miyamoto, O. (459) 179 Ito, A., Miyake, M., Morishita, M., Ito, K., Torii, S. and Sakamoto, T. Dexamethasone reduces lung eosinophilia, and VCAM-1 and ICAM-1 expression induced by Sephadex beads in rats (468) 59 Ito, H., see Niwa, M. (466) 245 Ito, H., see Onai, Y. (481) 217 Ito, K., see Ito, A. (468) 59 Ito, K., see Kato, Y. (473) 163 Ito, Y., see Yunoki, T. (482) 287 Itoh, F., Aoyagi, S., Furihata-Komatsu, H., Aoki, M., Kusama, H., Kojima, M. and Kogo, H. Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures (477) 9 Itoh, T., see Hattori, T. (464) 101 Iva´nyi, B., see Rakonczay Jr., Z. (464) 217 Iwamoto, T., see Ogata, M. (478) 187 Iwamoto, Y., see Okamoto, H. (466) 147 Iwasaki, K., see Yamagishi, K. (462) 53 Iwasawa, K., see Ma, J. (464) 79 Iwase, M., see Sonoki, K. (475) 139 Iyo, M., see Okamura, N. (461) 93 Izumi, M., see Nagasaka, T. (472) 197

Jackson, B.A., see Grider, J.S. (473) 185 Jackson, E.K., see Thomas, N.J. (465) 133 Jacobsen, P., see Høy, M. (466) 213 Jakab, B., see Ne´meth, J. (458) 313 Jancar, S., see Gama Landgraf, R. (460) 75 Jancso´, G., see Csont, T. (476) 107 Jandrot-Perrus, M., see Haloui, M. (474) 175 Janiak, P., see Bidouard, J.-P. (461) 49 Janiak, P., see Barbe, F. (474) 117 Janowsky, A., see Skolnick, P. (461) 99 Janowsky, A., see Shimazu, S. (482) 9 Janoyan, J.J., see Darmani, N.A. (459) 83 Jansen-Olesen, I., Jørgensen, L., Engel, U. and Edvinsson, L. In-depth characterization of CGRP receptors in human intracranial arteries (481) 207 Janssen, L.J. and Wattie, J. Electrophysiological effects of erythromycin, but lack of mechanical effects, in airway smooth muscle (475) 93 Jansson, L., see Svensson, A.M. (459) 59 Jantos, H., see Monti, J.M. (478) 121 Ja¨rbe, T.U.C., Lamb, R.J., Liu, Q. and Makriyannis, A. (R)-Methanandamide and D9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A (466) 121 Javitch, J.A., see Goldberg, N.R. (479) 3 Jembrek, M.J., see Pericˇic´, D. (482) 117 Jenkins, D.W., Sellers, L.A., Feniuk, W. and Humphrey, P.P.A. Characterization of bradykinin-induced prostaglandin E2 release from cultured rat trigeminal ganglion neurones (469) 29 Jensen, B.S., see Blackburn-Munro, G. (460) 109 Jensen, B.S., see Dupuis, D.S. (465) 201 Jensen, R.T., see Moody, T.W. (474) 21 Jesmin, S., see Zhang, X.-H. (476) 131 Jespersen, T., see Dupuis, D.S. (465) 201 Jha, A. and Deshpande, S.B. Aglycemia and ischemia depress spinal synaptic transmission via inhibitory systems involving NMDA receptors (481) 189 Ji, A., see Ma, S.-X. (472) 179 Jian, X., see Xiaochao, M. (461) 89 Jiang, J., Backx, P.H., Teoh, H. and Ward, M.E. Role of Cl currents in rat aortic smooth muscle activation by prostaglandin F2a (481) 133

Master author index to volumes 458 – 482 (2003) Jiang, M.H., see Hada, J. (467) 119 Jiang, W., see Qiu, Y. (472) 73 Jimbo, M., see Yamagishi, K. (462) 53 Jin, D.-Q., see Soo Lee, Y. (476) 173 Jin, Z.-j., see Qiu, Y. (468) 1 Jindo, T., see Tsuchiya, Y. (475) 119 Jing, X., see Holtman Jr., J.R. (470) 149 Jo, T., see Ma, J. (464) 79 Johansen, J.E., Fetissov, S., Fischer, H., Arvidsson, S., Ho¨kfelt, T. and Schalling, M. Approaches to anorexia in rodents: focus on the anx/anx mouse (480) 171 Johansson, R., Andersson, K.-E. and Persson, K. Nerve-mediated bladder contraction is impaired by cytokines: involvement of inducible nitric oxide synthase (476) 221 John, T.M., see Qiu, Y. (472) 73 Johnson-Davis, K.L., Fleckenstein, A.E. and Wilkins, D.G. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity (482) 151 Johnston, G.A.R., see Huang, S.H. (464) 1 Johnston, K.D., see Sam, T.S.W. (472) 135 Jones, R.L., see Chow, K.B.S. (474) 7 Jones, R.L., see Kan, K.K.W. (477) 247 Jones, R.L., see Kan, K.K.W. (482) 297 Jongsma, M., see Klintenberg, R. (459) 231 Joo, G., see Horvath, G. (458) 291 Jørgensen, L., see Jansen-Olesen, I. (481) 207 Joshua, I.G., see Adeagbo, A.S.O. (458) 145 Joshua, I.G., see Adeagbo, A.S.O. (481) 91 Juaneda, C., Dumont, Y., Chabot, J.-G., Fournier, A. and Quirion, R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues (474) 165 Juhasz, B., see Vecsernyes, M. (470) 177 Juha´sz, G., see Nyitrai, G. (478) 111 Jullien, V., see Elimadi, A. (468) 93 Jung, S.H., see Lee, Y.S. (465) 191 Juretschke, H.-P., see Petty, M.A. (474) 53 Jurkiewicz, A., see Ribeiro, R.d.A. (470) 37 Jurkiewicz, N.H., see Ribeiro, R.d.A. (470) 37 Jyoyama, H., see Tomita, Y. (472) 147

Kadavil, E.A., see Oriowo, M.A. (482) 255 Kadonosono, K., see Yamakawa, T. (478) 39 Kadowaki, M., Nagakura, Y., Tokita, K., Hanaoka, K. and Tomoi, M. Adenosine A1 receptor blockade reverses experimental postoperative ileus in rat colon (458) 197 Kagawa, Y., see Kurokawa, M. (474) 283 Kahlig, K.M. and Galli, A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine (479) 153 Kai, H., see Kai, M. (481) 79 Kai, M., Tominaga, K., Okimoto, K., Yamauchi, A., Kai, H. and Kataoka, Y. Ovariectomy aggravates nifedipine-induced flushing of tail skin in mice (481) 79 Kaisary, A., see Amobi, N. (462) 169 Kaisary, A., see Amobi, N. (464) 241 Kajikuri, J., see Hattori, T. (464) 101 Kaku, T., see Hada, J. (467) 119 Kakuta, S., see Tanihata, S. (461) 197 Kalisch, J., see Petty, M.A. (474) 53 Kalkman, H.O. and Loetscher, E. a2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs (462) 33 Kalogjera, L., see Bedekovic, V. (477) 73

17

Kalsbeek, A., see Kreier, F. (480) 51 Kamal, A., see Mathon, D.S. (480) 97 Kamanyi, A., see Njamen, D. (468) 67 Kamei, C., see Shinomiya, K. (460) 139 Kamei, C., see Sugimoto, Y. (470) 113 Kamei, J., Morita, K., Saitoh, A. and Nagase, H. The antitussive effects of endomorphin-1 and endomorphin-2 in mice (467) 219 Kamei, J., Nakamura, R., Ichiki, H. and Kubo, M. Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang) (469) 159 Kamei, J., see Isomae, K. (465) 97 Kamei, J., see Morita, K. (474) 269 Kamei, J., see Yamakawa, T. (478) 39 Kameo, K., see Takahashi, K. (458) 155 Kaminski, R.M., Gasior, M., Carter, R.B. and Witkin, J.M. Protective efficacy of neuroactive steroids against cocaine kindledseizures in mice (474) 217 Kan, K.K.W., see Sam, T.S.W. (466) 163 Kan, K.K.W., see Sam, T.S.W. (472) 135 Kan, K.K.W., Jones, R.L., Ngan, M.-P. and Rudd, J.A. Action of prostanoids on the emetic reflex of Suncus murinus (the house musk shrew) (477) 247 Kan, K.K.W., Jones, R.L., Ngan, M.-P., Rudd, J.A. and Wai, M.-K. Emetic action of the prostanoid TP receptor agonist, U46619, in Suncus murinus (house musk shrew) (482) 297 Kan, S.-F., Kau, M.-M., Low-Tone Ho, L. and Wang, P.S. Inhibitory effects of bromocriptine on corticosterone secretion in male rats (468) 141 Kanahara, N., see Okamura, N. (461) 93 Kanai, Y. and Hediger, M.A. The glutamate and neutral amino acid transporter family: physiological and pharmacological implications (479) 237 Kanamaru, H., see Takahashi, M. (467) 185 Kanamori, Y., see Niwa, M. (466) 245 Kaneko, S., see Osakada, F. (465) 15 Kaneko, S., see Taguchi, R. (477) 195 Kang, B.Y., Lee, S.W. and Kim, T.S. Stimulation of interleukin-12 production in mouse macrophages via activation of p38 mitogen-activated protein kinase by a2-adrenoceptor agonists (467) 223 Kang, J., Chen, X.-L., Wang, H. and Rampe, D. Interactions of the narcotic l-a-acetylmethadol with human cardiac K+ channels (458) 25 Kang, J.J., see Hu, C.M. (468) 37 Kang, M.-J., see Choi, S. (468) 83 Kania, J., see Konturek, P.C. (472) 213 Kanno, M., see Matsumoto, M. (482) 177 Kanzık, I˙., see So¨ylemez, S. (464) 163 Kao, L.-S., see Liu, P.-S. (460) 9 Kapoor, K., Arulmani, U., Heiligers, J.P.C., Willems, E.W., Doods, H., Villalo´n, C.M. and Saxena, P.R. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig (475) 69 Kapui, Z., see Bidouard, J.-P. (461) 49 Karaki, H., see Nagasaka, T. (472) 197 Karamanoli, E., see Pantos, C. (478) 53 Karasawa, H., Taketo, M.M. and Matsui, M. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4 (468) 15 Kardos, J., see Nyitrai, G. (478) 111 Karmakar, S., see Maity, S. (470) 103 Karolewicz, B., see Antkiewicz-Michaluk, L. (466) 263 Karunagaran, D., see Srinivas, G. (473) 117

18

Master author index to volumes 458 – 482 (2003)

Kas, M.J.H., Van Elburg, A.A., Van Engeland, H. and Adan, R.A.H. Refinement of behavioural traits in animals for the genetic dissection of eating disorders (480) 13 Kasai, H., see Miyamoto, O. (459) 179 Kasai, K., see Hattori, Y. (481) 153 Kaschina, E., see Sandmann, S. (458) 3 Kashii, S., see Takahata, K. (458) 81 Kassack, M., see Hu¨lsmann, M. (470) 1 Kassuya, C.A.L., Silvestre, A.A., Rehder, V.L.G. and Calixto, J.B. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain (478) 145 Kaszaki, J., see Rakonczay Jr., Z. (464) 217 Katagiri, H., see Fukushima, Y. (468) 47 Kataoka, Y., see Kai, M. (481) 79 Katayama, K.-i., see Nakajima, M. (459) 113 Katayama, M., see Niwa, M. (466) 245 Kato, K., see Niwa, M. (466) 245 Kato, M., see Abe, K. (465) 237 Kato, Y., Kita, Y., Hirasawa-Taniyama, Y., Nishio, M., Mihara, K., Ito, K., Yamanaka, T., Seki, J., Miyata, S. and Mutoh, S. Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig (473) 163 Katsoris, P., see Hatziapostolou, M. (460) 1 Katsuda, S., see Matsui, S. (469) 165 Katsuki, H., see Takahata, K. (458) 81 Katsuki, H., see Osakada, F. (465) 15 Katsuki, H., see Taguchi, R. (477) 195 Katsuki, H., see Shimazu, S. (482) 9 Katsuta, K., Umemura, K., Ueyama, N. and Matsuoka, N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils (467) 103 Katsuya, H., see Hattori, T. (464) 101 Katz, J.L., Libby, T.A., Kopajtic, T., Husbands, S.M. and Newman, A.H. Behavioral effects of rimcazole analogues alone and in combination with cocaine (468) 109 Kau, M.-M., see Kan, S.-F. (468) 141 Kawamata, M., Mitsui-Saito, M., Kimura, T., Takayanagi, Y., Yanagisawa, T. and Nishimori, K. Vasopressin-induced contraction of uterus is mediated solely by the oxytocin receptor in mice, but not in humans (472) 229 Kawano, Y., see Fukuda, S. (476) 239 Kawase, T., Okuda, K. and Burns, D.M. Immature human osteoblastic MG63 cells predominantly express a subtype 1-like CGRP receptor that inactivates extracellular signal response kinase by a cAMP-dependent mechanism (470) 125 Kawashima, N., see Chaki, S. (464) 49 Kawata, K., see Sekiguchi, F. (465) 153 Kawata, T., see Yasuda, N. (459) 159 Keays, D.A. and Nolan, P.M. N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders (480) 205 Keck, M.E., see Ohl, F. (480) 219 Keenan, S.M., see Williams, J.B. (464) 189 Ke´kesi, K.A., see Nyitrai, G. (478) 111 Kela, J., see Salmi, P. (458) 101 Kelley, S.P., Bratt, A.M. and Hodge, C.W. Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice (461) 19 Kelly, L., see Houlihan, W.J. (458) 263 Kelly, S. and Chapman, V. Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation (474) 209 Kelly-Sullivan, D.M., see Hildebrandt, A.L. (462) 125

Kemmotsu, O., see Zhang, X.-H. (476) 131 Kendall, D., see Dickenson, J.M. (474) 43 Kendall, D.A., see Tep-areenan, P. (465) 125 Kendall, D.A., see Tep-areenan, P. (476) 139 Kennedy, S., Wadsworth, R.M. and Wainwright, C.L. Effect of antiproliferative agents on vascular function in normal and in vitro balloon-injured porcine coronary arteries (481) 101 Kerbel, R.S., see Bocci, G. (477) 17 Kerr, D.I.B. and Ong, J. Potentiation of metabotropic GABAB receptors by L-amino acids and dipeptides in rat neocortex (468) 103 Khamdang, S., Takeda, M., Babu, E., Noshiro, R., Onozato, M.L., Tojo, A., Enomoto, A., Huang, X.-L., Narikawa, S., Anzai, N., Piyachaturawat, P. and Endou, H. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics (465) 1 Khandoudi, N., see Maddock, H.L. (477) 235 Khare, S., Banai, Y., Gokulan, K., Smith III, R., Linthicum, D.S. and Modiano, J.F. Early changes in metabolism of leukemic cell lines upon induction of apoptosis by cytotoxic drugs (465) 23 Khisti, R.T., Kumar, S. and Morrow, A.L. Ethanol rapidly induces steroidogenic acute regulatory protein expression and translocation in rat adrenal gland (473) 225 Kido, H., see Kitamura, H. (465) 31 Kieffer, B.L., see Oakley, S.M. (466) 91 Kiess, W., see Kru¨gel, U. (482) 185 Kietzmann, M., see Ba¨umer, W. (481) 271 Kikuchi, T., see Nakai, S. (472) 89 Kilicarslan, H., Yildirim, S., Bagcivan, I., Gokce, G., Sarac, B. and Sarioglu, Y. The effect of chronic renal failure on phosphodiesterase inhibitorinduced relaxation responses in rabbit cavernosal strips (462) 155 Killam, S., see Gorzalka, B. (471) 129 Kim, H.J., see Kim, S.H. (482) 67 Kim, H.S., see Lim, D.K. (476) 179 Kim, J., see Reinscheid, R.K. (478) 27 Kim, J.-A., see Soo Lee, Y. (476) 173 Kim, K.Y., Kim, S.-O., Lim, H., Yoo, S.-E. and Hong, K.W. KR-31372 inhibits KDR/Flk-1 tyrosine phosphorylation via K+ATP channel opening in its antiangiogenic effect (465) 219 Kim, S.H., Kim, H.J. and Kim, T.S. Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin (482) 67 Kim, S.-O., see Kim, K.Y. (465) 219 Kim, T.S., see Kang, B.Y. (467) 223 Kim, T.S., see Kim, S.H. (482) 67 Kim, Y.I., see Choi, S. (468) 83 Kim, Y.M., see Lee, Y.S. (465) 191 Kim, Y.S., see Lee, Y.S. (465) 191 Kimura, I., see Tanaka, K. (466) 191 Kimura, M., see Akasofu, S. (472) 57 Kimura, T., see Kawamata, M. (472) 229 King, C., see Anderson, J.J. (473) 35 King, M.A., Su, W., Nielan, C.L., Chang, A.H., Schu¨tz, J., Schmidhammer, H. and Pasternak, G.W. 14-Methoxymetopon, a very potent A-opioid receptor-selective analgesic with an unusual pharmacological profile (459) 203 Kiniwa, M., see Tanaka, K. (466) 191 Kiniwa, M., see Ohmori, K. (471) 69 Kintscher, U., see Bruemmer, D. (466) 225 Kipman, A., see Gorwood, P. (480) 163 Kirchrath, L., see Debey, S. (474) 161 Kirichenko, S.V., see Baydas, G. (462) 67 Kiseleva, E.V., see Dugina, T.N. (471) 141 Kiso, Y., see Fujii, T. (474) 261 Kita, Y., see Kato, Y. (473) 163

Master author index to volumes 458 – 482 (2003) Kitaichi, K., Morishita, Y., Doi, Y., Ueyama, J., Matsushima, M., Zhao, Y.-L., Takagi, K. and Hasegawa, T. Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats (464) 39 Kitaichi, K., see Matsushima, M. (464) 111 Kitamura, H., Cui, P., Sharmin, S., Yano, M. and Kido, H. Binding of a new bioactive 31-amino-acid endothelin-1 to an endothelin ETB or ETB-like receptor in porcine lungs (465) 31 Kitamura, K., see Uchida, R. (466) 53 Kitamura, Y., Araki, H., Shibata, K., Gomita, Y. and Tanizaki, Y. 5-HT1A receptor full agonist, 8-OH-DPAT, exerts antidepressant-like effects in the forced swim test in ACTH-treated rats (481) 75 Kitanaka, J., see Kitanaka, N. (474) 63 Kitanaka, N., Kitanaka, J. and Takemura, M. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration (474) 63 Kitayama, S. and Dohi, T. Norepinephrine transporter splice variants and their interaction with substrates and blockers (479) 65 Kitazawa, T., Hatakeyama, H., Cao, J. and Taneike, T. Pregnancy-associated changes in responsiveness of the porcine myometrium to bioactive substances (469) 135 Kitazawa, T., see Inoue, M. (461) 207 Kitchen, I., see Oakley, S.M. (466) 91 Kittner, H., see Kru¨gel, U. (482) 185 Kiuchi, Y., see Tanaka, S. (465) 61 Kiyono, T., see Bruemmer, D. (462) 15 Kleeberg, U., see Krusekopf, S. (466) 7 Klein, S.I., see Valadares, M.C. (473) 191 Klintenberg, R., Arts, J., Jongsma, M., Wikstro¨m, H., Gunne, L. and Andre´n, P.E. Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism (459) 231 Klitgaard, H., see Margineanu, D.G. (466) 255 Klitgaard, H., see Lamberty, Y. (469) 97 Klitgaard, H., see Ardid, D. (473) 27 Klitgaard, H., see Fuks, B. (478) 11 Kloosterboer, H.J., see Berendsen, H.H.G. (482) 329 Kmonı´e`kova´, E., see Zı´dek, Z. (475) 149 Knebel, N., see Yasar, S. (465) 257 Knuepfer, M.M., see Williams, J.B. (464) 189 Koakutsu, A., see Yuyama, H. (478) 61 Kobayashi, H., Miwa, T., Nagao, T. and Adachi-Akahane, S. Negative modulation of L-type Ca2+ channels via h-adrenoceptor stimulation in guinea-pig detrusor smooth muscle cells (470) 9 Kobayashi, H., see Kubohara, Y. (460) 93 Kobayashi, M., see Tomita, Y. (472) 147 Kobayashi, M., see Itagaki, S. (475) 85 Kobayashi, S., see Yasuda, N. (459) 159 Kobayashi, Y., see Takahata, K. (458) 81 Kocsan, R., see Vecsernyes, M. (470) 177 Koek, W., see Bruins Slot, L.A. (466) 271 Koek, W., see Lamb, R.J. (470) 157 Koek, W., see Wu, W.-P. (478) 131 Koenig, J.A., see Gonza´lez-Maeso, J. (481) 15 Kogo, H., see Unemoto, T. (472) 119 Kogo, H., see Itoh, F. (477) 9 Kohanrooz, B., see Oryan, S. (477) 123 Kohjitani, A., Miyawaki, T., Funahashi, M., Mitoh, Y., Matsuo, R. and Shimada, M. Mexiletine inhibits nonadrenergic noncholinergic lower oesophageal sphincter relaxation in rabbits (465) 145 Kohno, S., see Hirata, R. (474) 255 Kohno, S., see Sugahara, S. (476) 229 Kohno, S., see Fukuda, S. (476) 239 Koike, K., see Horinouchi, T. (473) 79

19

Koike, K., see Matsushita, M. (482) 235 Kojima, M., see Itoh, F. (477) 9 Kolhatkar, R., see Dutta, A.K. (479) 93 Komatsu, N., see Okamura, N. (461) 93 Komori, M., see Sekiguchi, F. (465) 153 Komori, S., see Zhu, B.-M. (460) 43 Kompella, U.B., see Ayalasomayajula, S.P. (458) 283 Komuro, G., see Ohta, T. (476) 159 Kondo, T., see Nakajima, M. (459) 113 Konishi, R., see Miyamoto, O. (459) 179 Kono, T., see Nakade, Y. (460) 135 Kono, T., see Yoneda, M. (478) 173 Konturek, J.W., see Konturek, S.J. (481) 1 Konturek, P.C., Brzozowski, T., Kania, J., Konturek, S.J., Kwiecien, S., Pajdo, R. and Hahn, E.G. Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat (472) 213 Konturek, P.C., see Harsch, I.A. (481) 249 Konturek, S.J., Zabielski, R., Konturek, J.W. and Czarnecki, J. Neuroendocrinology of the pancreas; role of brain – gut axis in pancreatic secretion (481) 1 Konturek, S.J., see Konturek, P.C. (472) 213 Konturek, S.J., see Dembin´ski, A. (473) 207 Konturek, S.J., see Harsch, I.A. (481) 249 Koolhaas, J.M., see De Boer, S.F. (463) 145 Koomans, H.A., see Braam, B. (464) 87 Kopajtic, T., see Katz, J.L. (468) 109 Kopljar, M., see Bedekovic, V. (477) 73 Koriyama, Y., Chiba, K. and Mohri, T. Propentofylline protects h-amyloid protein-induced apoptosis in cultured rat hippocampal neurons (458) 235 Korohoda, W., see Michalik, M. (475) 1 Korpi, E.R., see Ingman, K. (468) 121 Kosasa, T., see Akasofu, S. (472) 57 Koschorreck, S., Wenzel, F., Fuhrmann, M. and Racke´, K. Effects of phosphodiesterase inhibitors on L-arginine pathways in rat alveolar macrophages (471) 229 Koshikawa, N., see Adachi, K. (464) 147 Koshikawa, N., see Adachi, K. (473) 47 Koss, M.C., see Yu, Y. (471) 135 Kossmehl, P., see Rothermund, L. (468) 209 Kosugi, T., see Yoshinaga, M. (461) 9 Kosugi, T., see Yoshinaga, M. (465) 203 Kotlinska, J., Rafalski, P., Biala, G., Dylag, T., Rolka, K. and Silberring, J. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats (474) 233 Kourounakis, P.N., see Poussios, D. (465) 275 Kovacs, P., see Vecsernyes, M. (470) 177 Kova´cs, P., see Csont, T. (476) 107 Kow, L.-M., see Mong, J. (480) 229 Kowal, D., see Zhang, J.Y. (472) 33 Koyama, A., see Nishiki, K. (460) 171 Koyama, Y., see Sakaue, M. (458) 141 Kozawa, O., see Niwa, M. (466) 245 Kozlowski, R.Z., see Belsey, M.J. (474) 185 Kraft, P., see Qiu, Y. (472) 73 Kramer, V., see Pelissier, T. (477) 23 Kraneveld, A.D., see van der Kleij, H.P.M. (476) 249 Krause, D.N., see Stirone, C. (478) 35 Kreier, F., Kalsbeek, A., Ruiter, M., Yilmaz, A., Romijn, J.A., Sauerwein, H.P., Fliers, E. and Buijs, R.M. Central nervous determination of food storage—a daily switch from conservation to expenditure: implications for the metabolic syndrome (480) 51

20

Master author index to volumes 458 – 482 (2003)

Kremastinos, D.Th., see Sbarouni, E. (467) 163 Kreutz, R., see Rothermund, L. (468) 209 Krieg, J.-C., see Heiser, P. (476) 167 Kru¨gel, U., Schraft, T., Kittner, H., Kiess, W. and Illes, P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin (482) 185 Kruse, M.-L., see Sandmann, S. (458) 3 Krusekopf, S., Roots, I. and Kleeberg, U. Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43 (466) 7 Kubo, C., see Hirayama, K. (481) 59 Kubo, M., see Kamei, J. (469) 159 Kubohara, Y., Hanaoka, Y., Akaishi, E., Kobayashi, H., Maeda, M. and Hosaka, K. DIF-1, an anti-tumor substance found in Dictyostelium discoideum, inhibits progesterone-induced oocyte maturation in Xenopus laevis (460) 93 Kubota, A., see Akasofu, S. (472) 57 Kubota, Y., Nakahara, T., Mitani, A., Maruko, T., Sakamoto, K. and Ishii, K. Augmentation of rat urinary bladder relaxation mediated by h1adrenoceptors in experimental diabetes (467) 191 Kubota, Y., see Yunoki, M. (470) 65 Kudo, I., see Saito, M. (467) 151 Ku¨hn, J.P., see Staudt, Y. (466) 1 Kukharsky, V., see Harsch, I.A. (481) 249 Kula, N.S., see Neumeyer, J.L. (474) 137 Kulkarni, S.K., see Singh, A. (477) 87 Kumagai, K., see Ayada, K. (460) 63 Kumagai, Y., see Inoue, K.-i. (481) 261 Kumakiri, C., see Okamura, N. (461) 93 Kumar, R., Palit, G. and Dhawan, B.N. Comparative behavioural effects of typical and atypical antipsychotic drugs in rhesus monkey (462) 133 Kumar, S., see Khisti, R.T. (473) 225 Kume, T., see Takahata, K. (458) 81 Kume, T., see Osakada, F. (465) 15 Kume, T., see Taguchi, R. (477) 195 Kun, A., Martinez, A.C., Tanko´, L.B., Pataricza, J., Papp, J.Gy. and Simonsen, U. Ca2+-activated K+ channels in the endothelial cell layer involved in modulation of neurogenic contractions in rat penile arteries (474) 103 Kuno, Y., see Sato, E. (468) 191 Kuo, S.-C., see Chan, H.-C. (467) 31 Kurachi, M., see Uehara, T. (459) 211 Kurachi, M., see Takano, N. (471) 223 Kuraishi, Y., see Tanaka, K. (466) 191 Kurata, H., see Fujii, T. (474) 261 Kurata, H., see Fujii, T. (481) 241 Kurata, K., see Uehara, T. (459) 211 Kurata, Y., see Tabata, Y. (461) 73 Kurata, Y., see Tabata, Y. (465) 299 Kurihara, H., see Fukushima, Y. (468) 47 Kurihara, K.-i., see Tabata, Y. (461) 73 Kurihara, K.-i., see Tabata, Y. (465) 299 Kurihara, Y., see Fukushima, Y. (468) 47 Kurita, A., see Ishizuka, T. (468) 27 Kurokawa, M., Brown, J., Kagawa, Y. and Shiraki, K. Cytokine-regulatory activity and therapeutic efficacy of cinnamyl derivatives in endotoxin shock (474) 283 Kurosaki, E., Nakano, R., Momose, K., Shimaya, A., Suzuki, T., Shibasaki, M. and Shikama, H. Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats (468) 151

Kurosawa, H., see Yatsu, T. (458) 191 Kusama, H., see Itoh, F. (477) 9 Kuwabara, K., see Tomita, Y. (472) 147 Kwan, Y.W., see Chau, W.H. (464) 177 Kwan, Y.W., see Shan Au, A.L. (468) 199 Kwan, Y.W., see Lau, W.H. (470) 45 Kwiecien, S., see Konturek, P.C. (472) 213 Kwok, C.C., see Shan Au, A.L. (468) 199 Kwong, H.-L., see Wu, J.-C. (473) 9 Kyriakides, Z.S., see Sbarouni, E. (467) 163

La Casa, C., see Villegas, I. (460) 209 La Casa, C., see Martı´n, A.R. (481) 281 Laan, M., see Prause, O. (462) 193 Lacroix, P., Crumb, W.J., Durando, L. and Ciottoli, G.B. Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk (477) 69 La¨hdesma¨ki, J., Scheinin, M., Pertovaara, A. and Mansikka, H. The a2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception (468) 183 ¨ zdog˘an, U ¨ .K. (460) 127 La¨hdesma¨ki, J., see O Lai, C.-S., see Pieper, G.M. (472) 127 Lai, Z.-F., Chen, Y.-Z. and Nishi, K. Modulation of intracellular Cl homeostasis by lectin-stimulation in Jurkat T lymphocytes (482) 1 Lam, F.F.Y. and Ng, E.S.K. Characterisation of somatostatin actions on knee joint blood vessels of the rat (474) 295 Lamb, R.J., Munn, J., Duiker, N.J., Coop, A., Wu, H., Koek, W. and France, C.P. Interactions of g-hydroxy butyrate with ethanol and NCS 382 (470) 157 Lamb, R.J., see Ja¨rbe, T.U.C. (466) 121 Lamba´s Sen˜as, L., see Astier, B. (459) 17 Lamberty, Y., Falter, U., Gower, A.J. and Klitgaard, H. Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in the rat (469) 97 Lamberty, Y., see Ardid, D. (473) 27 Lamberty, Y., see Gower, A.J. (481) 67 Lambrecht, G., see Hu¨lsmann, M. (470) 1 Landes, R.D., see Byrnes-Blake, K.A. (461) 119 ¨ ., see Wu, W.-P. (482) 133 Langel, U Langenegger, D., see Nunn, C. (465) 211 Laorden, M.L., see Martı´nez, M.D. (471) 113 Laskowski, M., see Colvin, R.A. (479) 171 Lau, A.H.Y. and Chow, S.S.M. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells (464) 229 Lau, W.H., Kwan, Y.W., Au, A.L.S. and Cheung, W.H. An in vitro study of histamine on the pulmonary artery of the Wistar – Kyoto and spontaneously hypertensive rats (470) 45 Lau, W.H., see Chau, W.H. (464) 177 Laubinger, W., Wang, H., Welte, T. and Reiser, G. P2Y receptor specific for diadenosine tetraphosphate in lung: selective inhibition by suramin, PPADS, Ip5I, and not by MRS-2197 (468) 9 Laurens, M., see Crenesse, D. (473) 177 Laurenzana, E.M., see Byrnes-Blake, K.A. (461) 119 Laurido, C., see Pelissier, T. (477) 23 Lavich, T.R., Cordeiro, R.S.B., Calixto, J.B., E Silva, P.M.R. and Martins, M.A. Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats (462) 185 Law, P.-Y., see Portoghese, P.S. (478) 207 Law, R.E., see Bruemmer, D. (462) 15

Master author index to volumes 458 – 482 (2003) Law, R.E., see Bruemmer, D. (466) 225 Lawson, D., see Cannon, K.E. (470) 139 Lawson, J.A., see Hurst, R.S. (482) 31 Lazar, M.J., see Weiss, H.R. (481) 25 La´za´r, Z., see Benko´, R. (478) 73 Lazzarini, R., see da Silva, F.R. (478) 97 Leahy, C., see Olivier, B. (463) 117 Leal, S., see Diniz, C. (460) 191 Leander, J.D., see Wolff, M.C. (477) 213 LeBlanc, M.H., see Feng, Y. (481) 169 Leblond, F., see Bleau, A.-M. (473) 197 Lebre, V., see Castel-Branco, M. (482) 163 Lecchini, S., see Giaroni, C. (476) 63 Lee, B.H., see Choi, E.J. (482) 281 Lee, C.C., see Hu, C.M. (468) 37 Lee, D., see Gerasimov, M.R. (477) 45 Lee, E.-S., see Soo Lee, Y. (476) 173 Lee, J., see Adachi, K. (473) 47 Lee, J.-H., see Choi, S. (468) 83 Lee, K., see Lenkowski, P.W. (467) 23 Lee, M.Y.K. and Man, R.Y.K. The phytoestrogen genistein enhances endothelium-independent relaxation in the porcine coronary artery (481) 227 Lee, S.-M., see Choi, S. (468) 83 Lee, S.W., see Kang, B.Y. (467) 223 Lee, W.H., see Chau, W.H. (464) 177 Lee, Y.S., Yang, H.O., Shin, K.H., Choi, H.S., Jung, S.H., Kim, Y.M., Oh, D.K., Linhardt, R.J. and Kim, Y.S. Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achatina fulica (465) 191 Leitermann, R., see Mizoguchi, H. (461) 35 Lejeune, F. and Millan, M.J. The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats (464) 127 Lemus, A.E., see Perusquı´a, M. (475) 161 Lengyel, C., see Taka´cs, J. (470) 163 Lenkowski, P.W., Shah, B.S., Dinn, A.E., Lee, K. and Patel, M.K. Lidocaine block of neonatal Nav1.3 is differentially modulated by coexpression of h1 and h3 subunits (467) 23 Leone, S., see Mioni, C. (477) 227 Lepage, J.-F., see Roulet, A. (460) 85 Lepra´n, I. and Papp, J.Gy. Effect of long-term oral pretreatment with levosimendan on cardiac arrhythmias during coronary artery occlusion in conscious rats (464) 171 Leprince, P., see Fuks, B. (478) 11 Leriche, L., see Guillin, O. (480) 89 Lerner, M., see Matsumoto, R.R. (469) 1 Lesch, K.P., Zeng, Y., Reif, A. and Gutknecht, L. Anxiety-related traits in mice with modified genes of the serotonergic pathway (480) 185 Lesourd, M., see Astier, B. (459) 17 Leung, C.-H., see Wu, J.-C. (473) 9 Leung, S.W.S., see Cheng, X. (458) 299 Leurs, R., see Zhang, L. (482) 169 Leusink-Muis, T., see Ten Broeke, R. (476) 151 Levandoski, M.M., Piket, B. and Chang, J. The anthelmintic levamisole is an allosteric modulator of human neuronal nicotinic acetylcholine receptors (471) 9 Levent, A., see Bu¨yu¨kafsßar, K. (459) 263 Levin, E.D., see Rezvani, A.H. (465) 83 Levy, B., see Mansart, A. (475) 61 Levy-Toledano, S., see Capra, V. (474) 149 Leyton, J., see Moody, T.W. (474) 21

Li, Li, Li, Li, Li, Li, Li, Li, Li, Li,

21

C.G., see Che, Y. (462) 161 C.H., see Hu, C.M. (468) 37 D., see Wu, J.-C. (473) 9 G., see Zhang, Z. (467) 41 G.-R., see Xiao, G.-S. (473) 97 J., see Li, Y.F. (469) 81 J., see Lu, G. (478) 139 J., see Su, J. (482) 61 J.-X., see Zhang, Q. (467) 145 M. and McMillan, D.E. Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training (476) 79 Li, M.-H., see Zhang, L.-R. (462) 9 Li, M.-h., see Tan, W.-f. (459) 255 Li, S. and Zhao, Z.-Q. Morphine-induced decrease in mechanical allodynia is mediated by central, but not peripheral, opioid receptors in rats with inflammation (481) 203 Li, T., see Collier, D.A. (480) 177 Li, W., see Su, J. (482) 61 Li, Y.F., Gong, Z.H., Cao, J.B., Wang, H.L., Luo, Z.P. and Li, J. Antidepressant-like effect of agmatine and its possible mechanism (469) 81 Li, Y.-J., see Qin, X.-P. (464) 63 Liang, C.-s., see Qin, F. (461) 149 Liang, J.-H., see Zhang, Q. (467) 145 Liang, S., see Xiao, Y. (477) 1 Liang, X.-Q., see Zhang, Y. (474) 141 Liao, D.-F., see Qin, X.-P. (464) 63 Liao, J.-F., Hung, W.-Y. and Chen, C.-F. Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice (464) 141 Liao, J.W., see Hu, C.M. (468) 37 Liautaud-Roger, F., see Gimonet, D. (482) 25 Liaw, C.-T., see Liu, P.-S. (460) 9 Libby, T.A., see Katz, J.L. (468) 109 Lim, D.K. and Kim, H.S. Opposite modulation of glutamate uptake by nicotine in cultured astrocytes with/without cAMP treatment (476) 179 Lim, H., see Kim, K.Y. (465) 219 Lim, S.L., see Cheng, X. (458) 299 Lin, C.-H., see Hsiao, G. (465) 281 Lin, K.-H., see Hsiao, G. (465) 281 Lin, L.-F., see Liu, P.-S. (460) 9 Lin, L.-p., see Tan, W.-f. (459) 255 Lin, M.-K., see Liu, P.-S. (460) 9 Lin, Z., see Uhl, G.R. (479) 71 Lindblom, J., see Lindqvist, N. (482) 85 Linde´n, A., see Prause, O. (462) 193 Lindquist, C.E.L., see Smith, M. (478) 21 Lindqvist, N., Na¨pa¨nkangas, U., Lindblom, J. and Hallbo¨o¨k, F. Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection (482) 85 Ling, N., see Mackay, K.B. (469) 111 Linhardt, R.J., see Lee, Y.S. (465) 191 Linthicum, D.S., see Khare, S. (465) 23 Liou, K.-T., Shen, Y.-C., Chen, C.-F., Tsao, C.-M. and Tsai, S.-K. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production (475) 19 Lippa, A.S., see Skolnick, P. (461) 99 Liu, C., see Chen, J. (467) 57 Liu, C.-H., see Chan, H.-C. (467) 31 Liu, E.S.L., see Cho, C.H. (460) 177 Liu, J., see Bruemmer, D. (462) 15

22

Master author index to volumes 458 – 482 (2003)

Liu, J., see Bruemmer, D. (466) 225 Liu, P.-S., Liaw, C.-T., Lin, M.-K., Shin, S.-H., Kao, L.-S. and Lin, L.-F. Amphetamine enhances Ca2+ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells (460) 9 Liu, Q., see Wang, Y. (459) 269 Liu, Q., see Ja¨rbe, T.U.C. (466) 121 Liu, Q., see Gan, L. (471) 217 Liu, R.-H., Mizuta, M. and Matsukura, S. Long-term oral nicotine administration reduces insulin resistance in obese rats (458) 227 Liu, R.-K., see Zhang, Q. (467) 145 Liu, S., Hu, H.-Z., Gao, C., Gao, N., Wang, G., Wang, X., Gao, X., Xia, Y. and Wood, J.D. Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine (459) 27 Liu, S., Hu, H.-Z., Gao, C., Gao, N., Xia, Y. and Wood, J.D. Actions of galanin on neurotransmission in the submucous plexus of guinea pig small intestine (471) 49 Liu, Y., see Matsumoto, R.R. (469) 1 Liu, Y.-C. and Wu, S.-N. Block of erg current by linoleoylamide, a sleep-inducing agent, in pituitary GH3 cells (458) 37 Livni, E., see Madras, B.K. (479) 41 Lloyd-Davies, R.W., see Amobi, N. (462) 169 Lloyd-Davies, R.W., see Amobi, N. (464) 241 Loeb, J., see Neudeck, B.L. (467) 81 Loetscher, E., see Kalkman, H.O. (462) 33 Lo¨f, E., see Ericson, M. (467) 85 Lograno, M.D. and Romano, M.R. Pharmacological characterization of the 5-HT1A, 5-HT2 and 5-HT3 receptors in the bovine ciliary muscle (464) 69 Loh, H.H., see Portoghese, P.S. (478) 207 Loizzo, A., Capasso, A., Galietta, G., Severini, C., Campana, G. and Spampinato, S. Vas deferens response to selective opioid receptor agonists in adult mice is impaired following postnatal repeated mild stress (458) 201 Loland, C.J., Norgaard-Nielsen, K. and Gether, U. Probing dopamine transporter structure and function by Zn2+-site engineering (479) 187 Longmore, J., see Scott, P. (458) 319 Lonovics, J., see Rakonczay Jr., Z. (464) 217 Lo´pez, M., see Rivero, A. (482) 77 Lo´pez, U.G., see De´ciga-Campos, M. (460) 99 Lo´pez-Caldero´n, A., see Iba´n˜ez de Ca´ceres, I. (481) 293 Lo´pez-Corcuera, B., see Arago´n, C. (479) 249 Lo´pez-Mun˜oz, F.J., see De´ciga-Campos, M. (460) 99 Lo´pez-Mun˜oz, F.J., see Herna´ndez-Delgadillo, G.P. (469) 71 Lo´pez-Rodrı´guez, M.L., see Pascual, D. (462) 99 Loprevite, M., see de Cupis, A. (473) 83 Loscalzo, J., see Scribner, A.W. (482) 95 Lo¨scher, W., Potschka, H., Wlaz´, P., Danysz, W. and Parsons, C.G. Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats (466) 99 Lo¨tvall, J., see Prause, O. (462) 193 Louch, W.E., see Au, A. (476) 45 Louhelainen, M., see Cheng, Z.J. (461) 159 Lovenberg, T.W., see Chen, J. (467) 57 Low, K.S.Y., see Sachidhanandam, S.B. (474) 121 Low-Tone Ho, L., see Kan, S.-F. (468) 141 Lowery, O.B., see Breivogel, C.S. (459) 139 Lowes, S., Cavet, M.E. and Simmons, N.L. Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers (458) 49 Lu, G., Su, R.-B., Li, J. and Qin, B.-Y. Modulation by a-difluoromethyl-ornithine and aminoguanidine of pain threshold, morphine analgesia and tolerance (478) 139

Lu, J., see Sachidhanandam, S.B. (474) 121 Lu¨bbert, H., see Simmen, U. (458) 251 Luciani, S., see Bova, S. (470) 185 Lu¨hrmann, A., see Ba¨umer, W. (481) 271 Lukevics, E., see Arsenyan, P. (465) 229 Lundeen, S., see Qiu, Y. (472) 73 Lundstro¨m, L., see Wu, W.-P. (482) 133 Lunzer, M.M., see Portoghese, P.S. (467) 233 Luo, Z.P., see Li, Y.F. (469) 81 Lynch, B., see Fuks, B. (478) 11

Ma, J., Nakajima, T., Iida, H., Iwasawa, K., Terasawa, K., Oonuma, H., Jo, T., Morita, T., Imuta, H., Suzuki, J.-i., Hirose, K., Okuda, Y., Yamada, N., Nagai, R. and Omata, M. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells (464) 79 Ma, S.-X., Ji, A., Pandjaitan, M. and Ojije, G. Enhanced nitric oxide release/synthesis in the posterior hypothalamus during nitroglycerin tolerance in rats (472) 179 Ma, X., Wang, H., Xin, J., Zhang, T. and Tu, Z. Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A (461) 89 Maack, C., see Cremers, B. (467) 169 Mabley, J., Soriano, F., Pacher, P., Hasko´, G., Marton, A., Wallace, R., Salzman, A. and Szabo´, C. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5V-Nmethyluronamide, is protective in two murine models of colitis (466) 323 Macalello, M.A., see Di Micco, B. (460) 59 Macielag, M., see Qiu, Y. (472) 73 MacIntyre, D.E., see Shearman, L.P. (475) 37 Mackay, K.B., Stiefel, T.H., Ling, N. and Foster, A.C. Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the rat (469) 111 MacLeod, K.M., see Subramanian, R. (477) 143 Ma˛czewski, M. and Bere˛sewicz, A. Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart (461) 139 Maddock, H.L., Gardner, N.M., Khandoudi, N., Bril, A. and Broadley, K.J. Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA (477) 235 Madras, B.K., Fahey, M.A., Miller, G.M., De La Garza, R., Goulet, M., Spealman, R.D., Meltzer, P.C., George, S.R., O’Dowd, B.F., Bonab, A.A., Livni, E. and Fischman, A.J. Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors (479) 41 Maeda, M., see Kubohara, Y. (460) 93 Maeda, Y., see Yamamoto, T. (477) 253 Maeyama, K., see Yokota, T. (481) 233 Mager, S. and Sloan, J. Possible role of amino acids, peptides, and sugar transporter in protein removal and innate lung defense (479) 263 Maione, S., see De Novellis, V. (462) 73 Maior, R.S., see Barros, M. (482) 197 Maity, S., Ukil, A., Karmakar, S., Datta, N., Chaudhuri, T., Vedasiromoni, J.R., Ganguly, D.K. and Das, P.K. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis (470) 103 Maki, M., see Okamoto, H. (466) 147 Makino, I., see Nakade, Y. (460) 135 Makriyannis, A., see Ja¨rbe, T.U.C. (466) 121 Malan, D., see Bedendi, I. (476) 87 Malan, S.F., see Geldenhuys, W.J. (458) 73 Maldonado, P.D., see Pedraza-Chaverrı´, J. (473) 71 Maldonado, R., see Ce´le´rier, E. (465) 69 Malek, S., see Min, J.-Y. (471) 41

Master author index to volumes 458 – 482 (2003) Malinin, A.I., Atar, D., Callahan, K.P., McKenzie, M.E. and Serebruany, V.L. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease (462) 139 Malizia, A.L., see Melichar, J.K. (459) 217 Mallet, P.E., see Norwood, C.S. (465) 105 Mallie´, J.-P., see Mansart, A. (475) 61 Malliopoulou, V., see Pantos, C. (460) 155 Malliopoulou, V., see Pantos, C. (478) 53 Malmsjo¨, M., Hou, M., Pendergast, W., Erlinge, D. and Edvinsson, L. The stable pyrimidines UDPhS and UTPgS discriminate between contractile cerebrovascular P2 receptors (458) 305 Man, R.Y.K., see Lee, M.Y.K. (481) 227 Ma´n˜ez, S., see Sala, A. (460) 219 Ma´n˜ez, S., see Sala, A. (461) 53 Manda, T., see Hosogai, N. (473) 65 Manda, T., see Hosogai, N. (477) 171 Manda, T., see Yamamoto, T. (477) 253 Manduteanu, I., Voinea, M., Antohe, F., Dragomir, E., Capraru, M., Radulescu, L. and Simionescu, M. Effect of enoxaparin on high glucose-induced activation of endothelial cells (477) 269 Manev, H., see Satta, R. (473) 149 Manfredi, B., see Rossoni, G. (477) 59 Mangravite, L.M., Badagnani, I. and Giacomini, K.M. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney (479) 269 Mann, B.E., see Stanford, S.J. (473) 135 Mannaioni, P.F., see Vannacci, A. (465) 289 Ma¨nnisto¨, P.T., see Yavich, L. (462) 83 Mano, Y., see Matsumoto, M. (482) 177 Mansart, A., Bollaert, P.-E., Levy, B., Nicolas, M.-B. and Mallie´, J.-P. Comparative effects of dexamethasone and L-canavanine in experimental septic shock (475) 61 Mansfield, K.J., Mitchelson, F.J., Moore, K.H. and Burcher, E. Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes (482) 101 Mansikka, H., see La¨hdesma¨ki, J. (468) 183 Mansvelder, H.D., De Rover, M., McGehee, D.S. and Brussaard, A.B. Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction (480) 117 Mao, W., see Qin, F. (461) 149 Marabese, I., see De Novellis, V. (462) 73 Marcantoni, A., see Bedendi, I. (476) 87 Marchese, G., see Casu, M.A. (459) 97 Marco, J., see Silvestre, R.A. (469) 195 Marek, G.J. Behavioral evidence for A-opioid and 5-HT2A receptor interactions (474) 77 Maresch, M.J., see Rasmussen, S.G.F. (479) 13 Margineanu, D.G. and Klitgaard, H. Levetiracetam has no significant g-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats (466) 255 Marino, R., see Castorina, M. (477) 129 Markou, A., see Semenova, S. (472) 99 Markwardt, F., see Hu¨lsmann, M. (470) 1 Maronas, P.A., see Zapata-Sudo, G. (470) 79 Marques, F.F., see Holder, J.R. (462) 41 Marti, L., see Visentin, V. (466) 235 Martı´n, A.I., see Iba´n˜ez de Ca´ceres, I. (481) 293 Martı´n, A.R., La Casa, C. and Alarco´n de la Lastra, C. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats (481) 281 Martin, B.R., see Breivogel, C.S. (459) 139 Martin, B.R., see Darmani, N.A. (459) 83

23

Martin, B.R., see Wiley, J.L. (471) 185 Martı´n, M.I., see Pascual, D. (462) 99 Martinelli, C., see Nieri, P. (475) 115 Martinez, A.C., see Kun, A. (474) 103 Martinez, L.L., see Zanardo, R.C.O. (478) 211 Martı´nez, M.A., Ferna´ndez, N., Climent, B., Garcı´a-Villalo´n, A.-L., Monge, L., Sanz, E. and Die´guez, G. Coronary effects of vasopressin during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids (473) 55 Martı´nez, M.A., see Garcı´a-Villalo´n, A.L. (459) 247 Martı´nez, M.A., see Ferna´ndez, N. (481) 109 Martı´nez, M.D., Milane´s, M.V. and Laorden, M.L. Implication of the signal transduction pathways in the enhancement of noradrenaline turnover induced by morphine withdrawal in the heart (471) 113 Martinotti, E., see Nieri, P. (459) 75 Martinotti, E., see Nieri, P. (475) 115 Martins, M.A., see Lavich, T.R. (462) 185 Martins, M.A., see Carvalho, V.F. (472) 221 Marton, A., see Mabley, J. (466) 323 Maruko, T., see Kubota, Y. (467) 191 Maruko, T., see Moriuchi, H. (470) 57 Maruko, T., see Yunoki, M. (470) 65 Marumo, M., see Wakabayashi, I. (464) 27 Maruoka, H., see Tomimori, Y. (478) 179 Marzocca, C., see Vannacci, A. (465) 289 Mascia, F.M., see Onali, P. (471) 77 Masini, E., see Vannacci, A. (465) 289 Masood, A., Banerjee, B., Vijayan, V.K. and Ray, A. Modulation of stress-induced neurobehavioral changes by nitric oxide in rats (458) 135 Massalas, J.S., see Wong, J.Y.F. (472) 39 Massingham, R., see Christophe, B. (470) 87 Massingham, R., see Gillard, M. (478) 1 Masuda, H., see Yamagishi, K. (462) 53 Mather, L.E., see Edwards, S.R. (460) 27 Matheson, P.J., see Adeagbo, A.S.O. (481) 91 Mathon, D.S., Kamal, A., Smidt, M.P. and Ramakers, G.M.J. Modulation of cellular activity and synaptic transmission in the ventral tegmental area (480) 97 Mathy, M.-J., see Nap, A. (469) 117 Matsuda, H., Pongpiriyadacha, Y., Morikawa, T., Ochi, M. and Yoshikawa, M. Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: structural requirements and mode of action (471) 59 Matsuda, N., see Zhang, X.-H. (476) 131 Matsuda, T., see Sakaue, M. (458) 141 Matsuda, T., see Takahashi, K. (458) 155 Matsui, H., see Yokota, T. (481) 233 Matsui, M., see Karasawa, H. (468) 15 Matsui, S., Zong, Z.-P., Han, J.-F., Katsuda, S., Yamaguchi, N. and Fu, M.L.X. Amiodarone minimizes experimental autoimmune myocarditis in rats (469) 165 Matsui, T., see Ishizuka, T. (468) 27 Matsukura, S., see Liu, R.-H. (458) 227 Matsumoto, K. and Iijima, H. Sibutramine sensitivity assay revealed a unique phenotype of bombesin BB3 receptor-deficient mice (473) 41 Matsumoto, K., see Tokutomi, Y. (477) 137 Matsumoto, M., Kanno, M., Togashi, H., Ueno, K.-i., Otani, H., Mano, Y. and Yoshioka, M. Involvement of GABAA receptors in the regulation of the prefrontal cortex on dopamine release in the rat dorsolateral striatum (482) 177

24

Master author index to volumes 458 – 482 (2003)

Matsumoto, R.R., Liu, Y., Lerner, M., Howard, E.W. and Brackett, D.J. j Receptors: potential medications development target for anti-cocaine agents (469) 1 Matsumura, Y., see Ohkita, M. (472) 159 Matsumura, Y., see Fujii, T. (474) 261 Matsumura, Y., see Ogata, M. (478) 187 Matsumura, Y., see Fujii, T. (481) 241 Matsuno, H., see Niwa, M. (466) 245 Matsuo, M., see Yamamoto, T. (477) 253 Matsuo, R., see Kohjitani, A. (465) 145 Matsuoka, N., see Katsuta, K. (467) 103 Matsushima, M., Kitaichi, K., Tatsumi, Y., Hasegawa, T. and Takagi, K. The expression of mRNA for calcitonin receptor-like receptor/ receptor-activity modifying proteins in rat peritoneal mast cells (464) 111 Matsushima, M., see Kitaichi, K. (464) 39 Matsushita, M., Horinouchi, T., Tanaka, Y., Tsuru, H. and Koike, K. Characterization of h3-adrenoceptor-mediated relaxation in rat abdominal aorta smooth muscle (482) 235 Matsuura, B., see Yokota, T. (481) 233 Matsuura, N., see Ohmori, K. (471) 69 Matsuyama, H., see Thapaliya, S. (461) 129 Maurel, P., see Bleau, A.-M. (473) 197 Mayorgas, I., see Ruiz-Nun˜o, A. (481) 41 Mazzola, C., Micale, V. and Drago, F. Amnesia induced by h-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade (477) 219 Mazzola, C., see Nicosia, A. (469) 103 Mbafor, J.T., see Njamen, D. (468) 67 Mbanya, J.-C., see Njamen, D. (468) 67 McCullumsmith, R.E., Stincic, T.L., Agrawal, S.M. and Meador-Woodruff, J.H. Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat (477) 101 McDonald, M.C., d’Emmanuele di Villa Bianca, R., Wayman, N.S., Pinto, A., Sharpe, M.A., Cuzzocrea, S., Chatterjee, P.K. and Thiemermann, C. A superoxide dismutase mimetic with catalase activity (EUK-8) reduces the organ injury in endotoxic shock (466) 181 McDonald, M.C., see Chatterjee, P.K. (482) 271 McDonald, W.G., see Hurst, R.S. (482) 31 McFadzean, I., see Gibson, A. (471) 213 McGehee, D.S., see Mansvelder, H.D. (480) 117 McGrath, J.P., see Hurst, R.S. (482) 31 McGregor, G.P., see Hagner, S. (481) 147 McGregor, I.S., see Norwood, C.S. (465) 105 McGregor, I.S., see Cornish, J.L. (482) 339 McKenzie, M.E., see Malinin, A.I. (462) 139 McMahon, L.R., Coop, A., France, C.P., Winger, G. and Woolverton, W.L. Evaluation of the reinforcing and discriminative stimulus effects of 1,4-butanediol and g-butyrolactone in rhesus monkeys (466) 113 McMillan, D.E., see Li, M. (476) 79 McNaughton, N.C.L., see Hainsworth, A.H. (467) 77 McPhie, G.I., see Evans, N.M. (466) 31 Meador-Woodruff, J.H., see McCullumsmith, R.E. (477) 101 Mealing, G., see Tauskela, J.S. (464) 17 Mechiel Korte, S. and De Boer, S.F. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze (463) 163 Mechoulam, R., see Fride, E. (461) 27 Medico, M., see Nicosia, A. (469) 103 Medina-Campos, O.N., see Pedraza-Chaverrı´, J. (473) 71 Meglasson, M.D., see Hurst, R.S. (482) 31 Mehlhorn, U., see Bundkirchen, A. (476) 97

Mehr, S.E., Samini, M., Namiranian, K., Homayoun, H., Gaskari, S.A. and Dehpour, A.R. Inhibition by immunophilin ligands of morphine-induced tolerance and dependence in guinea pig ileum (467) 205 Meilhac, O., see Haloui, M. (474) 175 Meissner, A., see Min, J.-Y. (471) 41 Melani, A., see Corsi, C. (464) 33 Meldrum, B.S., see Moldrich, R.X. (476) 3 Melichar, J.K., Nutt, D.J. and Malizia, A.L. Naloxone displacement at opioid receptor sites measured in vivo in the human brain (459) 217 Mello Jr., E.L., see Barros, M. (482) 197 Melo, P.S., see Albino de Almeida, A.B. (472) 205 Meltzer, P.C., see Madras, B.K. (479) 41 Mendoza, E., see Barral, J. (462) 91 Mennini, T., Fumagalli, E., Gobbi, M., Fattorusso, C., Catalanotti, B. and Campiani, G. Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations (479) 291 Menniti, F.S., see Ramirez, A.D. (475) 29 Merasto, S., see Cheng, Z.J. (461) 159 Mercer, J.G. and Tups, A. Neuropeptides and anticipatory changes in behaviour and physiology: seasonal body weight regulation in the Siberian hamster (480) 43 Mervaala, E.M.A., see Cheng, Z.J. (461) 159 Meurs, H., see Gosens, R. (481) 125 Meyer-Kirchrath, J., see Debey, S. (474) 161 Mezzadri, C.M., see Tubaro, E. (467) 173 Mi, Z., see Thomas, N.J. (465) 133 Micale, V., see Mazzola, C. (477) 219 Michalik, M., Pierzchalska, M., Pabian´czyk-Kulka, A. and Korohoda, W. Procaine-induced enhancement of fluid-phase endocytosis and inhibition of exocytosis in human skin fibroblasts (475) 1 Michaluk, J., see Antkiewicz-Michaluk, L. (466) 263 Michel, J.-B., see Haloui, M. (474) 175 Michel, P., see Gillard, M. (478) 1 Michel, P., see Fuks, B. (478) 11 Michelsen, S., see Voss, J. (482) 215 Miczek, K.A., see Covington III, H.E. (467) 1 Midoro, K., see Fukuda, S. (476) 239 Mihara, K., see Kato, Y. (473) 163 Milane´s, M.V., see Martı´nez, M.D. (471) 113 Millan, M.J. and Brocco, M. The Vogel conflict test: procedural aspects, g-aminobutyric acid, glutamate and monoamines (463) 67 Millan, M.J., see Lejeune, F. (464) 127 Miller, G.M., see Madras, B.K. (479) 41 Min, J.-Y., Meissner, A., Feng, X., Wang, J., Malek, S., Wang, J.-F., Simon, R. and Morgan, J.P. Dantrolene: effects on abnormal intracellular Ca2+ handling and inotropy in postinfarcted rat myocardium (471) 41 Minami, H., see Yasuda, N. (459) 159 Minneman, K.P., see Pupo, A.S. (462) 1 Mio, M., see Shinomiya, K. (460) 139 Mioni, C., Giuliani, D., Cainazzo, M.M., Leone, S., Iannone, C., Bazzani, C., Grieco, P., Novellino, E., Tomasi, A., Bertolini, A. and Guarini, S. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors (477) 227 Mise, S., see Bedekovic, V. (477) 73 Mishima, K., see Yamagishi, K. (462) 53 Misiano, P., Scott, B.B., Scheideler, M.A. and Garnier, M. PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation (468) 159

Master author index to volumes 458 – 482 (2003) Mitani, A., Nakahara, T., Sakamoto, K. and Ishii, K. Expression of multidrug resistance protein 4 and 5 in the porcine coronary and pulmonary arteries (466) 223 Mitani, A., see Kubota, Y. (467) 191 Mitani, A., see Yunoki, M. (470) 65 Mitch, C.H., see Statnick, M.A. (482) 139 Mitchell, J.A., see Price, S. (472) 111 Mitchell, J.A., see Stanford, S.J. (473) 135 Mitchell, S.N., see Moss, S. (460) 117 Mitchelson, F.J., see Mansfield, K.J. (482) 101 Mitoh, Y., see Kohjitani, A. (465) 145 Mitsui-Saito, M., see Kawamata, M. (472) 229 Mitsumoto, Y., see Zhai, H. (474) 199 Mitsuyo, T., Adachi, N., Yorozuya, T., Tabo, E., Nagaro, T. and Arai, T. Facilitation of ischemia-induced release of dopamine and neuronal damage by dexamethasone in the rat striatum (465) 267 Miwa, T., see Kobayashi, H. (470) 9 Miwa, T., see Nakai, S. (472) 89 Miyahara, Y., see Okatani, Y. (465) 163 Miyahara, Y., see Okatani, Y. (469) 145 Miyajima, K., see Ohta, T. (476) 159 Miyake, M., see Ito, A. (468) 59 Miyamoto, O., Tamae, K., Kasai, H., Hirakawa, H., Hayashida, Y., Konishi, R. and Itano, T. Suppression of hyperemia and DNA oxidation by indomethacin in cerebral ischemia (459) 179 Miyamoto, S., see Zhu, B.-M. (460) 43 Miyata, K., see Sugiyama, A. (466) 137 Miyata, K., see Terai, K. (467) 95 Miyata, K., see Yuyama, H. (478) 61 Miyata, S., see Kato, Y. (473) 163 Miyatake, T., see Abe, K. (465) 237 Miyawaki, T., see Kohjitani, A. (465) 145 Miyayasu, K., see Hirayama, Y. (467) 197 Miyazaki, K., see Itagaki, S. (475) 85 Mizoguchi, H., Hung, K.-c., Leitermann, R., Narita, M., Nagase, H., Suzuki, T. and Tseng, L.F. Blockade of A-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice (461) 35 Mizuta, M., see Liu, R.-H. (458) 227 Mizutani, N., see Sugahara, S. (476) 229 Mo, B. and Pater, A. Apoptosis, 5-fluorouracil sensitivity and expression of apoptotic proteins in a human ectocervical cell carcinogenesis model using different media (467) 15 Mobini, R., see Staudt, Y. (466) 1 Modiano, J.F., see Khare, S. (465) 23 Mohri, T., see Koriyama, Y. (458) 235 Mohy El-Din, M.M., see El-Mas, M.M. (468) 217 Molander, A. and So¨derpalm, B. Pre- and postsynaptic dopamine mechanisms after repeated nicotine: effects of adrenalectomy (481) 51 Molander, A., see Ericson, M. (467) 85 Moldrich, R.X., Chapman, A.G., De Sarro, G. and Meldrum, B.S. Glutamate metabotropic receptors as targets for drug therapy in epilepsy (476) 3 Molina-Jimenez, M.F., Sanchez-Reus, M.I. and Benedi, J. Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine (472) 81 Molinari, P., see Granata, F. (482) 17 Molinoff, P.B., see Nakai, S. (472) 89 Molleman, A., see Ihenetu, K. (458) 207 Molleman, A., see Ihenetu, K. (464) 207 Moller, D.E., see Bruemmer, D. (466) 225 Momose, K., see Kurosaki, E. (468) 151 Momose, K., see Nobe, K. (471) 195

25

Moncada, A., Cenda´n, C.M., Baeyens, J.M. and Del Pozo, E. Effects of serine/threonine protein phosphatase inhibitors on morphineinduced antinociception in the tail flick test in mice (465) 53 Monette, R., see Tauskela, J.S. (464) 17 Mong, J., Easton, A., Kow, L.-M. and Pfaff, D. Neural, hormonal and genetic mechanisms for the activation of brain and behavior (480) 229 Monge, L., see Garcı´a-Villalo´n, A.L. (459) 247 Monge, L., see Sanz, E. (471) 35 Monge, L., see Martı´nez, M.A. (473) 55 Monge, L., see Ferna´ndez, N. (481) 109 Monteiro, P., Duarte, A.I., Moreno, A., Goncßalves, L.M. and Provideˆncia, L.A. Carvedilol improves energy production during acute global myocardial ischaemia (482) 245 Monti, J.M. and Jantos, H. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat (478) 121 Moochhala, S.M., see Sachidhanandam, S.B. (474) 121 Moody, T.W., Leyton, J., Garcia-Marin, L. and Jensen, R.T. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells (474) 21 Moore, K., see Yang, W. (461) 41 Moore, K.H., see Mansfield, K.J. (482) 101 Moraitis, P., see Pantos, C. (460) 155 Moraitis, P., see Pantos, C. (478) 53 Morales, B., see Coddou, C. (472) 49 Morales, L., see Herrado´n, G. (465) 251 Moreira, O.R., see Zapata-Sudo, G. (470) 79 Moreland, R.B., see Hsieh, G.C. (458) 183 Moreland, R.S., see Adegunloye, B.J. (476) 201 Morelli, M., see Corsi, C. (464) 33 Moreno, A., see Monteiro, P. (482) 245 Moretti, M.D.L., see Peana, A.T. (460) 37 Morgan, J.P., see Min, J.-Y. (471) 41 Morgan, N.G., see Cooper, E.J. (482) 189 Morgulis, M.S.F.A., see da Silva, F.R. (478) 97 Mori, H., see Niwa, M. (466) 245 Mori, M., see Fujimoto, S. (459) 65 Mori, M., see Yuyama, H. (478) 61 Morikawa, T., see Matsuda, H. (471) 59 Morimoto, K., see Hada, J. (467) 119 Morimoto, S., see Isomae, K. (465) 97 Morin, D., see Elimadi, A. (468) 93 Morishita, M., see Ito, A. (468) 59 Morishita, Y., see Kitaichi, K. (464) 39 Morita, K. and Kamei, J. Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist (474) 269 Morita, K., see Isomae, K. (465) 97 Morita, K., see Kamei, J. (467) 219 Morita, M., see Inoue, K.-i. (481) 261 Morita, T., see Ma, J. (464) 79 Moriuchi, H., Nakahara, T., Maruko, T., Sakamoto, K. and Ishii, K. Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle (470) 57 Morley, K.C., see Cornish, J.L. (482) 339 Morley, P., see Tauskela, J.S. (464) 17 Morley, R.M., see Belsey, M.J. (474) 185 Morrow, A.L., see Khisti, R.T. (473) 225 Morteau, O., see van der Kleij, H.P.M. (476) 249 Mortensen, M., Wafford, K.A., Wingrove, P. and Ebert, B. Pharmacology of GABAA receptors exhibiting different levels of spontaneous activity (476) 17 Mortensen, O.V. and Amara, S.G. Dynamic regulation of the dopamine transporter (479) 159

26

Master author index to volumes 458 – 482 (2003)

Moskowitz, M.A., see Salomone, S. (469) 125 Moss, S., Sharott, A., Goodhead, L.H. and Mitchell, S.N. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens (460) 117 Mossay, D., see Boland, A. (466) 21 Motterlini, R., see Stanford, S.J. (473) 135 Mourouzis, I., see Pantos, C. (460) 155 Mourouzis, I., see Pantos, C. (478) 53 Muccioli, G., see Bedendi, I. (476) 87 Mu¨hl, H., Ho¨fler, S. and Pfeilschifter, J. Inhibition of lipopolysaccharide/ATP-induced release of interleukin-18 by KN-62 and glyburide (482) 325 Mu¨hlbauer, E. and Rommelspacher, H. Ethanol differently affects stress protein and HERG K+ channel expression in SH-SY5Y cells (459) 121 Mule`, F., see Serio, R. (460) 183 Mu¨ller, C.P., see Barros, M. (482) 197 Munn, J., see Lamb, R.J. (470) 157 Mun˜oz, C., see Astier, B. (459) 17 Munzar, P., see Yasar, S. (465) 257 Mura, E., see Six, I. (458) 327 Murad, J.M., see Watanabe, M.A.E. (465) 205 Murakami, M., see Yasuda, N. (459) 159 Murakami, Y., see Okada, S. (467) 125 Muramatsu, I., see Takahashi, M. (467) 185 Muraoka, S., see Takahata, K. (458) 81 Muraoka, T., see Fujii, T. (474) 261 Muraoka, T., see Fujii, T. (481) 241 Murari, G., see Spampinato, S. (469) 89 Murayama, S., see Yoshinaga, M. (461) 9 Murayama, S., see Yoshinaga, M. (465) 203 Murayama, T., see Nemoto, T. (458) 17 Murray, F., see Guscott, M.R. (476) 193 Muto, T., see Tomimori, Y. (478) 179 Muto, Y., Suzuki, K., Sato, E. and Ishii, H. Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats (461) 181 Mutoh, S., see Hirayama, Y. (467) 197 Mutoh, S., see Hosogai, N. (473) 65 Mutoh, S., see Kato, Y. (473) 163 Mutoh, S., see Hosogai, N. (477) 171 Mutoh, S., see Yamamoto, T. (477) 253

Nabe, T., see Hirata, R. (474) 255 Nabe, T., see Sugahara, S. (476) 229 Nabe, T., see Fukuda, S. (476) 239 Nabeshima, T., see Hefco, V. (474) 227 Nabeshima, T., see Hefco, V. (475) 55 Nagai, R., see Ma, J. (464) 79 Nagai, R., see Fukushima, Y. (468) 47 Nagakura, Y., see Kadowaki, M. (458) 197 Nagao, T., see Hagiwara, M. (466) 63 Nagao, T., see Kobayashi, H. (470) 9 Nagaoka, J., see Yasuda, N. (459) 159 Nagaro, T., see Mitsuyo, T. (465) 267 Nagasaka, T., Izumi, M., Hori, M., Ozaki, H. and Karaki, H. Positive inotropic effect of endothelin-1 in the neonatal mouse right ventricle (472) 197 Nagasawa, Y., see Zhu, B.-M. (460) 43 Nagase, H., see Okura, T. (459) 9 Nagase, H., see Kamei, J. (467) 219 Nagase, H., see Mizoguchi, H. (461) 35 Nagase, H., see Umeuchi, H. (477) 29 Nagata, K., see Yasuda, N. (459) 159 Nagaya, H., see Fukuda, S. (476) 239

Nah, S.-Y., see Choi, S. (468) 83 Naidu, P.S., see Singh, A. (477) 87 Naito, S., see Yunoki, T. (482) 287 Nakade, K., see Zhai, H. (474) 199 Nakade, Y., Yoneda, M., Yokohama, S., Tamori, K., Nakamura, K., Watanobe, H., Kono, T., Makino, I. and Terano, A. Central injection of astressin inhibits carbon tetrachloride-induced acute liver injury in rats (460) 135 Nakahara, T., see Mitani, A. (466) 223 Nakahara, T., see Kubota, Y. (467) 191 Nakahara, T., see Moriuchi, H. (470) 57 Nakahara, T., see Yunoki, M. (470) 65 Nakahata, N., Tsuchiya, C., Nakatani, K., Ohizumi, Y. and Ohkubo, S. Baicalein inhibits Raf-1-mediated phosphorylation of MEK-1 in C6 rat glioma cells (461) 1 Nakai, M., see Nakai, S. (472) 89 Nakai, S., Hirose, T., Uwahodo, Y., Imaoka, T., Okazaki, H., Miwa, T., Nakai, M., Yamada, S., Dunn, B., Burris, K.D., Molinoff, P.B., Tottori, K., Altar, C.A. and Kikuchi, T. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone (472) 89 Nakai, T., see Hayashi, M. (462) 61 Nakaie, C.R., see Francßa, L.P. (476) 25 Nakajima, M., Hayashi, K., Katayama, K.-i., Amano, Y., Egi, Y., Uehata, M., Goto, N. and Kondo, T. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions (459) 113 Nakajima, T., see Ma, J. (464) 79 Nakamura, K., Okada, S., Ono, K. and Yokotani, K. Effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2a on the release of noradrenaline from the isolated rat stomach (470) 73 Nakamura, K., see Yokotani, K. (459) 187 Nakamura, K., see Nakade, Y. (460) 135 Nakamura, K., see Yoneda, M. (478) 173 Nakamura, M., see Yoshinaga, M. (461) 9 Nakamura, M., see Yoshinaga, M. (465) 203 Nakamura, R., see Kamei, J. (469) 159 Nakamura, Y., see Sugiyama, A. (466) 137 Nakamura, Y., see Sugimoto, Y. (470) 113 Nakano, R., see Kurosaki, E. (468) 151 Nakao, K., see Umeuchi, H. (477) 29 Nakashima, T., see Sone, M. (482) 313 Nakatani, K., see Nakahata, N. (461) 1 Nakayama, K., see Saito, M. (467) 151 Nakayama, K., see Hayashi, K.-i. (482) 305 Nakazawa, K., Ojima, H., Ishii-Nozawa, R., Takeuchi, K. and Ohno, Y. Intracellular disulfide bond that affects ATP responsiveness of P2X2 receptor/channel (474) 205 Nalwalk, J.W., see Cannon, K.E. (470) 139 Namiki, T., see Bai, C.-X. (476) 35 Namiranian, K., see Mehr, S.E. (467) 205 Nangle, M.R., Cotter, M.A. and Cameron, N.E. Protein kinase Ch inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice (475) 99 Nango, R., Terada, C. and Tsukamoto, I. Jun N-terminal kinase activation and upregulation of p53 and p21WAF1/CIP1 in selenite-induced apoptosis of regenerating liver (471) 1 Nap, A., Mathy, M.-J., Balt, J.C., Pfaffendorf, M. and van Zwieten, P.A. Pre- and postsynaptic inhibitory potencies of the angiotensin AT1 receptor antagonists eprosartan and candesartan (469) 117 Na¨pa¨nkangas, U., see Lindqvist, N. (482) 85 Napoli, C., see Scribner, A.W. (482) 95 Nappi, G., see Tassorelli, C. (464) 159 Narikawa, S., see Khamdang, S. (465) 1 Narita, M., see Mizoguchi, H. (461) 35 Navar, L.G., see Braam, B. (464) 87

Master author index to volumes 458 – 482 (2003) Navarrete, E., see Perusquı´a, M. (475) 161 Navratilova, E., see Okura, T. (459) 9 Nawoschik, S., see Zhang, J.Y. (472) 33 Nedzvetskii, V.S., see Baydas, G. (462) 67 Nelemans, S.A., see Gosens, R. (481) 125 Ne´meth, J., Helyes, Z., Oroszi, G., Jakab, B., Pinte´r, E., Szilva´ssy, Z. and Szolcsa´nyi, J. Role of voltage-gated cation channels and axon reflexes in the release of sensory neuropeptides by capsaicin from isolated rat trachea (458) 313 Nemoto, T., Shimma, N., Horie, S., Saito, T., Okuma, Y., Nomura, Y. and Murayama, T. Involvement of the system L amino acid transporter on uptake of Snitroso-L-cysteine, an endogenous S-nitrosothiol, in PC12 cells (458) 17 Nesic, M., see Taka´cs, J. (470) 163 Nesterova, A., see Arsenyan, P. (465) 229 Neudeck, B.L., Loeb, J. and Buck, J. Activation of the n-opioid receptor in Caco-2 cells decreases interleukin-8 secretion (467) 81 Neumann-Haefelin, C., see Petty, M.A. (474) 53 Neumeyer, J.L., Kula, N.S., Bergman, J. and Baldessarini, R.J. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines (474) 137 Newaz, M., see Sofola, O. (474) 241 Newman, A.H., see Katz, J.L. (468) 109 Ng, E.S.K., see Lam, F.F.Y. (474) 295 Ngan, M.P., see Sam, T.S.W. (466) 163 Ngan, M.P., see Sam, T.S.W. (472) 135 Ngan, M.-P., see Kan, K.K.W. (477) 247 Ngan, M.-P., see Kan, K.K.W. (482) 297 Ngomba, R.T., see Granata, F. (482) 17 Nguyen, Q., see Bundkirchen, A. (460) 19 Nguyen, Q., see Bundkirchen, A. (476) 97 Nickel, P., see Hu¨lsmann, M. (470) 1 Nicolas, M.-B., see Mansart, A. (475) 61 Nicolussi, E., see Bellasio, S. (482) 127 Nicosia, A., Giardina, L., Di Leo, F., Medico, M., Mazzola, C., Genazzani, A.A. and Drago, F. Long-lasting behavioral changes induced by pre- or neonatal exposure to diazepam in rats (469) 103 Nicosia, S., see Capra, V. (474) 149 Nielan, C.L., see King, M.A. (459) 203 Nieri, P., Martinotti, E., Testai, L., Adinolfi, B., Calderone, V. and Breschi, M.C. R(+)-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors (459) 75 Nieri, P., Martinotti, E., Testai, L., Martinelli, C. and Breschi, M.C. Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea (475) 115 Nijkamp, F.P., see Smit, J.J. (470) 193 Nijkamp, F.P., see Ten Broeke, R. (476) 151 Nijkamp, F.P., see van der Kleij, H.P.M. (476) 249 Nishi, K., see Tokutomi, Y. (477) 137 Nishi, K., see Lai, Z.-F. (482) 1 Nishida, T., see Honda, M. (458) 91 Nishikawa, H., see Taguchi, R. (477) 195 Nishikawa, M., see Ogata, M. (478) 187 Nishiki, K., Tsuruoka, S., Wakaumi, M., Yamamoto, H., Koyama, A. and Fujimura, A. Dosing time-dependent variation in the hypocalcemic effect of calcitonin in rat (460) 171 Nishimori, K., see Kawamata, M. (472) 229 Nishimoto, T., see Amano, Y. (466) 155 Nishimura, M., see Satoh, E. (465) 9 Nishimura, S., see Itagaki, S. (475) 85

27

Nishio, M., see Yoshida, J. (472) 23 Nishio, M., see Kato, Y. (473) 163 Nishiwaki, Y., see Onai, Y. (481) 217 Nishiyama, A., see Fujii, T. (481) 241 Nishiyama, T., Gyermek, L., Trudell, M.L. and Hanaoka, K. Spinally mediated analgesia and receptor binding affinity of epibatidine analogs (470) 27 Niwa, M., Hotta, K., Kanamori, Y., Hatakeyama, D., Hirade, K., Katayama, M., Hara, A., Mori, H., Ito, H., Kato, K., Matsuno, H., Uematsu, T. and Kozawa, O. Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils (466) 245 Niwa, T., see Enomoto, A. (466) 13 Njamen, D., Talla, E., Mbafor, J.T., Fomum, Z.T., Kamanyi, A., Mbanya, J.-C., Cerda´-Nicola´s, M., Giner, R.M., Recio, M.C. and Rı´os, J.L. Anti-inflammatory activity of erycristagallin, a pterocarpene from Erythrina mildbraedii (468) 67 Nobe, H., see Nobe, K. (471) 195 Nobe, K., Sakai, Y., Nobe, H. and Momose, K. Dysfunction of aorta involves different patterns of intracellular signaling pathways in diabetic rats (471) 195 Nogueira, R.L., see Zanoveli, J.M. (473) 153 Nojiri, R., see Ohkita, M. (472) 159 Nolan, P.M., see Keays, D.A. (480) 205 Noma, T., see Ogawa, N. (474) 273 Nomura, K., see Tomita, Y. (472) 147 Nomura, Y., see Nemoto, T. (458) 17 Norgaard-Nielsen, K., see Loland, C.J. (479) 187 Norwood, C.S., Cornish, J.L., Mallet, P.E. and McGregor, I.S. Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats (465) 105 Noshiro, R., see Khamdang, S. (465) 1 Noshiro, R., see Enomoto, A. (466) 13 Novellino, E., see Mioni, C. (477) 227 Nowak, E., see Filip, M. (459) 239 Numazawa, S., see Tanaka, S. (465) 61 Nunes, D.S., see Albino de Almeida, A.B. (472) 205 Nunn, C., Langenegger, D., Hurth, K., Schmidt, K., Fehlmann, D. and Hoyer, D. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists (465) 211 Nutt, D.J., see Melichar, J.K. (459) 217 Nyakas, C., see van Dijk, G. (480) 31 Nyberg, F., see Ce´le´rier, E. (465) 69 Nygren, J.M., see Poljakovic, M. (469) 21 Nyitrai, G., Ke´kesi, K.A., Emri, Z., Sza´rics, E´., Juha´sz, G. and Kardos, J. GABAB receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro (478) 111

Oakley, S.M., Toth, G., Borsodi, A., Kieffer, B.L. and Kitchen, I. G-protein coupling of y-opioid receptors in brains of A-opioid receptor knockout mice (466) 91 Ochalski, R., see Zhang, J.Y. (472) 33 Ochi, M., see Matsuda, H. (471) 59 O’Connor, M., see Zingarelli, B. (469) 183 O’Connor, S.E., see Bidouard, J.-P. (461) 49 O’Connor, S.E., see Barbe, F. (474) 117 O’Dowd, B.F., see Madras, B.K. (479) 41 Oda, S., see Tanihata, S. (461) 197 Ogata, M., Iwamoto, T., Tazawa, N., Nishikawa, M., Yamashita, J., Takaoka, M. and Matsumura, Y. A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury (478) 187

28

Master author index to volumes 458 – 482 (2003)

Ogawa, N., Sugawara, Y., Fujiwara, Y. and Noma, T. Roxithromycin promotes lymphocyte apoptosis in Dermatophagoidessensitive asthma patients (474) 273 Ogawa, S.-i., see Chaki, S. (474) 95 Ogawa, T., see Hosogai, N. (477) 171 Ogihara, T., see Fukushima, Y. (468) 47 Ogonowski, A.A., see Smith, J.B. (471) 121 Oguchi, K., see Tanaka, S. (465) 61 Oguri, S., see Ayada, K. (460) 63 Oh, D.K., see Lee, Y.S. (465) 191 Ohashi, Y., see Fukushima, Y. (468) 47 Ohdo, S., see Sonoki, K. (475) 139 Ohgami, Y., see Yamagishi, K. (462) 53 Ohizumi, Y., see Nakahata, N. (461) 1 Ohizumi, Y., see Rohra, D.K. (465) 141 Ohizumi, Y., see Rohra, D.K. (476) 123 Ohizumi, Y., see Tsuchida, H. (477) 53 Ohkita, M., Takaoka, M., Sugii, M., Shiota, Y., Nojiri, R. and Matsumura, Y. The role of nuclear factor-nB in the regulation of endothelin-1 production by nitric oxide (472) 159 Ohkubo, S., see Nakahata, N. (461) 1 Ohkubo, Y., see Hirayama, Y. (467) 197 Ohl, F. and Keck, M.E. Behavioural screening in mutagenised mice—in search for novel animal models of psychiatric disorders (480) 219 Ohmori, K., Yamada, H., Yasuda, A., Yamamoto, A., Matsuura, N. and Kiniwa, M. Anti-hyperlipidemic action of a newly synthesized benzoic acid derivative, S-2E (471) 69 Ohno, Y., see Nakazawa, K. (474) 205 Ohta, T., Miyajima, K., Komuro, G., Furukawa, N. and Yonemori, F. Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto – Kakizaki rats (476) 159 Oikawa, T., see Aoki, K. (459) 131 Oishi, R., see Hirayama, K. (481) 59 Oja, S.S., see Hilgier, W. (468) 21 Ojije, G., see Ma, S.-X. (472) 179 Ojima, H., see Nakazawa, K. (474) 205 Okada, K., see Takahashi, M. (467) 185 Okada, S., Murakami, Y. and Yokotani, K. Role of brain thromboxane A2 in the release of noradrenaline and adrenaline from adrenal medulla in rats (467) 125 Okada, S., Shimizu, T. and Yokotani, K. Extrahypothalamic corticotropin-releasing hormone mediates ( )nicotine-induced elevation of plasma corticosterone in rats (473) 217 Okada, S., Shimizu, T. and Yokotani, K. Brain phospholipase C and diacylglycerol lipase are involved in corticotropin-releasing hormone-induced sympatho-adrenomedullary outflow in rats (475) 49 Okada, S., Yokotani, K. and Yokotani, K. Inducible nitric oxide synthase is involved in corticotropinreleasing hormone-mediated central sympatho-adrenal outflow in rats (477) 95 Okada, S., see Yokotani, K. (459) 187 Okada, S., see Nakamura, K. (470) 73 Okamoto, H., Iwamoto, Y., Maki, M., Sotani, T., Yonemori, F. and Wakitani, K. Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals (466) 147 Okamoto, S., see Tokutomi, Y. (477) 137 Okamura, N., Hashimoto, K., Kanahara, N., Shimizu, E., Kumakiri, C., Komatsu, N. and Iyo, M. Protective effect of the antipsychotic drug zotepine on dizocilpineinduced neuropathological changes in rat retrosplenial cortex (461) 93 Okano, K., see Umeuchi, H. (477) 29

Okatani, Y., Wakatsuki, A., Enzan, H. and Miyahara, Y. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver (465) 163 Okatani, Y., Wakatsuki, A., Reiter, R.J., Enzan, H. and Miyahara, Y. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver (469) 145 Okayasu, I., see Tomita, Y. (472) 147 Okazaki, H., see Nakai, S. (472) 89 Okimoto, K., see Kai, M. (481) 79 Okonogi, T., see Tabata, Y. (461) 73 Okonogi, T., see Tabata, Y. (465) 299 Okuda, K., see Kawase, T. (470) 125 Okuda, K., see Yamakawa, T. (478) 39 Okuda, Y., see Ma, J. (464) 79 Okuma, C., see Shinomiya, K. (460) 139 Okuma, Y., see Nemoto, T. (458) 17 Okura, T., Varga, E.V., Hosohata, Y., Navratilova, E., Cowell, S.M., Rice, K., Nagase, H., Hruby, V.J., Roeske, W.R. and Yamamura, H.I. Agonist-specific down-regulation of the human y-opioid receptor (459) 9 Okuyama, C.E., see Baracat, J.S. (477) 163 Okuyama, S., see Chaki, S. (464) 49 Okuyama, S., see Chaki, S. (474) 95 Olariu, A., see Hefco, V. (474) 227 Olds, C.L., see Pieper, G.M. (472) 127 Olesen, S.P., see Dupuis, D.S. (465) 201 Olianas, M.C., see Onali, P. (471) 77 Olivares, R., see Ruiz-Nun˜o, A. (481) 41 Olivier, B., Zethof, T., Pattij, T., Van Boogaert, M., Van Oorschot, R., Leahy, C., Oosting, R., Bouwknecht, A., Veening, J., Van der Gugten, J. and Groenink, L. Stress-induced hyperthermia and anxiety: pharmacological validation (463) 117 Olivier, B., see Groenink, L. (463) 185 Olivier, B., see De Groote, L. (476) 71 Olsen, H.L., see Høy, M. (466) 213 Omar, A.G., see El-Mas, M.M. (468) 217 Omari, T., see Symonds, E. (470) 95 Omata, M., see Ma, J. (464) 79 Omata, M., see Fukushima, Y. (468) 47 Onai, Y., Suzuki, J.-i., Nishiwaki, Y., Gotoh, R., Berens, K., Dixon, R., Yoshida, M., Ito, H. and Isobe, M. Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury (481) 217 Onali, P., Mascia, F.M. and Olianas, M.C. Positive regulation of GABAB receptors dually coupled to cyclic AMP by the allosteric agent CGP7930 (471) 77 O’Neill, A.B., see Hsieh, G.C. (458) 183 Ong, J., see Kerr, D.I.B. (468) 103 Onishi, M., see Takahashi, K. (458) 155 Onji, M., see Yokota, T. (481) 233 Ono, H., see Honda, M. (458) 91 Ono, H., see Fukushima, Y. (468) 47 Ono, H., see Fujii, T. (474) 261 Ono, H., see Honda, M. (482) 155 Ono, K., see Nakamura, K. (470) 73 Ono, T., see Tomita, Y. (472) 147 Onozato, M.L., see Khamdang, S. (465) 1 Oonuma, H., see Ma, J. (464) 79 Oosting, R., see Olivier, B. (463) 117 Oosting, R.S., see Groenink, L. (463) 185 O’Regan, M.H., see Phillis, J.W. (476) 211 Oriowo, M.A., Chandrasekhar, B. and Kadavil, E.A. a1-adrenoceptor subtypes mediating noradrenaline-induced contraction of pulmonary artery from pulmonary hypertensive rats (482) 255 Orjales, A., see Villegas, I. (460) 209

Master author index to volumes 458 – 482 (2003) Oroszi, G., see Ne´meth, J. (458) 313 Oryan, S., see Eidi, M. (465) 91 Oryan, S., see Zarrindast, M.-R. (471) 105 Oryan, S., Eidi, M., Eidi, A. and Kohanrooz, B. Effects of a1-adrenoceptors and muscarinic cholinoceptors on water intake in rats (477) 123 Oryan, S., see Eidi, M. (478) 105 Osakada, F., Hashino, A., Kume, T., Katsuki, H., Kaneko, S. and Akaike, A. Neuroprotective effects of a-tocopherol on oxidative stress in rat striatal cultures (465) 15 Osnes, J.-B., see Qvigstad, E. (481) 83 Ota, T., see Takahashi, K. (458) 155 Otagiri, M., see Tokutomi, Y. (477) 137 Otani, H., see Matsumoto, M. (482) 177 Ott, C.E., see Grider, J.S. (473) 185 Oudot, A., Vergely, C., Ecarnot-Laubriet, A. and Rochette, L. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia – reperfusion (462) 145 Owens, S.M., see Byrnes-Blake, K.A. (461) 119 Oyekan, A., see Sofola, O. (474) 241 Ozaki, H., see Nagasaka, T. (472) 197 ¨ zdog˘an, U ¨ .K., La¨hdesma¨ki, J. and Scheinin, M. O Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice (460) 127 ¨ zveren, E., see Bu¨yu¨kafsßar, K. (459) 263 O Pabian´czyk, M., see Dembin´ski, A. (473) 207 Pabian´czyk-Kulka, A., see Michalik, M. (475) 1 Pache, D.M., Ferna´ndez-Pe´rez, S. and Sewell, R.D.E. Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task (477) 205 Pacheco, N.A.S., see Francßa, L.P. (476) 25 Pacher, P., see Mabley, J. (466) 323 Paeile, C., see Pelissier, T. (477) 23 Paiva, A.C.M., see Francßa, L.P. (476) 25 Paizis, I., see Pantos, C. (478) 53 Pajdo, R., see Konturek, P.C. (472) 213 Palazzo, E., see De Novellis, V. (462) 73 Palermo-Neto, J., see da Silva, F.R. (478) 97 Palit, G., see Kumar, R. (462) 133 Palladini, G., see Granata, F. (482) 17 Paluchowska, M., see Weso»owska, A. (471) 27 Pandjaitan, M., see Ma, S.-X. (472) 179 Pang, C.C.Y., see Cheng, X. (458) 299 Pang, C.C.Y., see Abdelrahman, A.M. (466) 317 Pang, C.C.Y., see Cheng, X. (470) 171 Pani, L., see Casu, M.A. (459) 97 Panin, F., see D’Aquila, P.S. (458) 129 Panin, F., see D’Aquila, P.S. (460) 71 Pantos, C., Mourouzis, I., Tzeis, S., Moraitis, P., Malliopoulou, V., Cokkinos, D.D., Carageorgiou, H., Varonos, D. and Cokkinos, D. Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts: an effect reversed by thyroxine pretreatment (460) 155 Pantos, C., Malliopoulou, V., Mourouzis, I., Karamanoli, E., Moraitis, P., Tzeis, S., Paizis, I., Cokkinos, A.D., Carageorgiou, H., Varonos, D.D. and Cokkinos, D.V. Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia (478) 53 Papadimitriou, E., see Hatziapostolou, M. (460) 1 Papalois, A., see Poussios, D. (465) 275 Papathanassiou, M., see Giannoulaki, V. (481) 119 Papla, I., see Filip, M. (459) 239 Papp, J.Gy., see Lepra´n, I. (464) 171

29

Papp, J.Gy., see Taka´cs, J. (470) 163 Papp, J.Gy., see Kun, A. (474) 103 Parekh, B., see Darmani, N.A. (459) 83 Parihar, A.S., Coghlan, M.J., Gopalakrishnan, M. and Shieh, C.-C. Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation (471) 157 Parivar, K., see Eidi, M. (465) 91 Parker, C.A., see Cooper, E.J. (482) 189 Parker, M.S., see Parker, S.L. (474) 31 Parker, S.L., Parker, M.S., Buschauer, A. and Balasubramaniam, A. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides (474) 31 Paronis, C., see Yasar, S. (465) 257 Parsons, C.G., see Lo¨scher, W. (466) 99 Parsons, M., see Ihenetu, K. (464) 207 Parsons, M., see Talubmook, C. (469) 153 Parsons, M.E., see Ihenetu, K. (458) 207 Partridge, L.D., see Carta, M. (459) 167 Pascual, D., Giro´n, R., Alsasua, A., Benhamu´, B., Lo´pez-Rodrı´guez, M.L. and Martı´n, M.I. New benzimidazole derivatives: selective and orally active 5-HT3 receptor antagonists (462) 99 Passani, M.B., see Vannacci, A. (465) 289 Passarelli, F., see Granata, F. (482) 17 Pasternak, G.W., see King, M.A. (459) 203 Pataricza, J., see Kun, A. (474) 103 Patel, D., see Adeagbo, A.S.O. (458) 145 Patel, M.K., see Lenkowski, P.W. (467) 23 Pater, A., see Mo, B. (467) 15 Pattij, T., see Olivier, B. (463) 117 Pattij, T., see Groenink, L. (463) 185 Pawlik, T., see Harsch, I.A. (481) 249 Pawlowski, E., see Harsch, I.A. (481) 249 Paya´, M., see Rojas, J. (465) 183 Peana, A.T., see D’Aquila, P.S. (458) 129 Peana, A.T., see D’Aquila, P.S. (460) 71 Peana, A.T., D’Aquila, P.S., Chessa, M.L., Moretti, M.D.L., Serra, G. and Pippia, P. ( )-Linalool produces antinociception in two experimental models of pain (460) 37 Pearson, K.H., see Evans, N.M. (466) 31 Peck, M., see Christophe, B. (470) 87 Pedapati, E.V., see Stebbins, K.J. (471) 205 Pedata, F., see Corsi, C. (464) 33 Peddi, S., Roth, B.L., Glennon, R.A. and Westkaemper, R.B. Spiro[9,10-dihydroanthracene]-9,3V-pyrrolidine—a structurally unique tetracyclic 5-HT2A receptor antagonist (482) 335 Pedraza-Chaverrı´, J., Gonza´lez-Orozco, A.E., Maldonado, P.D., Barrera, D., Medina-Campos, O.N., and Herna´ndez-Pando, R. Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats (473) 71 Pela´, I.R., see Almeida, M.C. (467) 133 Pelissier, T., Laurido, C., Kramer, V., Herna´ndez, A. and Paeile, C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats (477) 23 Pendergast, W., see Malmsjo¨, M. (458) 305 Peng, C.-H., see Chiou, W.-F. (458) 217 Pereverzev, A., see Hainsworth, A.H. (467) 77 Pe´rez-Asensio, F.J., see Torregrosa, G. (482) 227 Pe´rez-Garcı´a, C., see Herrado´n, G. (465) 251 Pe´rez-Palacios, G., see Perusquı´a, M. (475) 161 Pericˇic´, D., Sˇtrac, D.Sˇ., Jembrek, M.J. and Rajcˇan, I. Prolonged exposure to g-aminobutyric acid up-regulates stably expressed recombinant a1h2g2s GABAA receptors (482) 117 Persson, K., see Poljakovic, M. (469) 21 Persson, K., see Johansson, R. (476) 221

30

Master author index to volumes 458 – 482 (2003)

Pertovaara, A., see La¨hdesma¨ki, J. (468) 183 Perusquı´a, M., Villalo´n, C.M., Navarrete, E., Garcı´a, G.A., Pe´rez-Palacios, G. and Lemus, A.E. Vasodilating effect of norethisterone and its 5a metabolites: a novel nongenomic action (475) 161 Petersen, J.S., see Høy, M. (466) 213 Petty, M.A., Neumann-Haefelin, C., Kalisch, J., Sarhan, S., Wettstein, J.G. and Juretschke, H.-P. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke (474) 53 Pfaff, D., see Mong, J. (480) 229 Pfaffendorf, M., see Nap, A. (469) 117 Pfeilschifter, J., see Mu¨hl, H. (482) 325 Phillis, J.W. and O’Regan, M.H. Effects of adenosine receptor antagonists on pial arteriolar dilation during carbon dioxide inhalation (476) 211 Piccinini, F., see Bradamante, S. (465) 115 Pichette, V., see Bleau, A.-M. (473) 197 Pick, C.G., see Weizman, T. (478) 155 Pickkers, P., Russel, F.G.M., Thien, T., Hughes, A.D. and Smits, P. Only weak vasorelaxant properties of loop diuretics in isolated resistance arteries from man, rat and guinea pig (466) 281 Picolo, G., Cassola, A.C. and Cury, Y. Activation of peripheral ATP-sensitive K+ channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom (469) 57 Pieper, G.M., Siebeneich, W., Olds, C.L. and Lai, C.-S. Chronic or delayed treatment with an oral dithiocarbamate analog decreases glycation and protects diabetic arteries (472) 127 Pierpaoli, S., see Vannacci, A. (465) 289 Pierzchalska, M., see Michalik, M. (475) 1 Pieters, L., see Caballero-George, C. (458) 257 Pijl, H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a ‘‘thrifty’’ genotype underlying the metabolic syndrome? (480) 125 Piket, B., see Levandoski, M.M. (471) 9 Pineau, T., see Roulet, A. (460) 85 Pinna, A., see Corsi, C. (464) 33 Pinte´r, E., see Ne´meth, J. (458) 313 Pinto, A., see McDonald, M.C. (466) 181 Pippia, P., see Peana, A.T. (460) 37 Pirani, P., see de Cupis, A. (473) 83 Pittoors, F., see Van Bogaert, P.P. (478) 161 Piyachaturawat, P., see Khamdang, S. (465) 1 Planas, E., Poveda, R., Sa´nchez, S., Romero, A. and Puig, M.M. Non-steroidal anti-inflammatory drugs antagonise the constipating effects of tramadol (482) 223 Poljakovic, M., Nygren, J.M. and Persson, K. Signalling pathways regulating inducible nitric oxide synthase expression in human kidney epithelial cells (469) 21 Polvani, G., see Rossoni, G. (477) 59 Pomata, P.E., see Goutman, J.D. (461) 79 Pongpiriyadacha, Y., see Matsuda, H. (471) 59 Popik, P., see Skolnick, P. (461) 99 Porcella, A., see Casu, M.A. (459) 97 Po´rsza´sz, R., see Benko´, R. (478) 73 Portmann, B., see Yang, W. (461) 41 Portoghese, P.S. and Lunzer, M.M. Identity of the putative y1-opioid receptor as a y – n heteromer in the mouse spinal cord (467) 233 Portoghese, P.S., Law, P.-Y. and Loh, H.H. Effect of opioid receptor ligands on the A-S196A knock-in and A knockout mouse vas deferens (478) 207 Potenza, R.L., see Granata, F. (482) 17 Potmeˇsˇil, P., see Zı´dek, Z. (475) 149 Potschka, H., see Lo¨scher, W. (466) 99

Poussios, D., Andreadou, I., Papalois, A., Rekka, E., Gavalakis, N., Aroni, K., Kourounakis, P.N., Fotiadis, C. and Sechas, M.N. Protective effect of a novel antioxidant non-steroidal anti-inflammatory agent (compound IA) on intestinal viability after acute mesenteric ischemia and reperfusion (465) 275 Poveda, R., see Planas, E. (482) 223 Prause, O., Laan, M., Lo¨tvall, J. and Linde´n, A. Pharmacological modulation of interleukin-17-induced GCP-2-, GROa- and interleukin-8 release in human bronchial epithelial cells (462) 193 Prediger, R.D.S. and Takahashi, R.N. Ethanol improves short-term social memory in rats. Involvement of opioid and muscarinic receptors (462) 115 Pre´vot, D., see Visentin, V. (466) 235 Price, S., Mitchell, J.A., Anning, P.B. and Evans, T.W. Type II nitric oxide synthase activity is cardio-protective in experimental sepsis (472) 111 Priego, T., see Iba´n˜ez de Ca´ceres, I. (481) 293 Priviero, F.B.M., see Baracat, J.S. (477) 163 Provideˆncia, L.A., see Monteiro, P. (482) 245 Prut, L. and Belzung, C. The open field as a paradigm to measure the effects of drugs on anxietylike behaviors: a review (463) 3 Przegalin´ski, E., see Filip, M. (459) 239 Pudova, O., see Arsenyan, P. (465) 229 Puel, O., see Roulet, A. (460) 85 Puig, M.M., see Planas, E. (482) 223 Punjabi, K., see Weiss, H.R. (481) 25 Pupo, A.S., Uberti, M.A. and Minneman, K.P. N-terminal truncation of human a1D-adrenoceptors increases expression of binding sites but not protein (462) 1 Pupo, A.S., see Campos, M. (471) 149 Qasem, A.R., see Spampinato, S. (469) 89 Qin, B.-Y., see Lu, G. (478) 139 Qin, F., Shite, J., Mao, W. and Liang, C.-s. Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function (461) 149 Qin, J.-F., see Zhang, Y. (474) 141 Qin, X.-P., Ye, F., Liao, D.-F. and Li, Y.-J. Involvement of calcitonin gene-related peptide in the depressor effects of losartan and perindopril in rats (464) 63 Qiu, Y., Chen, H.-z., Wu, X.-j. and Jin, Z.-j. 6h-Acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain (468) 1 Qiu, Y., Bhattacharjee, S., Kraft, P., John, T.M., Craig, E., Haynes-Johnson, D., Guan, J., Jiang, W., Macielag, M., Sui, Z., Clancy, J. and Lundeen, S. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ10258859 (472) 73 Queiroz, M.L.S., see Valadares, M.C. (473) 191 Quimby, S.J., see Statnick, M.A. (482) 139 Quintana, J., see Rivero, A. (482) 77 Quirion, R., see Juaneda, C. (474) 165 Qvigstad, E., Osnes, J.-B., Sandnes, D., Schiander, I., Bøkenes, J., Sjaastad, I. and Skomedal, T. Carvedilol blockade of rat myocardial a1-adrenoceptors (481) 83 Racke´, K., see Koschorreck, S. (471) 229 Radulescu, L., see Manduteanu, I. (477) 269 Rafalski, P., see Kotlinska, J. (474) 233 Ragone, R., see Di Micco, B. (460) 59 Rajcˇan, I., see Pericˇic´, D. (482) 117 Rajgopal, Y., Chetty, C.S. and Vemuri, M.C. Differential modulation of apoptosis-associated proteins by ethanol in rat cerebral cortex and cerebellum (470) 117

Master author index to volumes 458 – 482 (2003) Rakonczay Jr., Z., Duda, E., Kaszaki, J., Iva´nyi, B., Boros, I., Lonovics, J. and Taka´cs, T. The anti-inflammatory effect of methylprednisolone occurs downstream of nuclear factor-nB DNA binding in acute pancreatitis (464) 217 Ralevic, V., Farmer, M.R. and Gardiner, S.M. Vasoconstrictor responsiveness of tail arteries from endotoxaemic rats (460) 145 Ralevic, V. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission (472) 1 Ramakers, G.M.J., see Mathon, D.S. (480) 97 Ramirez, A.D., Wong, S.K.-F. and Menniti, F.S. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms (475) 29 Rampe, D., see Kang, J. (458) 25 Rand, M.J., see Che, Y. (462) 161 Randall, A.D., see Hainsworth, A.H. (467) 77 Randall, M.D., see Tep-areenan, P. (465) 125 Randall, M.D., see Tep-areenan, P. (476) 139 Rasmussen, S.G.F., Adkins, E.M., Carroll, F.I., Maresch, M.J. and Gether, U. Structural and functional probing of the biogenic amine transporters by fluorescence spectroscopy (479) 13 Rau, K.S., see Riddle, E.L. (458) 31 Rau, K.S., see Ugarte, Y.V. (472) 165 Rau, K.S., see Truong, J.G. (474) 223 Ravasi, S., see Capra, V. (474) 149 Ravens, U., see Dobrev, D. (461) 105 Ray, A., see Masood, A. (458) 135 Raymond, K., see Chau, W.H. (464) 177 Rayssiguier, Y., see Alloui, A. (469) 65 Razzaque, Z., see Scott, P. (458) 319 Reali, R., see Casu, M.A. (459) 97 Recio, M.C., see Sala, A. (460) 219 Recio, M.C., see Njamen, D. (468) 67 Recio, M.C., see Sala, A. (461) 53 Redegeld, F.A.M., see van der Kleij, H.P.M. (476) 249 Redhi, G., see Yasar, S. (465) 257 Reeder, S., see Dickenson, J.M. (474) 43 Rees, B., see Dickenson, J.M. (474) 43 Regan, J.W., see Fujino, H. (465) 39 Reggiani, A., see Bellasio, S. (482) 127 Rehder, V.L.G., see Kassuya, C.A.L. (478) 145 Reif, A., see Lesch, K.P. (480) 185 Reiners, K., see Hagner, S. (481) 147 Reinscheid, R.K., Kim, J., Zeng, J. and Civelli, O. High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels (478) 27 Reiser, G., see Laubinger, W. (468) 9 Reiter, R.J., see Okatani, Y. (469) 145 Reith, M.E.A., see Chen, N. (478) 89 Reith, M.E.A., see Dutta, A.K. (479) 93 Reith, M.E.A., see Chen, N. (479) 213 Rekka, E., see Poussios, D. (465) 275 Remschmidt, H., see Heiser, P. (476) 167 Ren, K., see Zhang, L. (482) 169 Renaud, B., see Astier, B. (459) 17 Rentero, N., see Astier, B. (459) 17 Reuter, U., see Salomone, S. (469) 125 Reval, Ma.I.D., see De´ciga-Campos, M. (460) 99 Revesz, L., see Tigani, B. (482) 319 Rezvani, A.H. and Levin, E.D. Nicotinic – glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats (465) 83 Rhim, H., see Choi, S. (468) 83 Ribeiro, I.M., see Soares, M.B.P. (459) 107

31

Ribeiro, R.d.A., Garcez do Carmo, L., Vladimirova, I., Jurkiewicz, N.H. and Jurkiewicz, A. Nantenine blocks muscle contraction and Ca2+ transient induced by noradrenaline and K+ in rat vas deferens (470) 37 Ribeiro dos Santos, R., see Soares, M.B.P. (459) 107 Rice, K., see Okura, T. (459) 9 Richelson, E., see Fredrickson, P. (458) 111 Richter, A. The NMDA receptor NR2B subtype selective antagonist Ro 25-6981 aggravates paroxysmal dyskinesia in the dtsz mutant (458) 107 Richter, A. and Hamann, M. The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia (478) 47 Riddle, E.L., Rau, K.S., Topham, M.K., Hanson, G.R. and Fleckenstein, A.E. Ceramide-induced alterations in dopamine transporter function (458) 31 Riddle, E.L., see Ugarte, Y.V. (472) 165 Rigai, T., see Weizman, T. (478) 155 Rı´os, J.L., see Njamen, D. (468) 67 Rı´os, J.-L., see Sala, A. (460) 219 Rı´os, J.-L., see Sala, A. (461) 53 Rise´, P., Ghezzi, S. and Galli, C. Relative potencies of statins in reducing cholesterol synthesis and enhancing linoleic acid metabolism (467) 73 Ritchie, R.H., Sun, X., Bilszta, J.L., Gulluyan, L.M. and Dusting, G.J. Cardioprotective actions of an N-terminal fragment of annexin-1 in rat myocardium in vitro (461) 171 Rivero, A., Quintana, J., Eiroa, J.L., Lo´pez, M., Triana, J., Bermejo, J. and Este´vez, F. Potent induction of apoptosis by germacranolide sesquiterpene lactones on human myeloid leukemia cells (482) 77 Rocha, B.A. Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice (479) 107 Rochette, L., see Oudot, A. (462) 145 Rodella, L., see De Novellis, V. (462) 73 Rodgers, R.J., see Holmes, A. (459) 221 Rodriguez, G.J., see Roman, D.L. (479) 53 Rodrı´guez-Gallardo, J., see Silvestre, R.A. (469) 195 Roeder, T. Metabotropic histamine receptors—nothing for invertebrates? (466) 85 Roeske, W.R., see Okura, T. (459) 9 Rohra, D.K., Saito, S.-y. and Ohizumi, Y. Extracellular acidosis results in higher intracellular acidosis and greater contraction in spontaneously hypertensive rat aorta (465) 141 Rohra, D.K., Saito, S.-y. and Ohizumi, Y. Strain-specific effects of acidic pH on contractile state of aortas from Wistar and Wistar Kyoto rats (476) 123 Rojas, J., Paya´, M., Domı´nguez, J.N. and Ferna´ndiz, Ma.L. ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties (465) 183 Rolka, K., see Kotlinska, J. (474) 233 Roloff, T., Ziegler, A., Heber, D. and Seebeck, J. Pharmacological inhibition of outwardly rectifying Cl currents in rat peritoneal mast cells: a comparison of different stilbene derivatives (478) 81 Roman, D.L., Walline, C.C., Rodriguez, G.J. and Barker, E.L. Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis (479) 53 Romano, M.R., see Lograno, M.D. (464) 69 Roman´ska, I., see Antkiewicz-Michaluk, L. (466) 263 Romero, A., see Planas, E. (482) 223 Romijn, J.A., see Kreier, F. (480) 51 Rommelspacher, H., see Mu¨hlbauer, E. (459) 121 Roots, I., see Krusekopf, S. (466) 7 Roppe, J., see Anderson, J.J. (473) 35 Rorsman, P., see Høy, M. (466) 213

32

Master author index to volumes 458 – 482 (2003)

Rosenberg, E., see Fride, E. (461) 27 Rossi, F., see De Novellis, V. (462) 73 Rossoni, G., Manfredi, B., Del Soldato, P., Polvani, G. and Berti, F. Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats (477) 59 Roth, B.L., see Peddi, S. (482) 335 Rothermund, L., Traupe, T., Dieterich, M., Kossmehl, P., Yagil, C., Yagil, Y. and Kreutz, R. Nephroprotective effects of the endothelin ETA receptor antagonist darusentan in salt-sensitive genetic hypertension (468) 209 Rothman, R.B. and Baumann, M.H. Monoamine transporters and psychostimulant drugs (479) 23 Rothstein, J.D., see Thomas, A.G. (471) 177 Roulet, A., Puel, O., Gesta, S., Lepage, J.-F., Drag, M., Soll, M., Alvinerie, M. and Pineau, T. MDR1-deficient genotype in Collie dogs hypersensitive to the Pglycoprotein substrate ivermectin (460) 85 Rovati, G.E., see Capra, V. (474) 149 Rubina, K., see Arsenyan, P. (465) 229 Rubini, P., see Borvendeg, S.J. (474) 71 Rudd, J.A., see Sam, T.S.W. (466) 163 Rudd, J.A., see Sam, T.S.W. (472) 135 Rudd, J.A., see Kan, K.K.W. (477) 247 Rudd, J.A., see Kan, K.K.W. (482) 297 Ruiter, M., see Kreier, F. (480) 51 Ruiu, S., see Casu, M.A. (459) 97 Ruiz-Nun˜o, A., Mayorgas, I., Herna´ndez-Guijo, J.M., Olivares, R., Garcı´a, A.G. and Gandı´a, L. Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells (481) 41 Russel, F.G.M., see Pickkers, P. (466) 281 Russo, B.M., see Di Micco, B. (460) 59 Rutherford-Root, K.L., see Hurst, R.S. (482) 31

Saba, P., see Casu, M.A. (459) 97 Sachidhanandam, S.B., Lu, J., Low, K.S.Y. and Moochhala, S.M. Herbimycin A attenuates apoptosis during heat stress in rats (474) 121 Sadakane, K., see Inoue, K.-i. (481) 261 Sadeghipour, H., Dehghani, M. and Dehpour, A.R. Role of opioid and nitric oxide systems in the nonadrenergic noncholinergic-mediated relaxation of corpus cavernosum in bile duct-ligated rats (460) 201 Sagen, J., see Hama, A. (459) 49 Sahebgharani, M., see Zarrindast, M.-R. (471) 105 Sahraei, H., see Gholami, A. (458) 119 Sahraei, H., see Zarrindast, M.-R. (482) 205 Saint-Paul, M.C., see Crenesse, D. (473) 177 Saito, K., see Tomimori, Y. (478) 179 Saito, M., Tanabe, Y., Kudo, I. and Nakayama, K. Endothelium-derived prostaglandin H2 evokes the stretch-induced contraction of rabbit pulmonary artery (467) 151 Saito, M., see Basavarajappa, B.S. (466) 73 Saito, O., see Yamamoto, T. (481) 175 Saito, S.-y., see Rohra, D.K. (465) 141 Saito, S.-y., see Rohra, D.K. (476) 123 Saito, T., see Nemoto, T. (458) 17 Saitoh, A., see Kamei, J. (467) 219 Saitoh, M., see Zhu, B.-M. (460) 43 Saitoh, T., see Fukushima, Y. (468) 47 Sakai, Y., see Nobe, K. (471) 195 Sakamoto, K., see Mitani, A. (466) 223 Sakamoto, K., see Kubota, Y. (467) 191 Sakamoto, K., see Moriuchi, H. (470) 57 Sakamoto, K., see Yunoki, M. (470) 65

Sakamoto, T., see Ito, A. (468) 59 Sakaue, M., Ago, Y., Sowa, C., Koyama, Y., Baba, A. and Matsuda, T. The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze (458) 141 Sakoda, H., see Fukushima, Y. (468) 47 Sakurai-Yamashita, Y., see Yoshida, A. (470) 99 Sakuraya, F., see Zhang, X.-H. (476) 131 Sala, A., Recio, M.C., Schinella, G.R., Ma´n˜ez, S., Giner, R.M. and Rı´os, J.-L. A new dual inhibitor of arachidonate metabolism isolated from Helichrysum italicum (460) 219 Sala, A., Recio, M.C., Schinella, G.R., Ma´n˜ez, S., Giner, R.M., Cerda´Nicola´s, M. and Rı´os, J.-L. Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside (461) 53 Salaices, M., see Ferrer, M. (466) 289 Salazar, L.A., see Herna´ndez-Delgadillo, G.P. (469) 71 Salmi, P., Kela, J., Arvidsson, U. and Wahlestedt, C. Functional interactions between y- and A-opioid receptors in rat thermoregulation (458) 101 Salom, J.B., see Torregrosa, G. (482) 227 Salomone, S., Yoshimura, S.-i., Reuter, U., Foley, M., Thomas, S.S., Moskowitz, M.A. and Waeber, C. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate (469) 125 Salvagno, C., see Carbonnelle, E. (471) 85 Salzman, A., see Mabley, J. (466) 323 Sam, T.S.W., Kan, K.K.W., Ngan, M.P., Rudd, J.A. and Yeung, J.H.K. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret (466) 163 Sam, T.S.W., Cheng, J.T.Y., Johnston, K.D., Kan, K.K.W., Ngan, M.P., Rudd, J.A., Wai, M.K. and Yeung, J.H.K. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew) (472) 135 Samini, M., see Mehr, S.E. (467) 205 Sanagi, M., see Yuyama, H. (478) 61 Sa´nchez, C. Stress-induced vocalisation in adult animals. A valid model of anxiety? (463) 133 Sa´nchez, C. R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model (464) 155 Sanchez, C., see Voss, J. (482) 215 Sa´nchez, M., see Ferrer, M. (466) 289 Sa´nchez, S., see Planas, E. (482) 223 Sanchez-Reus, M.I., see Molina-Jimenez, M.F. (472) 81 Sanders, M.J., Wiltgen, B.J. and Fanselow, M.S. The place of the hippocampus in fear conditioning (463) 217 Sandler, S., see Svensson, A.M. (459) 59 Sandmann, S., Kaschina, E., Blume, A., Kruse, M.-L. and Unger, T. Bradykinin B1 and B2 receptors differentially regulate cardiac Na+ – H+ exchanger, Na+ – Ca2+ exchanger and Na+ – HCO3 symporter (458) 3 Sandnes, D., see Qvigstad, E. (481) 83 Sandrini, G., see Tassorelli, C. (464) 159 Sandrini, M., see Tassorelli, C. (464) 159 Sanz, E., see Garcı´a-Villalo´n, A.L. (459) 247 Sanz, E., Ferna´ndez, N., Monge, L., Climent, B., Die´guez, G. and Garcı´a´ .L. Villalo´n, A Role of K+ channels in the coronary and renal vascular reactivity to vasopressin in diabetic rats (471) 35 Sanz, E., see Martı´nez, M.A. (473) 55 Sanz, E., see Ferna´ndez, N. (481) 109 Saponara, S., see Bova, S. (470) 185 Sarac, B., see Kilicarslan, H. (462) 155 Saransaari, P., see Hilgier, W. (468) 21

Master author index to volumes 458 – 482 (2003) Sarhan, S., see Petty, M.A. (474) 53 Sarioglu, Y., see Kilicarslan, H. (462) 155 Sarkis, J.J.F., see da Silva Torres, I.L. (481) 197 Sasaki, K., see Huang, S.H. (464) 1 Sasamata, M., see Terai, K. (467) 95 Sato, E., see Muto, Y. (461) 181 Sato, E., Takano, Y., Kuno, Y., Takano, M. and Sato, I. Involvement of spinal tyrosine kinase in inflammatory and N-methyl-Daspartate-induced hyperalgesia in rats (468) 191 Sato, I., see Sato, E. (468) 191 Sato, M., see Aoki, K. (459) 131 Sato, M., see Adachi, K. (464) 147 Sato, S., see Sugiyama, A. (466) 137 Sato, Y., see Yoneda, M. (478) 173 Satoh, E., Ishii, T. and Nishimura, M. Palytoxin-induced increase in cytosolic-free Ca2+ in mouse spleen cells (465) 9 Satoh, S., see Yatsu, T. (458) 191 Satoh, Y., see Takahara, A. (460) 51 Satoh, Y., see Sugiyama, A. (466) 137 Satoh, Y., see Takahara, A. (476) 115 Satta, R., Dimitrijevic, N. and Manev, H. Drosophila metabolize 1,4-butanediol into g-hydroxybutyric acid in vivo (473) 149 Sauerwein, H.P., see Kreier, F. (480) 51 Savci, V., Goktalay, G., Cansev, M., Cavun, S., Yilmaz, M.S. and Ulus, I.H. Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation (468) 129 Sawanobori, T., see Bai, C.-X. (476) 35 Saxena, P.R., see Kapoor, K. (475) 69 Sbarouni, E., Iliodromitis, E.K., Bofilis, E., Kyriakides, Z.S. and Kremastinos, D.Th. Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size (467) 163 Scates, S.M., see Breivogel, C.S. (459) 139 Schaeublin, E., see Tigani, B. (482) 319 Scha¨fers, H.-J., see Cremers, B. (467) 169 Schaffner, W., see Simmen, U. (458) 251 Schalling, M., see Johansen, J.E. (480) 171 Schechter, L., see Zhang, J.Y. (472) 33 Scheideler, M.A., see Misiano, P. (468) 159 ¨ zdog˘an, U ¨ .K. (460) 127 Scheinin, M., see O Scheinin, M., see La¨hdesma¨ki, J. (468) 183 Schenk, J.O., George, S.E. and Schumacher, P.D. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport? (479) 223 Scheuer, W.V., see Burgermeister, E. (466) 169 Scheurink, A.J.W., see van Dijk, G. (480) 31 Schiander, I., see Qvigstad, E. (481) 83 Schinella, G.R., see Sala, A. (460) 219 Schinella, G.R., see Sala, A. (461) 53 Schmalzing, G., see Hu¨lsmann, M. (470) 1 Schmid-Alliana, A., see Crenesse, D. (473) 177 Schmidhammer, H., see King, M.A. (459) 203 Schmidt, K., see Nunn, C. (465) 211 Schmidt, K.I., see Cremers, B. (467) 169 Schmidt, P., Schramm, M., Schro¨der, H. and Stasch, J.-P. Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase (468) 167 Schmitt, P., see Astier, B. (459) 17 Schneider, T., see Hainsworth, A.H. (467) 77 Schoeffter, P., see Simmen, U. (458) 251 Schofield, G.G., see Guo, J. (462) 25 Scholz, P.M., see Weiss, H.R. (481) 25 Schrøder, R.L., see Dupuis, D.S. (465) 201

33

Schraft, T., see Kru¨gel, U. (482) 185 Schramm, M., see Schmidt, P. (468) 167 Schreiber, S., see Weizman, T. (478) 155 Schro¨der, H., see Schmidt, P. (468) 167 Schro¨r, K., see Debey, S. (474) 161 Schu¨ler-Springorum, M., see Heiser, P. (476) 167 Schulte, E., see Heiser, P. (476) 167 Schumacher, P.D., see Schenk, J.O. (479) 223 Schuschke, D., see Adeagbo, A.S.O. (458) 145 Schu¨tz, J., see King, M.A. (459) 203 Schwartz, R.A., Greenwald, E.R., Fletcher, P.J., Houle, S. and DaSilva, J.N. Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments (459) 195 Schwinger, R.H.G., see Bundkirchen, A. (460) 19 Schwinger, R.H.G., see Bundkirchen, A. (476) 97 Scott, P., Razzaque, Z. and Longmore, J. Characterisation of bradykinin B1 and B2 receptors using rat isolated vas deferens (458) 319 Scott, B.B., see Misiano, P. (468) 159 Scribner, A.W., Loscalzo, J. and Napoli, C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress (482) 95 Sechas, M.N., see Poussios, D. (465) 275 Seddik, R., Bradaı¨a, A. and Trouslard, J. Choline induces Ca2+ entry in cultured sympathetic neurones isolated from rat superior cervical ganglion (471) 165 Seebeck, J., see Roloff, T. (478) 81 Seegers, U., see Ba¨umer, W. (481) 271 Seidler, R., see Touret, N. (459) 151 Seiwerth, S., see Bedekovic, V. (477) 73 Seki, J., see Kato, Y. (473) 163 Seki, N., see Yunoki, T. (482) 287 Sekiguchi, F., Kawata, K., Komori, M. and Sunano, S. Caffeine-induced contracture in oesophageal striated muscle of normotensive and hypertensive rats (465) 153 Sellers, L.A., see Jenkins, D.W. (469) 29 Selmeczy, Z., Szele´nyi, J. and Vizi, E.S. Intact noradrenaline transporter is needed for the sympathetic finetuning of cytokine balance (469) 175 Semenova, S., Bespalov, A. and Markou, A. Decreased prepulse inhibition during nicotine withdrawal in DBA/2J mice is reversed by nicotine self-administration (472) 99 Semino, C., see de Cupis, A. (473) 83 Senan, V.P., see Srinivas, G. (473) 117 Sepehrara, L., see Eidi, M. (478) 105 Serebruany, V.L., see Malinin, A.I. (462) 139 Serio, R., Alessandro, M., Zizzo, M.G., Tamburello, M.P. and Mule`, F. Neurotransmitters involved in the fast inhibitory junction potentials in mouse distal colon (460) 183 Serra, G., see D’Aquila, P.S. (458) 129 Serra, G., see Peana, A.T. (460) 37 Serra, G., see D’Aquila, P.S. (460) 71 Serra, M.F., see Carvalho, V.F. (472) 221 Seth, P., see File, S.E. (463) 35 Seu, E., see Dazzi, L. (476) 55 Seutin, V., see Boland, A. (466) 21 Severini, C., see Loizzo, A. (458) 201 Sevostianova, N., Zvartau, E., Bespalov, A. and Danysz, W. Effects of morphine on formalin-induced nociception in rats (462) 109 Sewell, R.D.E., see Pache, D.M. (477) 205 Seyfried, C.A., see Bartoszyk, G.D. (473) 229 Sgaragli, G., see Bova, S. (470) 185 Shah, B.S., see Lenkowski, P.W. (467) 23 Shahnawaz, Z., see Cornish, J.L. (482) 339

34

Master author index to volumes 458 – 482 (2003)

Shan Au, A.L., Kwan, Y.W., Kwok, C.C., Zhang, R.-Z. and He, G.-W. Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery (468) 199 Sharabi, F.M., see El-Mas, M.M. (468) 217 Sharma, R., see Yao, B.B. (482) 49 Sharmin, S., see Kitamura, H. (465) 31 Sharott, A., see Moss, S. (460) 117 Sharpe, M.A., see McDonald, M.C. (466) 181 Shearman, L.P., Camacho, R.E., Sloan Stribling, D., Zhou, D., Bednarek, M.A., Hreniuk, D.L., Feighner, S.D., Tan, C.P., Howard, A.D., Van der Ploeg, L.H.T., MacIntyre, D.E., Hickey, G.J. and Strack, A.M. Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats (475) 37 Shen, M.-Y., see Hsiao, G. (465) 281 Shen, Y.-C., Chiou, W.-F., Chou, Y.-C. and Chen, C.-F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes (465) 171 Shen, Y.-C., see Liou, K.-T. (475) 19 Shepel, P.N., Holden, C.P. and Geiger, J.D. Ryanodine receptor modulation by diadenosine polyphosphates in synaptosomal and microsomal preparations of rat brain (467) 67 Sher, E., see Evans, N.M. (466) 31 Shestakova, I., see Arsenyan, P. (465) 229 Sheu, J.-R., see Hsiao, G. (465) 281 Shi, Q.-X., see Bai, J.-P. (464) 9 Shi, Y.-L., see Bai, J.-P. (464) 9 Shibasaki, M., see Kurosaki, E. (468) 151 Shibata, K., see Kitamura, Y. (481) 75 Shieh, C.-C., see Parihar, A.S. (471) 157 Shigemoto, Y., see Shinomiya, K. (460) 139 Shikama, H., see Kurosaki, E. (468) 151 Shilliam, C.S. and Heidbreder, C.A. Gradient of dopamine responsiveness to dopamine receptor agonists in subregions of the rat nucleus accumbens (477) 113 Shimada, M., see Kohjitani, A. (465) 145 Shimada, S., see Yoshinaga, M. (461) 9 Shimada, S., see Yoshinaga, M. (465) 203 Shimaya, A., see Kurosaki, E. (468) 151 Shimazaki, T., see Chaki, S. (464) 49 Shimazu, S., Tsunekawa, H., Yoneda, F., Katsuki, H., Akaike, A. and Janowsky, A. Transporter-mediated actions of R-( )-1-(benzofuran-2-yl)-2-propylaminopentane (482) 9 Shimizu, E., see Okamura, N. (461) 93 Shimizu, T., see Okada, S. (473) 217 Shimizu, T., see Okada, S. (475) 49 Shimizu, Y., see Thapaliya, S. (461) 129 Shimizu, Y., see Fukushima, Y. (468) 47 Shimizu-Sasamata, M., see Sugiyama, A. (466) 137 Shimma, N., see Nemoto, T. (458) 17 Shimogori, H., see Horiike, O. (464) 75 Shimuta, S.I., see Francßa, L.P. (476) 25 Shin, K.H., see Lee, Y.S. (465) 191 Shin, S.-H., see Liu, P.-S. (460) 9 Shin, V.Y., see Cho, C.H. (460) 177 Shindo, T., see Fukushima, Y. (468) 47 Shinei, R., see Tabata, Y. (461) 73 Shinei, R., see Tabata, Y. (465) 299 Shinomiya, K., Shigemoto, Y., Okuma, C., Mio, M. and Kamei, C. Effects of short-acting hypnotics on sleep latency in rats placed on grid suspended over water (460) 139 Shiota, Y., see Ohkita, M. (472) 159 Shiraki, K., see Kurokawa, M. (474) 283 Shite, J., see Qin, F. (461) 149 Shojima, N., see Fukushima, Y. (468) 47

Shokoji, T., see Fujii, T. (481) 241 Shono, K., see Yamamoto, T. (481) 175 Siebeneich, W., see Pieper, G.M. (472) 127 Siegling, A., see Hofmann, H.A. (470) 17 Sikiric, P., see Bedekovic, V. (477) 73 Silber, R.-E., see Wangemann, T. (458) 163 Silberring, J., see Kotlinska, J. (474) 233 Silos-Santiago, I., see Cannon, K.E. (470) 139 Silva, G.L.M., see Zapata-Sudo, G. (470) 79 Silvestre, A.A., see Kassuya, C.A.L. (478) 145 Silvestre, R.A., Rodrı´guez-Gallardo, J., Egido, E.M. and Marco, J. Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas (469) 195 Simionescu, M., see Manduteanu, I. (477) 269 Simmen, U., Bobirnac, I., Ullmer, C., Lu¨bbert, H., Berger, Bu¨ter, K., Schaffner, W. and Schoeffter, P. Antagonist effect of pseudohypericin at CRF1 receptors (458) 251 Simmons, N.L., see Lowes, S. (458) 49 Simon, R., see Min, J.-Y. (471) 41 Simonsen, U., see Kun, A. (474) 103 Simpkins, J.W., see Aoun, P. (472) 65 Sim-Selley, L.J., see Darmani, N.A. (459) 83 Singh, A., Naidu, P.S. and Kulkarni, S.K. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia (477) 87 Sire´n, A.-L., see Vonhof, S. (459) 41 Sire´n, A.-L., see Vonhof, S. (473) 127 Sirois, P., see Gabra, B.H. (458) 329 Sirois, P., see Gama Landgraf, R. (460) 75 Sirois, P., see Eric, J. (475) 129 Sirvio¨, J., see Yavich, L. (462) 83 Sitaras, N.M., see Giannoulaki, V. (481) 119 Sitte, H.H. and Freissmuth, M. Oligomer formation by Na+ – Cl -coupled neurotransmitter transporters (479) 229 Sivarajah, A., see Chatterjee, P.K. (482) 271 Six, I., Gasan, G., Mura, E. and Bordet, R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia (458) 327 Sjaastad, I., see Qvigstad, E. (481) 83 Sjo¨berg, B., see Axelsson, L.-G. (467) 211 Skolnick, P., Popik, P., Janowsky, A., Beer, B. and Lippa, A.S. Antidepressant-like actions of DOV 21,947: a ‘‘triple’’ reuptake inhibitor (461) 99 Skomedal, T., see Qvigstad, E. (481) 83 Sloan Stribling, D., see Shearman, L.P. (475) 37 Sloan, J., see Mager, S. (479) 263 Sloan, J.W., see Holtman Jr., J.R. (470) 149 Slusher, B.S., see Thomas, A.G. (471) 177 Small, D.L., see Tauskela, J.S. (464) 17 Smidt, M.P., Smits, S.M. and Burbach, J.P.H. Molecular mechanisms underlying midbrain dopamine neuron development and function (480) 75 Smidt, M.P., see Mathon, D.S. (480) 97 Smit, J.J., Van Loveren, H., Hoekstra, M.O., Van der Kant, P.A.A., Folkerts, G. and Nijkamp, F.P. Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma (470) 193 Smith, D., see Zhang, J.Y. (472) 33 Smith, I.C.H., see Amobi, N. (462) 169 Smith, I.C.H., see Amobi, N. (464) 241 Smith, J.B. and Ogonowski, A.A. Behavioral effects of NMDA receptor agonists and antagonists in combination with nitric oxide-related compounds (471) 121

Master author index to volumes 458 – 482 (2003) Smith, M., Lindquist, C.E.L. and Birnir, B. Evidence for inhibitory effect of the agonist gaboxadol at human a1h2g2S GABAA receptors (478) 21 Smith III, R., see Khare, S. (465) 23 Smits, P., see Pickkers, P. (466) 281 Smits, S.M., see Smidt, M.P. (480) 75 So, W.H.L., see Cho, C.H. (460) 177 Soares, M.B.P., Bellintani, M.C., Ribeiro, I.M., Tomassini, T.C.B. and Ribeiro dos Santos, R. Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata L. (459) 107 Soares-da-Silva, P., see Bonifa´cio, M.J. (460) 163 So¨derberg, C., see Axelsson, L.-G. (467) 211 So¨derpalm, B., see Ericson, M. (467) 85 So¨derpalm, B., see Molander, A. (481) 51 So¨dersten, P., Bergh, C. and Ammar, A. Anorexia nervosa: towards a neurobiologically based therapy (480) 67 Sofola, O., Yakubu, M., Igbo, I., Newaz, M. and Oyekan, A. High salt diet modulates cAMP- and nitric oxide-mediated relaxation responses to isoproterenol in the rat aorta (474) 241 Sokoloff, P., see Guillin, O. (480) 89 Solis, P.N., see Caballero-George, C. (458) 257 Soll, M., see Roulet, A. (460) 85 Somogyi, G.T., see Benko´, R. (478) 73 Sone, M., Hayashi, H., Yamamoto, H., Tominaga, M. and Nakashima, T. A comparative study of intratympanic steroid and NO synthase inhibitor for treatment of cochlear lateral wall damage due to acute otitis media (482) 313 Sonoda, J., see Hirayama, K. (481) 59 Sonoki, K., Iwase, M., Iino, K., Ichikawa, K., Yoshinari, M., Ohdo, S., Higuchi, S. and Iida, M. Dilazep and fenofibric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cells (475) 139 Soo Lee, Y., Jin, D.-Q., Beak, S.-M., Lee, E.-S. and Kim, J.-A. Inhibition of ultraviolet-A-modulated signaling pathways by asiatic acid and ursolic acid in HaCaT human keratinocytes (476) 173 Soriano, F., see Mabley, J. (466) 323 Sotani, T., see Okamoto, H. (466) 147 Sotoda, Y., see Wakabayashi, I. (464) 27 Soulie`re, F., see Astier, B. (459) 17 Souza Brito, A.R.M., see Albino de Almeida, A.B. (472) 205 Souza, L.R., see Watanabe, M.A.E. (465) 205 Sowa, C., see Sakaue, M. (458) 141 Soyer, O.S., see Goldberg, N.R. (479) 3 So¨ylemez, S., Demiryu¨rek, A.T. and Kanzık, I˙. Involvement of tyrosine kinase in peroxynitrite-induced preconditioning in rat isolated heart (464) 163 Spampinato, S., see Loizzo, A. (458) 201 Spampinato, S., Qasem, A.R., Calienni, M., Murari, G., Gentilucci, L., Tolomelli, A. and Cardillo, G. Antinociception by a peripherally administered novel endomorphin-1 analogue containing h-proline (469) 89 Spangler, T., see Zhang, J.Y. (472) 33 Sparatore, F., see Carbonnelle, E. (471) 85 Spealman, R.D., see Madras, B.K. (479) 41 Spisani, S., Turchetti, M., Varani, K., Falzarano, S. and Cavicchioni, G. Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket (469) 13 Spreyer, P., see Hofmann, H.A. (470) 17 Srinivas, G., Anto, R.J., Srinivas, P., Vidhyalakshmi, S., Senan, V.P. and Karunagaran, D. Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9 (473) 117 Srinivas, P., see Srinivas, G. (473) 117 Stachura, J., see Dembin´ski, A. (473) 207

35

Stadel, R., see Cannon, K.E. (470) 139 Stanford, S.J., Walters, M.J., Hislop, A.A., Haworth, S.G., Evans, T.W., Mann, B.E., Motterlini, R. and Mitchell, J.A. Heme oxygenase is expressed in human pulmonary artery smooth muscle where carbon monoxide has an anti-proliferative role (473) 135 Staresinic, M., see Bedekovic, V. (477) 73 Stasch, J.-P., see Schmidt, P. (468) 167 Statnick, M.A., Suter, T.M., Gackenheimer, S.L., Emmerson, P.J., Quimby, S.J., Gehlert, D.R., Wheeler, W.J. and Mitch, C.H. Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist (482) 139 Staudt, A., see Staudt, Y. (466) 1 Staudt, Y., Mobini, R., Fu, M., Felix, S.B., Ku¨hn, J.P. and Staudt, A. h1-Adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes (466) 1 Stebbins, K.J., Carr, M.J., Pedapati, E.V. and Ellis, J.L. Effect of olvanil on the afferent and efferent function of capsaicinsensitive C-fibers in guinea pig airways (471) 205 Stella, N., see Franklin, A. (474) 195 Stiefel, T.H., see Mackay, K.B. (469) 111 Stincic, T.L., see McCullumsmith, R.E. (477) 101 Stirone, C., Chu, Y., Sunday, L., Duckles, S.P. and Krause, D.N. 17h-Estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction (478) 35 ´ and Ebert, B. Sto´rustovu, S.ı. Gaboxadol: in vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity (467) 49 Sˇtrac, D.Sˇ., see Percˇic´, D. (482) 117 Strack, A.M., see Shearman, L.P. (475) 37 Strom, R., see Granata, F. (482) 17 Strukova, S.M., see Dugina, T.N. (471) 141 Su, J., Li, J., Li, W., Altura, B.T. and Altura, B.M. Cocaine induces apoptosis in cerebral vascular muscle cells: potential roles in strokes and brain damage (482) 61 Su, R.-B., see Lu, G. (478) 139 Su, T.-P., see Hayashi, T. (464) 237 Su, W., see King, M.A. (459) 203 Su, X., see Adegunloye, B.J. (476) 201 Subramanian, R. and MacLeod, K.M. Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats (477) 143 Sudo, N., see Hirayama, K. (481) 59 Sudo, R.T., see Zapata-Sudo, G. (470) 79 Sudoh, K., see Yuyama, H. (478) 61 Sueyasu, M., see Hirayama, K. (481) 59 Sugahara, S., Nabe, T., Mizutani, N., Takenaka, H. and Kohno, S. Kinins are involved in the development of allergic nasal hyperresponsiveness in guinea pigs (476) 229 Sugawara, M., see Itagaki, S. (475) 85 Sugawara, Y., see Ogawa, N. (474) 273 Sugii, M., see Ohkita, M. (472) 159 Sugimoto, H., see Taguchi, R. (477) 195 Sugimoto, Y., Nakamura, Y., Alejandra Hossen, M., Watanabe, T. and Kamei, C. Evaluation of the effects of anti-pruritic drugs on scratch responses using histamine H1 receptor-deficient mice (470) 113 Sugiyama, A., Satoh, Y., Takahara, A., Nakamura, Y., Shimizu-Sasamata, M., Sato, S., Miyata, K. and Hashimoto, K. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems (466) 137 Sugiyama, A., see Takahara, A. (460) 51 Sugiyama, A., see Takahara, A. (476) 115 Sugiyama, Y., see Amano, Y. (466) 155 Sui, Z., see Qiu, Y. (472) 73

36

Master author index to volumes 458 – 482 (2003)

Sullivan, J.P., see Hsieh, G.C. (458) 183 Su¨lzle, B., see Ba¨umer, W. (481) 271 Sumida, M., see Tomimori, Y. (478) 179 Sumiyoshi, T., see Uehara, T. (459) 211 Sun, H.-S., see Wu, H.-e. (473) 143 Sun, X., see Ritchie, R.H. (461) 171 Sunagawa, M., see Yoshinaga, M. (461) 9 Sunagawa, M., see Yoshinaga, M. (465) 203 Sunami, A., see Bai, C.-X. (476) 35 Sunano, S., see Sekiguchi, F. (465) 153 Sunday, L., see Stirone, C. (478) 35 Suter, T.M., see Statnick, M.A. (482) 139 Suzuki, J.-i., see Ma, J. (464) 79 Suzuki, J.-i., see Onai, Y. (481) 217 Suzuki, K., see Muto, Y. (461) 181 Suzuki, K.T., see Tsuchiya, Y. (475) 119 Suzuki, M., see Terai, K. (467) 95 Suzuki, T., see Takahashi, K. (458) 155 Suzuki, T., see Mizoguchi, H. (461) 35 Suzuki, T., see Tanaka, K. (466) 191 Suzuki, T., see Kurosaki, E. (468) 151 Suzuki, Y., see Chaki, S. (464) 49 Svensson, A.M., Sandler, S. and Jansson, L. Role of superoxide anion in pancreatic islet blood flow regulation in anesthetized rats (459) 59 Symonds, E., Butler, R. and Omari, T. The effect of the GABAB receptor agonist baclofen on liquid and solid gastric emptying in mice (470) 95 Szabo´, C., see Mabley, J. (466) 323 Sza´rics, E´., see Nyitrai, G. (478) 111 Szele´nyi, J., see Selmeczy, Z. (469) 175 Szilva´ssy, Z., see Ne´meth, J. (458) 313 Szilva´ssy, Z., see Benko }, I. (477) 179 Szolcsa´nyi, J., see Ne´meth, J. (458) 313

Tabata, Y., Iizuka, Y., Shinei, R., Kurihara, K.-i., Okonogi, T., Hoshiko, S. and Kurata, Y. CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton (461) 73 Tabata, Y., Iizuka, Y., Shinei, R., Kurihara, K.-i., Okonogi, T., Hoshiko, S. and Kurata, Y. Erratum to ‘‘CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton’’ [Eur. J. Pharmacol. 461 (2003) 73 – 78] (465) 299 Tabo, E., see Mitsuyo, T. (465) 267 Taguchi, K., see Abe, K. (465) 237 Taguchi, R., Nishikawa, H., Kume, T., Terauchi, T., Kaneko, S., Katsuki, H., Yonaga, M., Sugimoto, H. and Akaike, A. Serofendic acid prevents acute glutamate neurotoxicity in cultured cortical neurons (477) 195 Tajima, T., see Hayashi, K.-i. (482) 305 Taka´cs, J., Iost, N., Lengyel, C., Vina´g, L., Nesic, M., Varro´, A. and Papp, J.Gy. Multiple cellular electrophysiological effects of azimilide in canine cardiac preparations (470) 163 Taka´cs, T., see Rakonczay Jr., Z. (464) 217 Takagi, K., see Kitaichi, K. (464) 39 Takagi, K., see Matsushima, M. (464) 111 Takahara, A., Sugiyama, A., Satoh, Y., Yoneyama, M. and Hashimoto, K. Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model (460) 51 Takahara, A., Sugiyama, A., Satoh, Y. and Hashimoto, K. Effects of mexiletine on the canine model of sparfloxacin-induced long QT syndrome (476) 115 Takahara, A., see Sugiyama, A. (466) 137

Takahashi, K., Takahashi, T., Suzuki, T., Onishi, M., Tanaka, Y., HamanoTakahashi, A., Ota, T., Kameo, K., Matsuda, T. and Baba, A. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia – reperfusion injuries (458) 155 Takahashi, M., Taniguchi, T., Tanaka, T., Kanamaru, H., Okada, K. and Muramatsu, I. Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors (467) 185 Takahashi, R.N., see Prediger, R.D.S. (462) 115 Takahashi, T., see Takahashi, K. (458) 155 Takahashi, Y., see Tsuchiya, Y. (475) 119 Takahata, K., Katsuki, H., Kobayashi, Y., Muraoka, S., Yoneda, F., Kume, T., Kashii, S., Honda, Y. and Akaike, A. Protective effects of selegiline and desmethylselegiline against Nmethyl-D-aspartate-induced rat retinal damage (458) 81 Takakura, S., see Hosogai, N. (473) 65 Takano, H., see Inoue, K.-i. (481) 261 Takano, M., see Sato, E. (468) 191 Takano, N., Arai, I. and Kurachi, M. Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis (471) 223 Takano, N., see Yunoki, T. (482) 287 Takano, Y., see Sato, E. (468) 191 Takaoka, M., see Ohkita, M. (472) 159 Takaoka, M., see Fujii, T. (474) 261 Takaoka, M., see Ogata, M. (478) 187 Takaoka, M., see Fujii, T. (481) 241 Takayama, F., see Enomoto, A. (466) 13 Takayanagi, Y., see Kawamata, M. (472) 229 Takeda, M., see Khamdang, S. (465) 1 Takeda, M., see Enomoto, A. (466) 13 Takemura, M., see Kitanaka, N. (474) 63 Takenaka, H., see Sugahara, S. (476) 229 Taketo, M.M., see Karasawa, H. (468) 15 Takeuchi, K., see Nakazawa, K. (474) 205 Takewaki, T., see Thapaliya, S. (461) 129 Taki, K., see Enomoto, A. (466) 13 Taki, N., see Touret, N. (459) 151 Talla, E., see Njamen, D. (468) 67 Talubmook, C., Forrest, A. and Parsons, M. Streptozotocin-induced diabetes modulates presynaptic and postsynaptic function in the rat ileum (469) 153 Tamae, K., see Miyamoto, O. (459) 179 Tamburello, M.P., see Serio, R. (460) 183 Tamori, K., see Nakade, Y. (460) 135 Tan, C.P., see Shearman, L.P. (475) 37 Tan, W.-f., Lin, L.-p., Li, M.-h., Zhang, Y.-X., Tong, Y.-g., Xiao, D. and Ding, J. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential (459) 255 Tanabe, M., see Honda, M. (482) 155 Tanabe, Y., see Saito, M. (467) 151 Tanaka, I., see Yasuda, N. (459) 159 Tanaka, K., Watanabe, M., Kuraishi, Y., Kimura, I., Suzuki, T. and Kiniwa, M. Peroral TAS-202 reduced vessel density in rats with adjuvant-induced arthritis (466) 191 Tanaka, N., see Yoshida, A. (470) 99 Tanaka, S., Tsuchida, A., Kiuchi, Y., Oguchi, K., Numazawa, S. and Yoshida, T. GABAergic modulation of hippocampal glutamatergic neurons: an in vivo microdialysis study (465) 61 Tanaka, S.-i., see Yamakawa, T. (478) 39

Master author index to volumes 458 – 482 (2003) Tanaka, T., see Takahashi, M. (467) 185 Tanaka, T., see Fujii, T. (474) 261 Tanaka, T., see Umeuchi, H. (477) 29 Tanaka, T., see Tomimori, Y. (478) 179 Tanaka, Y., see Takahashi, K. (458) 155 Tanaka, Y., see Horinouchi, T. (473) 79 Tanaka, Y., see Matsushita, M. (482) 235 Taneike, T., see Inoue, M. (461) 207 Taneike, T., see Kitazawa, T. (469) 135 Tang, C., see Chang, L. (473) 171 Tang, L., see Wang, Z.J. (465) 199 Taniguchi, T., see Takahashi, M. (467) 185 Tanihata, S., Oda, S., Kakuta, S. and Uchiyama, T. Antiemetic effect of a tachykinin NK1 receptor antagonist GR205171 on cisplatin-induced early and delayed emesis in the pigeon (461) 197 Taniyama, K., see Yoshida, A. (470) 99 Tanizaki, Y., see Kitamura, Y. (481) 75 Tanko´, L.B., see Kun, A. (474) 103 Tanneur, V., see Touret, N. (459) 151 Tarayre, J.-P., see Bruins Slot, L.A. (466) 271 Tassorelli, C., Greco, R., Wang, D., Sandrini, M., Sandrini, G. and Nappi, G. Nitroglycerin induces hyperalgesia in rats—a time-course study (464) 159 Tatsumi, Y., see Matsushima, M. (464) 111 Tattersall, J.E.H., see Harrison, P.K. (471) 97 Tauskela, J.S., Mealing, G., Comas, T., Brunette, E., Monette, R., Small, D.L. and Morley, P. Protection of cortical neurons against oxygen-glucose deprivation and N-methyl-D-aspartate by DIDS and SITS (464) 17 Tavi, P., see Voutilainen-Myllyla¨, S. (466) 41 Tazawa, N., see Ogata, M. (478) 187 Teixeira, C.E., see Baracat, J.S. (477) 163 Ten Broeke, R., Brandhorst, M.C., Leusink-Muis, T., Villain, M., De Clerck, F., Blalock, J.E., Nijkamp, F.P. and Folkerts, G. Ca2+ sensors modulate asthmatic symptoms in an allergic model for asthma (476) 151 Teoh, H., see Jiang, J. (481) 133 Tep-areenan, P., Kendall, D.A. and Randall, M.D. Mechanisms of vasorelaxation to testosterone in the rat aorta (465) 125 Tep-areenan, P., Kendall, D.A. and Randall, M.D. Mechanisms of vasorelaxation to 17h-oestradiol in rat arteries (476) 139 Ter Laak, M.P., Brakkee, J.H., Adan, R.A.H., Hamers, F.P.T. and Gispen, W.H. The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat (462) 179 Terada, C., see Nango, R. (471) 1 Terai, K., Suzuki, M., Sasamata, M., Yatsugi, S.-i., Yamaguchi, T. and Miyata, K. Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model (467) 95 Teramoto, N., see Yunoki, T. (482) 287 Terano, A., see Nakade, Y. (460) 135 Terano, A., see Yoneda, M. (478) 173 Terasawa, K., see Ma, J. (464) 79 Terauchi, T., see Taguchi, R. (477) 195 Terre’Blanche, G., see Geldenhuys, W.J. (458) 73 Terstappen, G., see Carbonnelle, E. (471) 85 Teshirogi, I., see Tomita, Y. (472) 147 Testai, L., see Nieri, P. (459) 75

37

Testai, L., see Nieri, P. (475) 115 Thapaliya, S., Matsuyama, H., El-Mahmoudy, A., Shimizu, Y. and Takewaki, T. An endothelium-derived factor modulates purinergic neurotransmission to mesenteric arterial smooth muscle of hamster (461) 129 Thiemermann, C., see McDonald, M.C. (466) 181 Thiemermann, C., see Collin, M. (476) 257 Thiemermann, C., see Chatterjee, P.K. (482) 271 Thien, T., see Pickkers, P. (466) 281 Thirumalai, S., see Adeagbo, A.S.O. (458) 145 Thomas, A.G., Corse, A.M., Coccia, C.F., Bilak, M.M., Rothstein, J.D. and Slusher, B.S. NAALADase inhibition protects motor neurons against chronic glutamate toxicity (471) 177 Thomas, B.J. and Wanstall, J.C. Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia (477) 153 Thomas, D., see Colvin, R.A. (479) 171 Thomas, N.J., Carcillo, J.A., Herzer, W.A., Mi, Z., Tofovic, S.P. and Jackson, E.K. Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats (465) 133 Thomas, S.S., see Salomone, S. (469) 125 Thompson, M.R., see Cornish, J.L. (482) 339 Thorlacius, H., see Wang, Y. (459) 269 Tigani, B., Di Padova, F., Zurbru¨gg, S., Schaeublin, E., Revesz, L., Fozard, J.R. and Beckmann, N. Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging (482) 319 Tikkanen, I., see Cheng, Z.J. (461) 159 Tiligada, E., see Giannoulaki, V. (481) 119 Tillement, J.-P., see Elimadi, A. (468) 93 Timmerman, H., see Zhang, L. (482) 169 Timo´teo, M.A., Faria, M. and Correia-de-Sa´, P. Endogenous adenosine prevents post-tetanic release facilitation mediated by a3h2 nicotinic autoreceptors (464) 115 Ting, Z., see Xiaochao, M. (461) 89 Tiron, A., see Hefco, V. (474) 227 Tiron, A., see Hefco, V. (475) 55 Tober, C., see Yasar, S. (465) 257 Toda, Y., see Chaki, S. (474) 95 Tofovic, S.P., see Thomas, N.J. (465) 133 Togashi, H., see Matsumoto, M. (482) 177 Togashi, Y., see Umeuchi, H. (477) 29 Tojo, A., see Khamdang, S. (465) 1 Tokita, K., see Kadowaki, M. (458) 197 Tokutomi, N., see Tokutomi, Y. (477) 137 Tokutomi, Y., Okamoto, S., Matsumoto, K., Otagiri, M., Nishi, K. and Tokutomi, N. Effects of a1-acid glycoprotein on isometric tension of mouse aorta (477) 137 Tolomelli, A., see Spampinato, S. (469) 89 Tomasi, A., see Mioni, C. (477) 227 Tomassini, T.C.B., see Soares, M.B.P. (459) 107 Tomaszewska, R., see Dembin´ski, A. (473) 207 Tomaz, C., see Barros, M. (482) 197 Tomimori, Y., Muto, T., Saito, K., Tanaka, T., Maruoka, H., Sumida, M., Fukami, H. and Fukuda, Y. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice (478) 179 Tominaga, K., see Kai, M. (481) 79 Tominaga, M., see Sone, M. (482) 313 Tomita, M., see Hosogai, N. (477) 171

38

Master author index to volumes 458 – 482 (2003)

Tomita, Y., Jyoyama, H., Kobayashi, M., Kuwabara, K., Furue, S., Ueno, M., Yamada, K., Ono, T., Teshirogi, I., Nomura, K., Arita, H., Okayasu, I. and Hori, Y. Role of group IIA phospholipase A2 in rat colitis induced by dextran sulfate sodium (472) 147 Tomoi, M., see Kadowaki, M. (458) 197 Tong, Y.-g., see Tan, W.-f. (459) 255 Topham, M.K., see Riddle, E.L. (458) 31 Torii, S., see Ito, A. (468) 59 Torkaman-Boutorabi, A., see Zarrindast, M.-R. (471) 105 Torkaman-Boutorabi, A., see Zarrindast, M.-R. (473) 19 Torregrosa, G., Burguete, M.C., Pe´rez-Asensio, F.J., Salom, J.B., Gil, J.V. and Alborch, E. Pharmacological profile of phytoestrogens in cerebral vessels: in vitro study with rabbit basilar artery (482) 227 Tosaki, A., see Vecsernyes, M. (470) 177 Toth, G., see Oakley, S.M. (466) 91 Toth, M. 5-HT1A receptor knockout mouse as a genetic model of anxiety (463) 177 Tottori, K., see Nakai, S. (472) 89 Toufexis, D.J., see Walker, D.L. (463) 199 Touret, N., Tanneur, V., Godart, H., Seidler, R., Taki, N., Bu¨rger, E., Da¨mmgen, J. and Counillon, L. Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects (459) 151 Townsend IV, D. and Brown, D.R. Characterization of specific y-opioid binding sites in the distal small intestine of swine (482) 111 Tozawa, R.-i., see Amano, Y. (466) 155 Traupe, T., see Rothermund, L. (468) 209 Trevisani, M., see Harrison, S. (475) 107 Triana, J., see Rivero, A. (482) 77 Troncoso, A.C., see Branda˜o, M.L. (463) 225 Trouslard, J., see Seddik, R. (471) 165 Trudell, M.L., see Nishiyama, T. (470) 27 Truong, J.G., Rau, K.S., Hanson, G.R. and Fleckenstein, A.E. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson’s neurodegeneration (474) 223 Tsai, S.-K., see Liou, K.-T. (475) 19 Tsai, S.-K., see Tsao, C.-M. (477) 183 Tsao, C.-M., Ho, S.-T., Chen, A., Wang, J.-J., Tsai, S.-K. and Wu, C.-C. Propofol ameliorates liver dysfunction and inhibits aortic superoxide level in conscious rats with endotoxic shock (477) 183 Tsao, C.-M., see Liou, K.-T. (475) 19 Tschernig, T., see Ba¨umer, W. (481) 271 Tse, J., see Weiss, H.R. (481) 25 Tseng, L.F., see Mizoguchi, H. (461) 35 Tseng, L.F., see Wu, H.-e. (473) 143 Tsuchida, A., see Tanaka, S. (465) 61 Tsuchida, H. and Ohizumi, Y. (+)-Nantenine isolated from Nandina domestica Thunb. inhibits adrenergic pressor responses in pithed rats (477) 53 Tsuchiya, C., see Nakahata, N. (461) 1 Tsuchiya, Y., Takahashi, Y., Jindo, T., Furuhama, K. and Suzuki, K.T. Comprehensive evaluation of canine renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer (475) 119 Tsukamoto, I., see Nango, R. (471) 1 Tsunekawa, H., see Shimazu, S. (482) 9 Tsuru, H., see Matsushita, M. (482) 235 Tsuruoka, N., see Fujii, T. (474) 261 Tsuruoka, S., see Nishiki, K. (460) 171 Tsushima, H., see Fujimoto, S. (459) 65 Tu, Z., see Ma, X. (461) 89

Tubaro, E., Belogi, L., Mezzadri, C.M. and Bettelli, E. Impact on the bowel of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug (467) 173 Tups, A., see Mercer, J.G. (480) 43 Turchetti, M., see Spisani, S. (469) 13 Turner, E., see Amobi, N. (462) 169 Turner, E., see Amobi, N. (464) 241 Tuzcu, M., see Baydas, G. (462) 67 Tymciu, S., see Wijkhuisen, A. (468) 175 Tzeis, S., see Pantos, C. (460) 155 Tzeis, S., see Pantos, C. (478) 53 Tzu, N.-H., see Hsiao, G. (465) 281 Uberti, M.A., see Pupo, A.S. (462) 1 Uchida, R., Yamazaki, J. and Kitamura, K. Characterization of Ca2+ current inhibition by cilnidipine using a h-subunit antisense oligonucleotide (466) 53 Uchiyama, K., see Inoue, K.-i. (481) 261 Uchiyama, T., see Tanihata, S. (461) 197 Uddman, E., Henriksson, M., Eskesen, K. and Edvinsson, L. Role of mitogen-activated protein kinases in endothelin ETB receptor up-regulation after organ culture of rat mesenteric artery (482) 39 Uehara, T., Kurata, K., Sumiyoshi, T. and Kurachi, M. Immobilization stress-induced increment of lactate metabolism in the basolateral amygdaloid nucleus is attenuated by diazepam in the rat (459) 211 Uehata, M., see Nakajima, M. (459) 113 Uematsu, T., see Niwa, M. (466) 245 Ueno, K.-i., see Matsumoto, M. (482) 177 Ueno, M., see Tomita, Y. (472) 147 Ueyama, J., see Kitaichi, K. (464) 39 Ueyama, N., see Katsuta, K. (467) 103 Ugarte, Y.V., Rau, K.S., Riddle, E.L., Hanson, G.R. and Fleckenstein, A.E. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors (472) 165 Uhl, G.R. and Lin, Z. The top 20 dopamine transporter mutants: structure – function relationships and cocaine actions (479) 71 Ukil, A., see Maity, S. (470) 103 Ullmer, C., see Simmen, U. (458) 251 Ulus, I.H., see Savci, V. (468) 129 Umemura, K., see Katsuta, K. (467) 103 Umeuchi, H., Togashi, Y., Honda, T., Nakao, K., Okano, K., Tanaka, T. and Nagase, H. Involvement of central A-opioid system in the scratching behavior in mice, and the suppression of it by the activation of n-opioid system (477) 29 ¨ n, I˙., see Bu¨yu¨kafsßar, K. (459) 263 U ¨ n, ˙I., see Bu¨yu¨kafsßar, K. (472) 235 U Unemoto, T., Honda, H. and Kogo, H. Differences in the mechanisms for relaxation of aorta induced by 17hestradiol or progesterone between normotensive and hypertensive rats (472) 119 Unger, T., see Sandmann, S. (458) 3 Urbain, N., see Astier, B. (459) 17 Utsunomiya, I., see Abe, K. (465) 237 Uwahodo, Y., see Nakai, S. (472) 89 ¨ . and Demiryu¨rek, A.T. Uzun, O Nuclear factor-nB inhibitors abolish hypoxic vasoconstriction in sheepisolated pulmonary arteries (458) 171 Valadares, M.C., Klein, S.I., Guaraldo, A.M.A. and Queiroz, M.L.S. Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour (473) 191

Master author index to volumes 458 – 482 (2003) Valenzuela, C.F., see Carta, M. (459) 167 Van Amsterdam, C., see Bartoszyk, G.D. (473) 229 Van Bogaert, P.P. and Pittoors, F. Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine (478) 161 Van Boogaert, M., see Olivier, B. (463) 117 Van de Kar, L.D., see Carrasco, G.A. (463) 235 Van den Buuse, M. Acute effects of antipsychotic drugs on cardiovascular responses to stress (464) 55 Van der Gugten, J., see Olivier, B. (463) 117 Van der Gugten, J., see Groenink, L. (463) 185 Van der Kant, P.A.A., see Smit, J.J. (470) 193 Van der Kleij, H.P.M., Kraneveld, A.D., Redegeld, F.A.M., Gerard, N.P., Morteau, O. and Nijkamp, F.P. The tachykinin NK1 receptor is crucial for the development of nonatopic airway inflammation and hyperresponsiveness (476) 249 Van der Ploeg, L.H.T., see Shearman, L.P. (475) 37 Van der Schyf, C.J., see Geldenhuys, W.J. (458) 73 Van der Stelt, M. and Di Marzo, V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders (480) 133 Van Dijk, G., de Vries, K., Benthem, L., Nyakas, C., Buwalda, B. and Scheurink, A.J.W. Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity (480) 31 Van Duivenvoorde, L.M., see Bueters, T.J.H. (481) 141 Van Elburg, A.A., see Kas, M.J.H. (480) 13 Van Engeland, H., see Kas, M.J.H. (480) 13 Van Helden, H.P.M., see Harrison, P.K. (471) 97 Van Helden, H.P.M., see Bueters, T.J.H. (481) 141 Van Herle, A., see Bruemmer, D. (462) 15 Van Loveren, H., see Smit, J.J. (470) 193 Van Oorschot, R., see Olivier, B. (463) 117 Van Overveld, F.J., Demkow, U.A., Go´recka, D., Zielinski, J. and De Backer, W.A. Inhibitory capacity of different steroids on neutrophil migration across a bilayer of endothelial and bronchial epithelial cells (477) 261 Van Rijn, C.M. and Willems-van Bree, E. Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex (464) 95 Van Zwieten, P.A., see Nap, A. (469) 117 Vandeputte, C., Aiden McCormick, P. and Docherty, J.R. Responsiveness to noradrenaline in aorta from wild-type, nitric oxide synthase-2, nitric oxide synthase-3 and a2A/D-adrenoceptor knockout mice (466) 129 Vanderheyden, P.M.L., see Caballero-George, C. (458) 257 Vannacci, A., Baronti, R., Zagli, G., Marzocca, C., Pierpaoli, S., Bani, D., Passani, M.B., Mannaioni, P.F. and Masini, E. Carbon monoxide modulates the response of human basophils to FcqRI stimulation through the heme oxygenase pathway (465) 289 Vapaatalo, H., see Cheng, Z.J. (461) 159 Varalakshmi, P., see Deepa, P.R. (478) 199 Varani, K., see Spisani, S. (469) 13 Varga, E.V., see Okura, T. (459) 9 Varney, M.A., see Anderson, J.J. (473) 35 Varonos, D., see Pantos, C. (460) 155 Varonos, D.D., see Pantos, C. (478) 53 Varro´, A., see Taka´cs, J. (470) 163 Vauquelin, G., see Caballero-George, C. (458) 257 Vecsernyes, M., Juhasz, B., Der, P., Kocsan, R., Feher, P., Bacskay, I., Kovacs, P. and Tosaki, A. The administration of a-melanocyte-stimulating hormone protects the ischemic/reperfused myocardium (470) 177 Vedasiromoni, J.R., see Maity, S. (470) 103 Vedder, H., see Heiser, P. (476) 167

39

Veening, J., see Olivier, B. (463) 117 Vemuri, M.C., see Rajgopal, Y. (470) 117 Vergely, C., see Oudot, A. (462) 145 Vertongen, P., see Gillard, M. (478) 1 Vertongen, P., see Fuks, B. (478) 11 Vetulani, J., see Antkiewicz-Michaluk, L. (466) 263 Vidhyalakshmi, S., see Srinivas, G. (473) 117 Vieira-Coelho, M.A., see Bonifa´cio, M.J. (460) 163 Vijayan, V.K., see Masood, A. (458) 135 Vijverberg, H., see Carbonnelle, E. (471) 85 Villain, M., see Ten Broeke, R. (476) 151 Villalo´n, C.M., see Kapoor, K. (475) 69 Villalo´n, C.M., see Perusquı´a, M. (475) 161 Villanu´a, M.A., see Iba´n˜ez de Ca´ceres, I. (481) 293 Villegas, I., La Casa, C., Orjales, A. and Alarco´n de la Lastra, C. Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats (460) 209 Villegas, I., see Martı´n, A.R. (481) 281 Vira´g, L., see Taka´cs, J. (470) 163 Visentin, V., Pre´vot, D., Martin, L. and Carpe´ne´, C. Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates (466) 235 Vizi, E.S., see Selmeczy, Z. (469) 175 Vladimirova, I., see Ribeiro, R.d.A. (470) 37 Vlietinck, A., see Caballero-George, C. (458) 257 Vogelaar, C.F., Hoekman, M.F.M., Gispen, W.H. and Burbach, J.P.H. Homeobox gene expression in adult dorsal root ganglia during sciatic nerve regeneration: is regeneration a recapitulation of development? (480) 233 Voigt, K., see Hagner, S. (481) 147 Voinea, M., see Manduteanu, I. (477) 269 Volkov, L., see Eric, J. (475) 129 Volsen, S.G., see Evans, N.M. (466) 31 Vonhof, S., Gudka, B.D. and Sire´n, A.-L. Tolerance and dependence following chronic intracerebroventricular infusions of Tyr-D-Arg2-Phe-Sar4 (TAPS) (459) 41 Vonhof, S., Feuerstein, G. and Sire´n, A.-L. Characterization of binding kinetics of [3H]Tyr-D-Arg2-Phe-Sar4 at opioid receptors (473) 127 Vosele, K., see Arsenyan, P. (465) 229 Voss, J., Sanchez, C., Michelsen, S. and Ebert, B. Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance (482) 215 Voutilainen-Myllyla¨, S., Tavi, P. and Weckstro¨m, M. Chelerythrine and bisindolylmaleimide I prolong cardiac action potentials by protein kinase C-independent mechanism (466) 41

Wada, K., see Huang, S.H. (464) 1 Waddington, J.L., see Wong, J.Y.F. (472) 39 Waddington, J.L., see Adachi, K. (473) 47 Wadsworth, R.M., see Kennedy, S. (481) 101 Waeber, C., see Salomone, S. (469) 125 Wafford, K.A., see Mortensen, M. (476) 17 Wahlestedt, C., see Salmi, P. (458) 101 Wai, M.K., see Sam, T.S.W. (472) 135 Wai, M.-K., see Kan, K.K.W. (482) 297 Wainwright, C.L., see Kennedy, S. (481) 101 Wakabayashi, I., Marumo, M. and Sotoda, Y. Diverse effects of monensin on capacitative Ca2+ entry and release of stored Ca2+ in vascular smooth muscle cells (464) 27 Wakatsuki, A., see Okatani, Y. (465) 163 Wakatsuki, A., see Okatani, Y. (469) 145 Wakaumi, M., see Nishiki, K. (460) 171 Wakino, S., see Bruemmer, D. (466) 225

40

Master author index to volumes 458 – 482 (2003)

Wakitani, K., see Okamoto, H. (466) 147 Wala, E.P., see Holtman Jr., J.R. (470) 149 Walker, D.L., Toufexis, D.J. and Davis, M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety (463) 199 Walker, J., see Adeagbo, A.S.O. (458) 145 Wallace, P., see Gibson, A. (471) 213 Wallace, R., see Mabley, J. (466) 323 Wallin, B., see Axelsson, L.-G. (467) 211 Walline, C.C., see Roman, D.L. (479) 53 Walters, M.J., see Stanford, S.J. (473) 135 Wang, D., see Tassorelli, C. (464) 159 Wang, G., see Liu, S. (459) 27 Wang, H., see Kang, J. (458) 25 Wang, H., see Ma, X. (461) 89 Wang, H., see Laubinger, W. (468) 9 Wang, H.L., see Li, Y.F. (469) 81 Wang, J., see Min, J.-Y. (471) 41 Wang, J.-F., see Min, J.-Y. (471) 41 Wang, J.-J., see Tsao, C.-M. (477) 183 Wang, J.-P. GEA3162 stimulates Ca2+ entry in neutrophils (458) 243 Wang, P.S., see Kan, S.-F. (468) 141 Wang, S.-J. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes (469) 47 Wang, X., see Liu, S. (459) 27 Wang, Y., see Adeagbo, A.S.O. (458) 145 Wang, Y., see Fukushima, Y. (468) 47 Wang, Y., see Han, B. (474) 15 Wang, Y., Liu, Q. and Thorlacius, H. Docosahexaenoic acid inhibits cytokine-induced expression of P-selectin and neutrophil adhesion to endothelial cells (459) 269 Wang, Y.-M., see Zhang, L.-R. (462) 9 Wang, Z.J., Tang, L. and Xin, L. Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca2+/calmodulin-dependent protein kinase II (465) 199 Wangemann, T., Giessler, C., Willmy-Matthes, P., Silber, R.-E. and Brodde, O.-E. The indirect negative inotropic effect of carbachol in h1-adrenoceptor antagonist-treated human right atria (458) 163 Wanstall, J.C., see Awabdy, D. (459) 1 Wanstall, J.C., see Thomas, B.J. (477) 153 Wanstall, J.C., see Homer, K.L. (482) 265 Ward, M.E., see Jiang, J. (481) 133 Warzecha, Z., see Dembin´ski, A. (473) 207 Watanabe, K., see Aoki, K. (459) 131 Watanabe, M., see Tanaka, K. (466) 191 Watanabe, M.A.E., Souza, L.R., Murad, J.M. and De Lucca, F.L. Antitumor activity induced by regulatory RNA: possible role of RNA-dependent protein kinase and nuclear factor-nB (465) 205 Watanabe, T., see Sugimoto, Y. (470) 113 Watanobe, H., see Nakade, Y. (460) 135 Watanobe, H., see Yoneda, M. (478) 173 Watson, D.G., see Aoun, P. (472) 65 Wattie, J., see Janssen, L.J. (475) 93 Waxemberg, M.D., see Goutman, J.D. (461) 79 Wayman, N.S., see McDonald, M.C. (466) 181 Webster, J.M., Bentley, M.T. and Wojcikiewicz, R.J.H. N,N,NV ,NV-Tetrakis(2-pyridylmethyl)ethylenediamine inhibits ligand binding to certain G protein-coupled receptors (474) 1 Weckstro¨m, M., see Voutilainen-Myllyla¨, S. (466) 41 Wei, E., see Zhang, L. (482) 169 Wei, T., see Zhang, Z. (467) 41

Weinstein, H., see Goldberg, N.R. (479) 3 Weiss, H.R., Lazar, M.J., Punjabi, K., Tse, J. and Scholz, P.M. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes (481) 25 Weizman, T., Pick, C.G., Backer, M.M., Rigai, T., Bloch, M. and Schreiber, S. The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms (478) 155 Welte, T., see Laubinger, W. (468) 9 Wenzel, F., see Koschorreck, S. (471) 229 Weso»owska, A., Paluchowska, M. and Chojnacka-Wo´jcik, E. Involvement of presynaptic 5-HT1A and benzodiazepine receptors in the anticonflict activity of 5-HT1A receptor antagonists (471) 27 Westenberg, H.G.M., see De Groote, L. (476) 71 Westkaemper, R.B., see Peddi, S. (482) 335 Wettstein, J.G., see Petty, M.A. (474) 53 Wheeler, W.J., see Statnick, M.A. (482) 139 Whelan, C., see Ihenetu, K. (464) 207 Whelan, C.J., see Ihenetu, K. (458) 207 Whittle, B.J.R., see Evans, S.M. (461) 63 Wiesenfeld-Hallin, Z., see Wu, W.-P. (478) 131 Wiesenfeld-Hallin, Z., see Wu, W.-P. (482) 133 Wijkhuisen, A., Tymciu, S., Fischer, J., Alexandrenne, C., Cre´minon, C., Frobert, Y., Grassi, J., Boquet, D., Conrath, M. and Couraud, J.-Y. Pharmacological properties of peptides derived from an antibody against the tachykinin NK1 receptor for the neuropeptide substance P (468) 175 Wikstro¨m, H., see Klintenberg, R. (459) 231 Wiley, J.L. and Martin, B.R. Cannabinoid pharmacological properties common to other centrally acting drugs (471) 185 Wilkins, D.G., see Johnson-Davis, K.L. (482) 151 Willems, E.W., see Kapoor, K. (475) 69 Willems-van Bree, E., see Van Rijn, C.M. (464) 95 Williams, J.B., Keenan, S.M., Gan, Q. and Knuepfer, M.M. Hemodynamic response profile predicts susceptibility to cocaineinduced toxicity (464) 189 Willmy-Matthes, P., see Wangemann, T. (458) 163 Wiltgen, B.J., see Sanders, M.J. (463) 217 Winger, G., see McMahon, L.R. (466) 113 Wingrove, P., see Mortensen, M. (476) 17 Wirkner, K., see Borvendeg, S.J. (474) 71 Wise, A., see Gonza´lez-Maeso, J. (481) 15 Wise, H., see Chow, K.B.S. (474) 7 Witchel, H.J., see Belsey, M.J. (474) 185 Witkin, J.M., see Kaminski, R.M. (474) 217 Wlaz´, P., see Lo¨scher, W. (466) 99 Wojcikiewicz, R.J.H., see Webster, J.M. (474) 1 Wolber, C., see Fozard, J.R. (475) 79 Wolff, M.C. and Leander, J.D. SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task (477) 213 Wong, B.C.Y., see Cho, C.H. (460) 177 Wong, C.S.S., Ho, M.K.C. and Wong, Y.H. The h6/a5 regions of Gai2 and GaoA increase the promiscuity of Ga16 but are insufficient for pertussis toxin-catalyzed ADP-ribosylation (473) 105 Wong, J.Y.F., Clifford, J.J., Massalas, J.S., Finkelstein, D.I., Horne, M.K., Waddington, J.L. and Drago, J. Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice (472) 39 Wong, S., see Cornish, J.L. (482) 339 Wong, S.K.-F., see Ramirez, A.D. (475) 29 Wong, T.M., see Cho, C.H. (460) 177

Master author index to volumes 458 – 482 (2003) Wong, T.-M., see Xiao, G.-S. (473) 97 Wong, Y.H., see Wong, C.S.S. (473) 105 Wood, J.D., see Liu, S. (459) 27 Wood, J.D., see Liu, S. (471) 49 Woolverton, W.L., see McMahon, L.R. (466) 113 Woon Lee, J., see Hama, A. (459) 49 Wotjak, C.T., see Henniger, M.S.H. (470) 33 Wotjak, C.T., see Henniger, M.S.H. (473) 231 Wu, C.-C., see Tsao, C.-M. (477) 183 Wu, D.-Z., see Fan, Y. (481) 33 Wu, H., see Lamb, R.J. (470) 157 Wu, H.-e., Sun, H.-S., Darpolar, M., Dunn III, W. and Tseng, L.F. Antinociceptive properties of oxymorphazole in the mouse (473) 143 Wu, J.-C., Fong, W.-F., Zhang, J.-X., Leung, C.-H., Kwong, H.-L., Yang, M.-S., Li, D. and Cheung, H.-Y. Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani (473) 9 Wu, K.K., see Cho, C.H. (460) 177 Wu, S., see Cho, C.H. (460) 177 Wu, S.-N., see Liu, Y.-C. (458) 37 Wu, W.-P., Hao, J.-X., Xu, X.-J., Wiesenfeld-Hallin, Z., Koek, W. and Colpaert, F.C. The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury (478) 131 ¨ ., Wu, W.-P., Hao, J.-X., Lundstro¨m, L., Weisenfeld-Hallin, Z., Langel, U Bartfai, T. and Xu, X.-J. Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury (482) 133 Wu, X.-j., see Qiu, Y. (468) 1 Xia, Y., see Liu, S. (459) 27 Xia, Y., see Liu, S. (471) 49 Xiang, Z., see Holder, J.R. (462) 41 Xiao, D., see Tan, W.-f. (459) 255 Xiao, G.-S., Zhou, J.-J., Cheung, Y.-F., Li, G.-R. and Wong, T.-M. Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes (473) 97 Xiao, Y. and Liang, S. Inhibition of neuronal tetrodotoxin-sensitive Na+ channels by two spider toxins: hainantoxin-III and hainantoxin-IV (477) 1 Xiaochao, M., Haixue, W., Jian, X., Ting, Z. and Zenghong, T. Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A (461) 89 Xin, L., see Wang, Z.J. (465) 199 Xin, W., see Zhang, Z. (467) 41 Xu, H.-B., see Gan, L. (471) 217 Xu, X.-J., see Erichsen, H.K. (458) 275 Xu, X.-J., see Wu, W.-P. (478) 131 Xu, X.-J., see Wu, W.-P. (482) 133

Yagil, C., see Rothermund, L. (468) 209 Yagil, Y., see Rothermund, L. (468) 209 Yakubu, M., see Sofola, O. (474) 241 Yamada, H., see Ohmori, K. (471) 69 Yamada, K., see Tomita, Y. (472) 147 Yamada, K., see Hefco, V. (474) 227 Yamada, K., see Hefco, V. (475) 55 Yamada, N., see Ma, J. (464) 79 Yamada, S., see Nakai, S. (472) 89 Yamagami, K., see Hirayama, Y. (467) 197 Yamagishi, K., Mishima, K., Ohgami, Y., Iwasaki, K., Jimbo, M., Masuda, H., Igarashi, Y., Inokuchi, J.-i. and Fujiwara, M. A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia (462) 53

41

Yamaguchi, K., see Ayada, K. (460) 63 Yamaguchi, N., see Matsui, S. (469) 165 Yamaguchi, T., see Terai, K. (467) 95 Yamakawa, T., Tanaka, S.-i., Kamei, J., Kadonosono, K. and Okuda, K. Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells (478) 39 Yamaki, K., see Inoue, K.-i. (481) 261 Yamamoto, A., see Ohmori, K. (471) 69 Yamamoto, H., see Nishiki, K. (460) 171 Yamamoto, H., see Sone, M. (482) 313 Yamamoto, T., Hanioka, N., Maeda, Y., Imazumi, K., Hamada, K., Matsuo, M., Manda, T. and Mutoh, S. Contribution of tachykinin receptor subtypes to micturition reflex in guinea pigs (477) 253 Yamamoto, T., Saito, O., Shono, K. and Hirasawa, S. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test (481) 175 Yamamura, H.I., see Okura, T. (459) 9 Yamanaka, T., see Kato, Y. (473) 163 Yamashita, H., see Horiike, O. (464) 75 Yamashita, J., see Ogata, M. (478) 187 Yamashita, K., see Yoshida, A. (470) 99 Yamashita, T., see Hayashi, K.-i. (482) 305 Yamauchi, A., see Kai, M. (481) 79 Yamazaki, J., see Uchida, R. (466) 53 Yan, Q.-S. Involvement of non-exocytotic mechanisms in ethanol-induced in vivo dopamine release: comparisons with cocaine (477) 37 Yanagisawa, R., see Inoue, K.-i. (481) 261 Yanagisawa, T., see Kawamata, M. (472) 229 Yang, H.O., see Lee, Y.S. (465) 191 Yang, J., see Chang, L. (473) 171 Yang, M.-S., see Wu, J.-C. (473) 9 Yang, W., Benjamin, I.S., Moore, K., Portmann, B. and Alexander, B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat (461) 41 Yang, X.-P. and Chiba, S. Interaction between neuropeptide Y Y1 receptors and a1B-adrenoceptors in the neurovascular junction of canine splenic arteries (466) 311 Yano, M., see Kitamura, H. (465) 31 Yao, B.B., Sharma, R., Cassar, S., Esbenshade, T.A. and Hancock, A.A. Cloning and pharmacological characterization of the monkey histamine H3 receptor (482) 49 Yasar, A., see Baydas, G. (462) 67 Yasar, S., Bergman, J., Munzar, P., Redhi, G., Tober, C., Knebel, N., Zschiesche, M. and Paronis, C. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys (465) 257 Yasuda, A., see Ohmori, K. (471) 69 Yasuda, N., Inoue, T., Horizoe, T., Nagata, K., Minami, H., Kawata, T., Hoshino, Y., Harada, H., Yoshikawa, S., Asano, O., Nagaoka, J., Murakami, M., Abe, S., Kobayashi, S. and Tanaka, I. Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes (459) 159 Yatsu, T., Kurosawa, H., Hayashi, M. and Satoh, S. The role of Ca2+ in the control of renin release from dog renal cortical slices (458) 191 Yatsu, T., Aoki, M. and Inagaki, O. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats (461) 191 Yatsugi, S.-i., see Terai, K. (467) 95 Yau-Chik Shum, A., see Chiou, W.-F. (458) 217 Yavich, L., Sirvio¨, J., Haapalinnaa A., Ylinen, A. and Ma¨nnisto¨, P.T. Atipamezole, an a2-adrenoceptor antagonist, augments the effects of LDOPA on evoked dopamine release in rat striatum (462) 83

42

Master author index to volumes 458 – 482 (2003)

Yazdi, M.T., see Ce´le´rier, E. (465) 69 Ye, B., see Zhang, L. (482) 169 Ye, F., see Qin, X.-P. (464) 63 Ye, Y.N., see Cho, C.H. (460) 177 Yerbury, S., see Fredrickson, P. (458) 111 Yeung, J.H.K., see Sam, T.S.W. (466) 163 Yeung, J.H.K., see Sam, T.S.W. (472) 135 Yildirim, S., see Kilicarslan, H. (462) 155 Yilmaz, A., see Kreier, F. (480) 51 Yilmaz, M.S., see Savci, V. (468) 129 Yin, F., see Bruemmer, D. (462) 15 Ylinen, A., see Yavich, L. (462) 83 Yokohama, S., see Nakade, Y. (460) 135 Yokohama, S., see Yoneda, M. (478) 173 Yokota, T., Matsui, H., Matsuura, B., Maeyama, K. and Onji, M. Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells (481) 233 Yokotani, K., Nakamura, K. and Okada, S. Prostanoid EP3 and TP receptors-mediated inhibition of noradrenaline release from the isolated rat stomach (459) 187 Yokotani, K., see Okada, S. (467) 125 Yokotani, K., see Nakamura, K. (470) 73 Yokotani, K., see Okada, S. (473) 217 Yokotani, K., see Okada, S. (475) 49 Yokotani, K., see Okada, S. (477) 95 Yonaga, M., see Taguchi, R. (477) 195 Yoneda, F., see Takahata, K. (458) 81 Yoneda, F., see Shimazu, S. (482) 9 Yoneda, M., see Nakade, Y. (460) 135 Yoneda, M., Sato, Y., Nakamura, K., Yokohama, S., Kono, T., Watanobe, H. and Terano, A. Involvement of calcitonin gene-related peptide and capsaicin-sensitive afferents in central thyrotropin-releasing hormone-induced hepatic cytoprotection (478) 173 Yonemori, F., see Okamoto, H. (466) 147 Yonemori, F., see Ohta, T. (476) 159 Yoneyama, M., see Takahara, A. (460) 51 Yoo, S.-E., see Kim, K.Y. (465) 219 Yorozuya, T., see Mitsuyo, T. (465) 267 Yoshida, A., Sakurai-Yamashita, Y., Yamashita, K., Tanaka, N. and Taniyama, K. Role of endothelin ETA and ETB receptors in the guinea-pig urinary bladder contraction (470) 99 Yoshida, J., Ishibashi, T. and Nishio, M. Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cells (472) 23 Yoshida, M., see Onai, Y. (481) 217 Yoshida, T., see Tanaka, S. (465) 61 Yoshikawa, M., see Matsuda, H. (471) 59 Yoshikawa, S., see Yasuda, N. (459) 159 Yoshikawa, T., see Inoue, K.-i. (481) 261 Yoshimura, S.-i., see Salomone, S. (469) 125 Yoshinaga, M., Sunagawa, M., Shimada, S., Nakamura, M., Murayama, S. and Kosugi, T. Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells (461) 9 Yoshinaga, M., Sunagawa, M., Shimada, S., Nakamura, M., Murayama, S. and Kosugi, T. Erratum to ‘‘Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells’’ [Eur. J. Pharmacol. 461 (2003) 9 – 17] (465) 203 Yoshinari, M., see Sonoki, K. (475) 139 Yoshino, S., see Inoue, K.-i. (481) 261 Yoshioka, M., see Matsumoto, M. (482) 177 Young, R., see Bondarev, M.L. (474) 85 Yu, S., see Zhang, Z. (467) 41

Yu, Y. and Koss, M.C. Functional characterization of a-adrenoceptors mediating pupillary dilation in rats (471) 135 Yuan, Z., Iida, H., Inoue, N., Ishikawa, Y. and Ishida, H. Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice (464) 197 Yunoki, M., Nakahara, T., Mitani, A., Maruko, T., Kubota, Y., Sakamoto, K. and Ishii, K. Lidocaine attenuates muscarinic receptor-mediated inhibition of adenylyl cyclase in airway smooth muscle (470) 65 Yunoki, T., Teramoto, N., Takano, N., Seki, N., Creed, K.E., Naito, S. and Ito, Y. The effects of MCC-134 on the ATP-sensitive K+ channels in pig urethra (482) 287 Yuyama, H., Sanagi, M., Koakutsu, A., Mori, M., Fujimori, A., Harada, H., Sudoh, K. and Miyata, K. Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist (478) 61

Zaagsma, J., see Gosens, R. (481) 125 Zabielski, R., see Konturek, S.J. (481) 1 Zagli, G., see Vannacci, A. (465) 289 Zahniser, N.R., see Gulley, J.M. (479) 139 Zanardo, R.C.O., Cruz, J.W.M.C., Martinez, L.L., de Oliveira, M.Ap. and Fortes, Z.B. Probucol restores the defective leukocyte – endothelial interaction in experimental diabetes (478) 211 Zanchet, E.M. and Cury, Y. Peripheral tackykinin and excitatory amino acid receptors mediate hyperalgesia induced by Phoneutria nigriventer venom (467) 111 Zanetti, E., see Giaroni, C. (476) 63 Zangrossi Jr., H., see Zanoveli, J.M. (473) 153 Zanoveli, J.M., Nogueira, R.L. and ZangrossiJr., H. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze (473) 153 Zapata-Sudo, G., Sudo, R.T., Maronas, P.A., Silva, G.L.M., Moreira, O.R., Aguiar, M.I.S. and Barreiro, E.J. Thienylhydrazone derivative increases sarcoplasmic reticulum Ca2+ release in mammalian skeletal muscle (470) 79 Zarrindast, M.-R., see Gholami, A. (458) 119 Zarrindast, M.-R., Assadi, E., Oryan, S., Torkaman-Boutorabi, A. and Sahebgharani, M. Influence of histamine, cimetidine and pyrilamine on naloxone-induced jumping in morphine-dependent mice (471) 105 Zarrindast, M.-R. and Torkaman-Boutorabi, A. Effects of imipramine on the expression and development of morphine dependence in mice (473) 19 Zarrindast, M.-R., Gholami, A., Sahraei, H. and Haeri-Rohani, A. Role of nitric oxide in the acquisition and expression of apomorphineor morphine-induced locomotor sensitization (482) 205 Zarrindast, M.-R., see Eidi, M. (465) 91 Zeng, J., see Reinscheid, R.K. (478) 27 Zeng, Y., see Lesch, K.P. (480) 185 Zenghong, T., see Xiaochao, M. (461) 89 Zethof, T., see Olivier, B. (463) 117 Zhai, H., Nakade, K., Mitsumoto, Y. and Fukuyama, Y. Honokiol and magnolol induce Ca2+ mobilization in rat cortical neurons and human neuroblastoma SH-SY5Y cells (474) 199 Zhang, J.-X., see Wu, J.-C. (473) 9 Zhang, J.Y., Nawoschik, S., Kowal, D., Smith, D., Spangler, T., Ochalski, R., Schechter, L. and Dunlop, J. Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein (472) 33

Master author index to volumes 458 – 482 (2003) Zhang, L., Chen, Z., Ren, K., Leurs, R., Chen, J., Zhang, W., Ye, B., Wei, E. and Timmerman, H. Effects of clobenpropit on pentylenetetrazole-kindled seizures in rats (482) 169 Zhang, L.-R., Li, M.-H., Cheng, N.-N., Chen, B.-Y. and Wang, Y.-M. Inhibition by fluoroquinolones of K+ currents in rat dissociated hippocampal neurons (462) 9 Zhang, Q., Li, J.-X., Zheng, J.-W., Liu, R.-K. and Liang, J.-H. L-type Ca2+ channel blockers inhibit the development but not the expression of sensitization to morphine in mice (467) 145 Zhang, R.-Z., see Shan Au, A.L. (468) 199 Zhang, S., see Dutta, A.K. (479) 93 Zhang, S.-H., see Gan, L. (471) 217 Zhang, T., see Ma, X. (461) 89 Zhang, W., see Zhang, L. (482) 169 Zhang, X.-H., Matsuda, N., Jesmin, S., Sakuraya, F., Gando, S., Kemmotsu, O. and Hattori, Y. Normalization by edaravone, a free radical scavenger, of irradiationreduced endothelial nitric oxide synthase expression (476) 131 Zhang, Y., Cao, E.-H., Liang, X.-Q. and Qin, J.-F. Increasing sensitivity to arsenic trioxide-induced apoptosis by altered telomere state (474) 141 Zhang, Y.-H., Chen, Y. and Zhao, Z.-Q. Resiniferatoxin reversibly blocks adjuvant-induced thermal hyperalgesia in the rat (481) 301 Zhang, Y.-X., see Tan, W.-f. (459) 255 Zhang, Z., Wei, T., Hou, J., Li, G., Yu, S. and Xin, W. Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid (467) 41 Zhang, Z., see Chang, L. (473) 171 Zhao, C.-H., see Chen, X.-C. (473) 1 Zhao, J., see Chang, L. (473) 171 Zhao, Y.-L., see Kitaichi, K. (464) 39 Zhao, Z.-Q., see Li, S. (481) 203

43

Zhao, Z.-Q., see Zhang, Y.-H. (481) 301 Zheng, J.-W., see Zhang, Q. (467) 145 Zhou, D., see Shearman, L.P. (475) 37 Zhou, J.-J., see Xiao, G.-S. (473) 97 Zhou, J.-Y., see Fan, Y. (481) 33 Zhou, W., see Zhu, H. (467) 141 Zhou, Y.-C., see Chen, X.-C. (473) 1 Zhu, B.-M., Miyamoto, S., Nagasawa, Y., Saitoh, M., Komori, S. and Hashimoto, K. Does Cl /HCO3 exchange play an important role in reperfusion arrhythmias in rats? (460) 43 Zhu, H. and Zhou, W. Morphine-induced potentiation in the dentate gyrus of the hippocampus involves norepinephrine (467) 141 Zhu, L.-A., see Chen, X.-C. (473) 1 Zhu, Y.-G., see Chen, X.-C. (473) 1 Zı´dek, Z., Potmeˇsˇil, P., Kmonı´e`kova´, E. and Holy´, A. Immunobiological activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, and 2,6-diaminopurines (475) 149 Ziegler, A., see Roloff, T. (478) 81 Zielinski, J., see van Overveld, F.J. (477) 261 Zingarelli, B., O’Connor, M. and Hake, P.W. Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis (469) 183 Zizzo, M.G., see Serio, R. (460) 183 Zong, Z.-P., see Matsui, S. (469) 165 Zschiesche, M., see Yasar, S. (465) 257 Zsuga, J., see Benko }, I. (477) 179 Zurbru¨gg, S., see Tigani, B. (482) 319 Zvartau, E., see Sevostianova, N. (462) 109 Zwart, R., see Evans, N.M. (466) 31 Zwart, R., see Carbonnelle, E. (471) 85